RESOLUTIONS ADOPTED BY THE BOARD OF VISITORS

SEPTEMBER 14-15, 2017


PAGE

Resolution to Approve Additional Agenda Items 10449

Election of the Ninth President of the University of Virginia 10450

Intent to Adopt University Regulation on Open Burn and Open Flame

Operations at the University of Virginia 10453

Recognition of Academical Village as University Facility 10454

Resolution with Respect to Civil War Tablets 10457

Election of the Executive Committee for 2017-2018 10460

Setting the Date of the 2018 Annual Meeting of the Board 10460

Setting the Dates of the 2020 and 2021 Board Meetings 10460

Resolution for Exclusion of Certain Directors and Officers – September 2017 10461

Addition to the Manual of the Board of Visitors on Appointing a Nonvoting Faculty

Representative and Amendment to Provision on Appointing a Nonvoting

Student Representative 10462

Commending Resolution for Kevin J. Fay 10463

Commending Resolution for Frank E. Genovese 10464

Commending Resolution for William H. Goodwin Jr. 10465

Approval of the Gifts and Grants Report 10466

Revised Enterprise Risk Management Charter 10471

Athletics Compliance Charter 10471

Naming of the Total Advising Center as Dathel and John Georges Student Center 10472

Renaming Lewis House as Yen House 10472

Demolition of 1939 Ivy Road 10472

Amendment to the Capital Project Procurement Process 10473

Signatory Authority Related to Change in Group Purchasing Organization 10473

Plaque Commemorating the University’s Bicentennial 10473

Revision to the 2017 Capital Plan – Baseball Stadium Expansion, Revised Scope 10474

Signatory Authority for Contracts Related to Security Recommendations 10474

Disposition of Real Property – Davis Estate Located at 700 Edwin Drive,

Virginia Beach, Virginia 10474

2018-2024 Six-Year Institutional Plans for the Academic Division and the

College at Wise 10475

State Operating Budget Requests for the 2018-20 Biennium for the Academic

Division and The University of Virginia’s College at Wise 10476

Issuance of General Revenue Pledge Bonds 10476

Establishment of the Kenneth G. Elzinga Professorship in Economics and the Law 10479

Establishment of a Second James R. Schlesinger Distinguished Professorship at

the Miller Center of Public Affairs 10479

Policy on the Administration of Athletics and the Athletics Advisory Council 10480

Formation of a Statewide Pediatric Clinically Integrated Network 10480

Use of Private Funds to Defray Concert for Charlottesville Expenses 10481

Faculty Personnel Actions 10481



PAGE

Elections 10481

Correction to the Election of Mr. Melur K. Ramasubramanian 10490

Actions Relating to Chairholders 10490

Election of Chairholders 10490

Promotion of Chairholder 10493

Change of Title of Chairholder 10493

Special Salary Actions of Chairholders 10493 Resignation of Chairholder 10494 Retirements of Chairholders 10494

Promotions 10494

Special Salary Actions 10494

Resignations 10495

Retirements 10496

Election of Professor Emeriti 10496

Election of Associate Professor Emeriti 10497

Deaths 10497


The University of Virginia’s College at Wise Appointments

Election 10497

Promotions 10497



Resolutions Not Requiring Action by the Full Board:

Resolutions Approved by the Health System Board on September 13, 2017:

Approved September 13, 2017 10500


Resolutions Approved by the Committee on The University of Virginia’s College at Wise on September 14, 2017:

PAGE

Resolutions Approved by the Buildings and Grounds Committee on

September 14, 2017:


Resolutions Approved by the Academic and Student Life Committee on

September 15, 2017:


Attachments









September 15, 2017


The Board of Visitors of the University of Virginia met in open session at 8:00 a.m. on Thursday, September 14, 2017, in the Board Room of the Rotunda. Frank M. Conner III, Rector, presided.


Present were Whittington W. Clement, Elizabeth M. Cranwell, Barbara J. Fried, John A. Griffin, Robert D. Hardie, Maurice A. Jones, Babur B. Lateef, M.D., John G. Macfarlane III, Tammy S. Murphy, James B. Murray Jr., James V. Reyes, Jeffrey C. Walker, Bryanna F. Miller, and Margaret F. Riley.


Absent were Robert M. Blue, Mark T. Bowles, L.D. Britt, M.D., and Thomas A. DePasquale.


Also present were Teresa A. Sullivan, Patrick D. Hogan, Thomas C. Katsouleas, Richard P. Shannon, M.D., Melody S. Bianchetto, Susan G. Harris, Donna P. Henry, Ronald R. Hutchins, Patricia M. Lampkin, W. Thomas Leback, Mark M. Luellen, David W. Martel, Debra D. Rinker, Roscoe C. Roberts, and Colette Sheehy.


Rector Conner began by thanking everyone for coming to the meeting and for all the hard work that goes into pulling together the Board meetings and materials. In particular, he thanked Bryanna Miller for her work; the many meetings and interviews that she held prior to the Board meetings. He also thanked Vice Rector Murray for his work in helping to organize the free concert for Charlottesville.


The Rector spoke briefly about the Health System Board meeting and the Vivian Pinn ceremony that took place on Wednesday afternoon. He said Vivian Pinn is truly a remarkable person who has had an amazing impact on healthcare, particularly healthcare for women. She is a graduate of UVA; she enrolled in 1967. She was the only African American in her class. She recalled her first day, looking around and not seeing anyone who looked like her. She contemplated leaving and telling her father she could not do this when two white males walked up to her and asked if she would like to be their lab partner. That started her on a path of tremendous success in healthcare. The Rector said her life demonstrates “productive progress.” She persevered, she had great success, and she came back to the University as one of its great supporters.


Rector Conner said he and President Sullivan had written statements they intended to read. He then read a statement that he said reflected his personal views and not those of the Board. The statement is reprinted here verbatim:

Previously, this University condemned the vile view of humanity that invaded Charlottesville and these Grounds on Aug. 11. It is easy to condemn the contemporary version of the abhorrent behavior for which history has sacrificed millions of lives to eradicate. The harder part is to ask, and to answer for ourselves, “How did it come to pass in the symbolic center of our University? And how are we to respond not just to its occurrence, but to its origin?

As to the first question, let me be clear. The torch-lit march down our Lawn intending to intimidate was deeply unacceptable. And we will not allow its recurrence. In good faith, members of this board and others, independent of the events of that Friday night, have reviewed our response that evening and, as we have shared with the University community, there are areas where our response could have been better.

A significant factor implicating nearly all of the tactical decisions made is the mental framework with which we approached that assemblage. We have long been a University that has welcomed and promoted the free exchange of ideas, regardless of their repugnancy, as a basic tenet of a free society. And we have policed numerous demonstrations, marches and forums with that mindset and, perhaps naively, with trust that that mindset was shared by those demonstrating.

But this march was different, and the country and other communities and universities took note. What we witnessed was far more than a march protected by the First Amendment, but rather one that weaponized the First Amendment with the intent to intimidate and terrorize our community and our values. Across the nation, universities are dealing with the role of the First Amendment on campus. As a result of recent events, we have lost our innocence and are in a different place today. We were not sufficiently nimble in adjusting to this reality on Aug. 11, but we have taken stock of the judgments made then and the policies guiding our response that night.

Let me also be clear with respect to another issue regarding safety. We as a University have as our highest priority the safety of all in our community. I heard it in the voice of our president when she called at midnight that Friday evening to share with me what had transpired. I learned it from our dean of students, Allen Groves, as he recounted his experience surrounded by the terrorists at the Jefferson statue, protecting and standing with our students and others who in turn were courageously protecting our values. I saw it in the tired faces of the first responders and our staff on that Sunday afternoon at our emergency management center as they coordinated our response efforts. And we all are aware of the remarkable effort made by our medical professionals to care for the injured. So while there is deserved criticism, there is also deserved respect and appreciation for the dedication and courage of the many in our community who make creating a safe environment their life’s purpose.

To the second question of how we respond not just to the occurrence of abhorrent behavior, but to its origin: What has become known, as both a lament and a call to arms, as “Charlottesville” lays bare once again the intractable challenges that our society faces with respect to racial reconciliation, social justice and economic opportunity. Will we listen this time? Will we dialogue civilly with one another to achieve progress? Will we act? I would hope that we follow the admonition offered recently in the Wall Street Journal by James Baker and Andrew Young:

The country faces a stark choice. Its citizens can continue screaming at each other, sometimes over largely symbolic issues. Or they can again do what the citizens of this country have done best in the past – work together on the real problems that confront everyone.”

At this University, we choose to work together. And you will hear from our president and the chair of the Deans’ Working Group as to how we will proceed in bringing new urgency to our previously defined mission for our third century.

There are some who believe that the history of this University is a barrier to achieving real change. That the legacy of Thomas Jefferson is one of racism and not equality. It is impossible to reconcile Jefferson’s words with his deeds. That the author of the religious freedom statute in Virginia and the fundamental aspiration of our democracy that “all men are created equal” could also enslave his fellow human beings rightfully leads to cynicism and rejection of his moral standing. Thomas Jefferson, like many, was flawed in many of his personal affairs. He embodied the flaws of the origin of this country. Reflect on the Constitution, principally crafted by James Madison, which denied any participation in the political process to women and valued the life of an African-American at 3/5’s of the value of others. And yet, it was ratified by all 13 original states before the Bill of Rights and 17 other subsequent amendments were enacted to begin to address the sins of this revolutionary experiment in democracy.

The genius of Jefferson and Madison and the other founders is that they began a journey for future generations to determine the concept of equality without restricting its scope, and created a government wary of the flaws of humanity that allowed for a dynamic process to address the original deficiencies. And they did so in a political process that created a nation with a revolutionary governance system that is monumental in its achievement. We will not turn our back on this history, but we are keenly aware of its shortcomings and have learned and will continue to learn as we move forward.

As Alexis de Tocqueville, the 19th-century French diplomat, wrote in “Democracy in America,” the “greatness of America lies not in it being more enlightened than any other nation, but rather in her ability to repair her faults.”

We embrace the entirety of our history – all of the good and, yes, all of the ill. Our history as a university is inextricably woven into the history of this country. No other university has had three former presidents lay its cornerstone, two of whom were the intellectual inspiration and principal authors of contemporary democratic principles. Our history is bound up with that of this nation’s founding, the Civil War, and the system of Jim Crow that followed. It is equally bound up with the great transformations of the mid-20th century that renewed the nation’s democratic promise and opened up its universities through the GI Bill, desegregation, and co-education. We reflect, for better and for worse, the great accomplishments and the great failures of this nation.

Despite the nation’s progress, fundamental faults remain. If we really want to improve the history of our past, we must improve the history of our future by continuing to acknowledge and repair our faults and bending the arc of history to provide real justice and equality for all. In the eloquent words of Maya Angelou, “[H]istory, despite its wrenching pain, cannot be unlived, but if faced with courage, need not be lived again.”

A critical first component of repairing our faults is ensuring the completeness of our history. What President Sullivan has been leading over her tenure through the President’s Commission on Slavery and the University is an effort to do just that – to recognize the contributions of those who previously were not recognized, and to honor in our community the contributions of those such as Gibbons, Martin, Foster, Willis and the enslaved laborers. In doing so, we enrich ourselves and create a more united community that reflects all of its participants. Similarly, we will address those symbols on our Grounds that undermine our community in a manner that is holistic, thoughtful and inclusive and calls upon the expertise of thought leaders in the relevant disciplines.

The hate demonstrated on Aug. 11 and 12 awakened the country to the continuing issues of our time. Let us not squander the energy that now exists. As Elie Wiesel once stated, “[T]he opposite of love is not hate, it’s indifference.” We cannot afford an approach of indifference. Otherwise, future generations will judge us as we judge prior generations.

So I ask each person in this community – each student, each faculty member, each staff member, each administrator and each member of this board: How will you improve the history of our future?

_ _ _ _ _ _ _ _ _ _

President Sullivan’s statement (reprinted verbatim) is as follows:

I want to begin by thanking the Rector for his words, and I want to echo one of his comments:

Safety is our top priority, as a University and as a community, and it’s my top priority as president. The torch-lit march on our Lawn on August 11 was something darker and more depraved, disguised as a protest march; it was an attack — an attack on our values; an attack on our University; and ultimately an attack on our people.

The work before us now is to learn from what happened and to defend our values, our University, and our people from any such future attacks.

Let me be clear:  At the University of Virginia, we denounce white supremacy, anti-Semitism, and every other form of bias and hate that the August 11 marchers brought to our Grounds, no matter which group espouses them.

Those beliefs belong in the “ash heap of history.” Diversity and inclusion make us a stronger nation and a stronger University.

Today we speak as a unified and diverse community to denounce those who would seek to divide us, but we know that words alone are not enough. We are committed to taking the measures necessary to prevent any similar attack from happening here again.

This week, the Working Group chaired by Law Dean Risa Goluboff issued its report assessing the events of August 11, with suggestions for how the University could have improved its response. You will hear from Risa tomorrow.

The report acknowledges the things we did right, such as increasing the number of UVA police on duty on the night of August 11 and working with our state and local partners to coordinate resources. It does not mention, but I wish to acknowledge, the mobilization of our hospital and Health System to handle a mass-casualty incident on the next day.

The report also makes several recommendations. During this board meeting, we are asking you for action on several related issues. They include:

Parenthetically, I also want to note that yesterday, we celebrated the naming of Pinn Hall for a distinguished African-American alumna and physician.

Prior to the Working Group’s report, we had already taken immediate steps to make UVA safer. These have included:

We will be taking more steps in the days ahead to create a safer, and more equitable and inclusive University community.

As we continue working toward greater diversity and inclusion, we must also continue to uphold the principles of the First Amendment, as the rector mentioned. We must continue to foster free speech, open discourse and the clash of ideas. Any restriction on free expression is incompatible with the values of higher education and our University’s commitment to the freedom of the human mind.

These two commitments — to free speech, and to inclusion —sometimes come into conflict with each other, but we cannot sacrifice one to preserve the other. We must uphold both, because both are essential to the excellence we seek.

What we absolutely cannot do, however, is allow the practice of free expression to cross the line into intimidation and violence and all-out attack on UVA and its people, as it did on August 11. We must and will take all necessary steps to prevent that escalation. 

For decades, peaceful protests and demonstrations have played out on college and university campuses across the country. As bastions of free speech, universities have been natural gathering points for such expressions of the First Amendment. Those generally peaceful protests are the type of event that universities have prepared for. 

August 11 marked a new day for UVA, and for universities across the country, and this new day will require a shift in our mental framework. In our policies and planning, we need to prepare for situations in which demonstrations spill over into intimidation and intentional violence. Our policies need to help us prevent such spill-over, and our planning needs to prepare us to act when such spill-over threatens to happen.

We will protect the Constitutional principles of free speech, because free expression is a core value of higher education. But we will vigorously protect our people, our University and our values when they are threatened by attack.

Last Friday, at the request of Congressman Bobby Scott, I spoke before the minority members of the House Committee on Education and the Workforce in Washington. The committee held a forum on “Affirmative Action, Inclusion and Racial Climate on America’s Campuses” — an issue that’s central to our discussion this morning.

I spoke about our efforts to build inclusion at UVA, including the work of the President’s Commission on Slavery and the University. I’m pleased that the commission has accomplished so much in a relatively short time. We have:

While the Commission on Slavery continues its work, we need to address other troublesome aspects of UVA’s history. For example, we know that in 1921 President Alderman received a pledge of $1,000 from the KKK. We have a newspaper account in which he acknowledged the pledge, but no evidence that the pledge was ever paid. The KKK began to wither as an organization by mid-decade, so it’s possible that they never fulfilled that pledge.

But we’re going to acknowledge the pledge, and we’re going do so in a way that would be as disagreeable as possible for any remnants of the KKK who may be watching.

That $1,000 pledge, if inflated to today’s dollars, would be worth about $12,400. With that number in mind, I have allocated $12,500 from private sources to the “Charlottesville Patient Support Fund,” which is managed by the UVA Health Foundation, to pay medical expenses for people who were injured during the violence in August. Any leftover funds will support care for other members of our community.

In other words, we are allocating that century-old pledge from white supremacists to heal the wounds inflicted by the dying vestiges of white supremacy that struck Charlottesville last month. I hope any remaining members of the KKK will appreciate the irony.

We will continue to see issues arise on our Grounds. On Tuesday night, some community members and students held a protest at the Thomas Jefferson statue by the Rotunda, and several protestors covered the Jefferson statue in a black shroud. Although I recognize the rights of those protesters to express their opinions, I strongly disagree with their act of covering the Jefferson statue.

The history of the Jefferson statue helps to explain why I disagree with the shrouding. The statue was designed by a Jewish sculptor named Moses Ezekiel. Ezekiel was born in 1844 in Richmond and faced anti-Semitism through much of his life. He built into the sculpture a tribute to Jefferson’s contribution to religious freedom. The names of deities — God, Jehovah, Allah and others — are carved into a tablet held by a figure on the statue that symbolizes religious freedom.

Ezekiel explained that he carved the deity names to show that “under our government, they … are all God and have … equal right and protection of our just laws as Americans.”

This reminds us that, in spite of our founder’s faults, he made monumental contributions to religious freedom and other kinds of freedom, and we risk losing sight of those contributions if we shroud him in darkness because of his shortcomings.

This part of the Jefferson statue story holds special relevance because the white supremacists who marched on the statue on August 11 shouted anti-Semitic slurs, and because unknown others put up anti-Muslim signs on our Grounds on the day of the statue shrouding.

Thomas Jefferson was imperfect, but he also contributed to the religious and other freedoms that we uphold against those who would seek to divide us.

The events of the last several weeks have put UVA and Charlottesville in the national spotlight — once again. This attention is not coincidental. What happens at UVA matters because UVA matters. Because of our unique history among American universities; because of our elevated position among the best universities in the country; because of the excellence of our teaching, research, and scholarship — for all these reasons, all eyes are upon us, watching what happens here and how we respond.

Our obligation now is to use this moment of focus and attention to provide leadership, once again. And working together, that’s what we will do.”

_ _ _ _ _ _ _ _ _

Resolution for Additions to the Agenda

The Rector said there would be several resolutions presented for the first time at the meetings. Therefore, in accordance with the Manual of the Board of Visitors, the Board must approve the addition of these items to the agenda.

On motion, the Board adopted the following resolution approving the consideration of addenda to the published agenda.


RESOLUTION TO APPROVE ADDITIONAL AGENDA ITEMS


RESOLVED, the Board of Visitors approves the consideration of addenda to the published Agenda.


_ _ _ _ _ _ _ _ _ _


Following the vote on the resolution, Rector Conner recessed the full Board meeting until 10:15 a.m. Friday morning. Committees of the Board met for the remainder of the day, followed by a dinner in the Rotunda Dome Room honoring Visitors Emeritus who left the Board on June 30.


Closed Session, Friday, September 15, 2017


At 10:15 a.m., after adopting the following motion, the voting members present, Mr. Conner, Mr. Murray, Mr. Blue, Mr. Bowles, Mr. Clement, Ms. Cranwell, Ms. Fried, Mr. Griffin, Mr. Hardie, Mr. Jones, Dr. Lateef, Mr. Macfarlane, Ms. Murphy, Mr. Reyes, Mr. Walker, Ms. Miller, Ms. Riley; and Susan G. Harris, Roscoe Roberts, and Cynthia Bailey (Attorney General’s Office) met in closed session.


Absent were Dr. Britt and Mr. DePasquale.


I move that the Board of Visitors go into closed session to:


  1. discuss and consider appointment, promotion, performance, salaries, resignations, and retirements of specific faculty and administrators, and to discuss and consider a recommendation from the Special Committee on the Nomination of a President of a candidate for the position of president. The relevant exemption is Section 2.2-3711(A)(1)of the Code of Virginia.”

  2. consult with legal counsel regarding specific legal matters requiring the provision of legal advice by such counsel; specifically, to consult with legal counsel regarding legal matters relating to appointing a president. The relevant exemption is Section 2.2-3711(A)(8) of the Code of Virginia.”

At 10:50 a.m., the Board resumed in open session, and, on motion, adopted the following resolution certifying that the deliberations in closed session had been conducted in accordance with the exemptions permitted by the Virginia Freedom of Information Act. Ms. Harris called the roll, and the following members voted in the affirmative: Mr. Conner, Mr. Murray, Mr. Blue, Mr. Bowles, Mr. Clement, Ms. Cranwell, Ms. Fried, Mr. Griffin, Mr. Hardie, Mr. Jones, Dr. Lateef, Mr. Macfarlane, Ms. Murphy, Mr. Reyes, Mr. Walker, Ms. Miller, and Ms. Riley. There were no votes in the negative.


That we vote on and record our certification that, to the best of each Board member’s knowledge, only public business matters lawfully exempted from open meeting requirements and which were identified in the motion authorizing the closed session, were heard, discussed or considered in closed session.


In open session, the voting members present elected Mr. James E. Ryan as the ninth president of the University of Virginia by unanimous voice vote.


ELECTION OF THE NINTH PRESIDENT OF THE UNIVERSITY OF VIRGINIA

 

    RESOLVED, the Board of Visitors elects Mr. James E. Ryan as the ninth president of the University of Virginia, effective October 1, 2018, for a term of six years and ten months; and

 

     RESOLVED FURTHER, the Rector, in consultation with the Office of the Attorney General, is authorized to negotiate and execute an employment agreement with Mr. Ryan consistent with law, established University policies, and the terms discussed in closed session with the Board of Visitors.

_ _ _ _ _ _ _ _ _ _


At 11:00 a.m., the Board of Visitors met on the portico of the Rotunda to introduce the president-elect, Mr. Ryan. Rector Conner and Rector Emeritus William H. Goodwin Jr. introduced Mr. Ryan. Mr. Ryan provided remarks. Along with the Board of Visitors, the members of the Special Committee on the Nomination of a President were present, as well as deans, vice presidents, all of the living presidents of the University, and many faculty, staff, and students.

_ _ _ _ _ _ _ _ _ _


Strategic Investment Fund Annual Report, Friday, September 15, 2017


Following lunch, the Board of Visitors reconvened in open session at 1:30 p.m. in the Board Room of the Rotunda. Frank M. Conner III, Rector, presided.


Present were James B. Murray Jr., Robert M. Blue, Mark T. Bowles, Whittington W. Clement, Elizabeth M. Cranwell, Thomas A. DePasquale, Barbara J. Fried, John A. Griffin, Robert D. Hardie, Maurice A. Jones, Babur B. Lateef, M.D., John G. Macfarlane III, James V. Reyes, Jeffrey C. Walker, Bryanna F. Miller, and Margaret F. Riley.


Absent was L.D. Britt, M.D.


Also present were Teresa A. Sullivan, Patrick D. Hogan, Thomas C. Katsouleas, Richard P. Shannon, M.D., Melody S. Bianchetto, Susan G. Harris, Patricia M. Lampkin, W. Thomas Leback, Mark M. Luellen, Roscoe C. Roberts, Colette Sheehy, and Farnaz F. Thompson.


President Sullivan spoke about a matching program for Bicentennial professorships similar to the one for scholarships. She said this will help in recruiting faculty.


Mr. Hogan reviewed the first year of performance of the Strategic Investment Fund (SIF). He referred to the annual report provided to every member of the Board. He gave an overview of the material in the annual report, which includes summaries of each grant.


Dr. Shannon gave an update on the type 1 diabetes research project. The project will be genotyping all children in Virginia in partnership with the National Institutes of Health. The first cohort has been collected. They have also established consultative services to practices in this area. He showed a video of a child with type 1 diabetes who has benefited from participating in the continuous glucose monitoring/artificial pancreas trials. The artificial pancreas monitors glucose levels and automatically adjusts to keep the patient from having extreme highs and lows.


Professor John Lach spoke about the cyber physical systems project in the Engineering School. Smart energy and smart phones are part of this industry. Cyber physical systems sit at the intersection of these emerging applications. They are using these technologies with dementia patients to monitor agitation, which will provide caregivers with more tools to address agitation triggers. The Link Lab is the physical space, which will be comprised of 17 faculty from five different departments in a very open environment to stimulate transdisciplinary conversations. They are in the process of building the lab, and it should be open by January. He spoke about PsiKick, a faculty spin-off that designs very low power circuits, which will have a huge impact on the environment.


Professor John Lach said students are critical to the research, and push many ideas forward. The cluster hires and other recent initiatives are about the University reinventing itself to move forward in these areas, with the intention of having a significant impact on society. He said there is a real sense that with the SIF, UVA can compete with the top institutions in the nation.


Following the Strategic Investment Fund presentation, the Board continued its meeting, sitting as the full Board.


Presenters were Eric M. Baumgartner, Risa L. Goluboff, Michael Phillips, Maggie Stein, and Alfred Weaver.


The Rector welcomed the recently appointed members of the Board and called on Mr. Murray to lead the Pledge of Allegiance.


Minutes of the June 8-9, 2017 Meeting of the Board of Visitors and the August 4-5, 2017 BOV Retreat


On motion, the Minutes of the Board meetings held on June 8-9, 2017 and August 4-5, 2017 were approved.


Remarks by the Rector and the President


The President said the march on August 11 at the University was not something that was well signaled to the University police. One of the police officers was injured, who is now off the force for several weeks because he was seeking to make an arrest at the event.


Ms. Sullivan described the events of August 12 as “horrific”, and mentioned the killing of Heather Heyer by a car driven into a crowd of pedestrians. She said several donors have stepped forward to pledge funds for a scholarship in Ms. Heyer’s name; the amount is sufficient to qualify for one-to-one matching from the Bicentennial Scholars Fund.


She described actions taken in response to the events of August 11 and 12. The police and others who work in Emergency Operations have had three “hot washes” to talk about what happened, and she asked Dean of the School of Law Risa Goluboff to chair a working group (the Deans Working Group) which is comprised of deans and others, including Craig Littlepage, Athletics Director; Bryanna Miller, student representative to the Board of Visitors; and Alf Weaver, chair of the Faculty Senate. Even before the working group was established, the University had already decided to revise the existing open flame policy, and it was changed this week by the University Policy Committee. President Sullivan said the University seeks to raise the policy to a state regulation, which has the force of state law. It takes at least a month after the resolution is approved by the Board of Visitors to achieve state regulation status because it must be posted publicly for a month for public comment.


The second resolution is Recognition of the University Academical Village as a Facility. The buildings are already considered a facility, but what is not included is the enclosed lawn between them. By recognizing it as a facility, it is then entitled to certain protections.


Upon motion, the following resolutions were approved:


INTENT TO ADOPT UNIVERSITY REGULATION ON OPEN BURN AND OPEN FLAME OPERATIONS AT THE UNIVERSITY OF VIRGINIA


WHEREAS, the University strives to protect life and property by reducing the risks posed to University buildings, property, and occupants from the use and operation of an open burn and open flame; and


WHEREAS, no person should kindle or maintain or authorize to be kindled or maintained any Open Burning unless it is: (1) approved by the Office of Environmental Health and Safety (EHS) or the University of Virginia Medical Center Fire Protection Inspector’s Office, as appropriate; and (2) conducted in accordance with the Virginia Statewide Fire Prevention Code, Statewide burning laws, and applicable local City and County codes and regulations; and


WHEREAS, no person should use an Open Flame or Open Flame Device unless it is: (1) approved by EHS or the UVA Medical Center Fire Protection Inspector’s Office as appropriate; (2) conducted in accordance with applicable University or Medical Center procedures; and (3) conducted in accordance with the Virginia Statewide Fire Prevention Code; and


WHEREAS, no person should use an Open Flame or Open Flame Device in any place where flammable, combustible, or explosive material is utilized or stored; and


WHEREAS, no Open Burn or Open Flame Device should be used or operated in any University Facility or on University Property unless operated and managed in accordance with appropriate policies and safety protocols; and


WHEREAS, the University first approved University Policy SEC-032: Open Burn and Open Flame Operations at the University of Virginia on January 18, 2013, and adopted revisions to the University Policy on September 13, 2017, prohibiting these activities and providing a process for seeking permission to conduct such activities in appropriate circumstances;


RESOLVED, the Board of Visitors directs and authorizes the Executive Vice President and Chief Operating Officer to take such necessary action to prepare the University Policy SEC-032: Open Burn and Open Flame Operations at the University of Virginia for approval as a University Regulation, for publication in the Virginia Register, and for later publication in the Virginia Administrative Code.


RECOGNITION OF ACADEMICAL VILLAGE AS UNIVERSITY FACILITY


WHEREAS, the Academical Village – defined as that property bounded by the Rotunda to the north, Hospital Drive to the east, McCormick Road to the west, and, for purposes of this Resolution, as including the South Lawn/Homer Flat to the south (thereby including the Rotunda, Lawn and Range rooms, hotels, gardens and pavilions) makes up Thomas Jefferson’s original plan for the University, envisioned as a school with students and professors living together in a holistic learning environment; and


WHEREAS, as the physical and spiritual core of this institution, the Academical Village remains integral to the University’s mission as it prepares to enter its third century; and


WHEREAS, befitting its importance to the Commonwealth, the nation, and the world, the Academical Village has been recognized in the Virginia State Register of Historic Places and National Register of Historic Places and has been designated a UNESCO World Heritage site; and


WHEREAS, the University has long been a thoughtful and careful steward of the Academical Village; and


WHEREAS, University Policy SEC-030 and University Regulations (8 Virginia Administrative Code 85-20) prohibit the possession, storage, or use of any weapon, firework or other explosive, or any lethal combustible chemical or combination of chemicals, by the general public or visitors, except by a law-enforcement officer, on university property in academic, administrative, athletic, entertainment, or student residence buildings, child care or dining facilities, or the University Medical Center, or while attending sporting, entertainment, or educational activities;


RESOLVED, in recognition of the Academical Village’s critical importance and consistent with its multi-purpose residential, academic, and administrative use, the Board of Visitors declares its intent that the Academical Village be recognized formally as a University facility encompassing a controlled outdoor area, subject to University policy and regulation; and


RESOLVED FURTHER, the Board directs and authorizes the Executive Vice President and Chief Operating Officer to propose appropriate policies and regulations including the Academical Village as a University facility within the scope of the University’s policies and regulations.

_ _ _ _ _ _ _ _ _ _


President Sullivan asked Dean Goluboff to speak about the Deans Working Group efforts.


Dean Goluboff said the Deans Working Group is important for her to undertake now because Charlottesville is her home and the University has been her intellectual and professional community for the past 15 years; she has a personal stake in the endeavor.


Dean Goluboff pointed out that her life’s work is as a civil rights historian and legal scholar, and from that vantage point, she hoped that when the story of the long march of civil rights is told, the white supremacist, neo-Nazi, and Klan violence and intimidation in Charlottesville will be seen as a late and ultimately futile reaction to the successes of the freedom struggles of the last 50 years. Those successes are far from complete. August 11-12 was a violent and disturbing reminder that progress is all too often accompanied by reaction.


She was struck at a Law School panel referencing the white supremacists and Neo-Nazis as “unpopular minorities,” because in the 1950s and 1960s, civil rights activists were the unpopular minorities and the white supremacists the majority. She is gratified to think that has flipped, and even a politically fractured Congress can unanimously denounce white supremacy. Massive change can happen, but it does not always happen for the better, so that is why the nation has to respond to this threat.

She and many others have felt a cascade of emotions over the last month including heartbreak, revulsion, sadness, grief, fear, anger, and vulnerability, but most of all, resolve to make the world, our city, our University a more just, equal, and inclusive place.


The Working Group’s mission is to assist the University community in both recovering from and responding to the threatening and violent white supremacists who invaded the Grounds and Charlottesville this summer. The group has taken that charge seriously, meeting weekly for the past four weeks, with frequent emails. They have also been reaching out to members of the University community, meeting one-on-one as well as in larger groups, with the faculty senate, diversity officers, student groups, and there is more dialogue to come.


Their charge has three parts:


  1. Respond to the events and ensure the future safety and security of our community, as well as the implications of those events;


  1. Examine and continue to improve the culture, climate, and environment; and


  1. Work on long-term development of, and investments in, the research and teaching mission in areas related to the events of the summer.


Dean Goluboff expanded on the three parts of the charge. With regard to charge number one, a No Trespass Order has been issued to one marcher and the University Police Department is investigating others.


She reviewed three main foci in changing University policy:


  1. Designating the lawn a Facility;



  1. Police enforcement of the open flame policy and elevating that policy to a regulation; and



  1. Considering time, place, and manner policies that would simultaneously protect robust nonviolent free speech on Grounds and better equip law enforcement officers with the tools they need to respond to violence and intimidation. She has asked First Amendment experts on the Law School faculty to offer some constitutional policy options.

The second part of the charge is longer term and vitally important: to lead by example of introspection and self-examination about the University’s climate, culture, and environment. As much as it is a university’s place to challenge students, faculty, and staff intellectually, we want to nourish them personally. Toward that end, the Deans Working Group took its first two steps toward recommitting themselves to that aspiration by authorizing a pan-university climate survey to identify how the University can be an ever more welcoming, diverse, inclusive, and equitable community, including encouraging recruiting and retaining the very best and diverse students, faculty, and staff; and authorizing the creation of an advisory committee on how the University understands and commemorates its past, to supplement work of the President’s Commission on Slavery and another university committee that has been convened on naming.


She remarked that the University faculty have expertise to draw on as we think about our history, including historians and architects - those who spend their scholarly lives thinking about memory, narrative, and space. We will look to them for principles that will provide a path to best remember and recognize the University’s history while fostering contemporary values and future aspirations and celebrating our highest ideals. 

The third part of the Working Group’s mission is identifying how the University can emerge from the events of August 11-12 a better university. We do that by exploring the issues that surround those events: race, religion, ethnicity and nationality, gender and sexuality, pluralism and tolerance, politics and civic engagement, social justice and economic opportunity, and speech and violence. We have to ask new questions, and three new questions come to the fore:


  1. How should we think about this rise in violent, armed, brazen white supremacy? How does it fit into larger historical, demographic, economic, and political trends? Where will it lead us?



  1. How should we think about the relationship between the First Amendment and the Second Amendment? What should be the relationship between bearing arms and speaking? How do we as a diverse community in so many ways have true dialogue across our differences?



  1. How do we escape the recent, completely false dichotomy between freedom of speech on the one hand and freedom from offense on the other? The University of Virginia is better situated than any other institution to begin to answer that question. We can and should be a model of dialogue across difference and free speech within a community of respect and empathy.

The University Press is planning to publish essays from expert faculty reflecting on the events and their implications, and the Provost’s Office is providing a $100,000 flash fund for programs and events to continue the conversation for the near future. Schools are already responding through Strategic Investment Fund proposals.


Finally, she identified two existing initiatives that the Board can invest in immediately to enable important work already underway: the Carter G. Woodson Institute for African-American and African Studies and the Democracy Initiative, which is an overall project on the history, philosophy, and principles of democracy and exploring a variety of fundamental challenges to democratic societies around the world. She said these are only first steps and many more would be coming.


Mr. Conner thanked Dean Goluboff and remarked on the difficulty of one internal group assessing the actions of another. He asked that a proposal for increased funding for the Carter Woodson Institute be developed before the Board’s meeting in December and he said he supports the Democracy Initiative, but we should take into account other initiatives to avoid duplicating effort.


Mr. Conner then reviewed the history of two tablets on the Rotunda memorializing those students and alumni who died in service to the Confederacy. The tablets were installed following approval by the Board of Visitors in 1903, authorizing their placement in a suitable location on Grounds, but not specifying the Rotunda. He said the tablets represent an incomplete recordation of the history of the University involvement in the Civil War because there were students, alumni, and faculty who fought for the Union. He proposed that we should be thinking about how we wish to position the University for its third century. The University needs great leadership, financial resources, and the talent of faculty and students, and he asked if the tablets further this goal because they are offensive to some in our community. Great ideas are necessary, and along with great ideas we need moral authority. The tablets are a powerful symbol that is anathema to acquiring the moral authority that says we take the action to back up our words. Some have told him not to take down the tablets, but the University can determine the tablets are not in a suitable location, take them down, and at the same time memorialize the call to duty along with everyone else who was impacted by the Civil War.


Following extensive discussion among members of the Board, the following resolution was approved unanimously:


RESOLUTION WITH RESPECT TO CIVIL WAR TABLETS


WHEREAS, the Rotunda’s façade has bronze tablets commemorating those students and alumni who fought and died in the service of the United States in World War I, World War II, the Korean War, the Vietnam War, and in the Iraq War; and


WHEREAS, the earliest of those tablets commemorates the students and alumni who died in service to the Confederacy during the Civil War. These tablets were erected following a meeting of the Board of Visitors on November 10, 1903, where, upon the recommendation of the Faculty, the Board of Visitors authorized the Ladies’ Confederate Association to erect “at some suitable place at the University, to be approved by the Chairman of the Faculty, Chairman of the Executive Committee & the Proctor, a bronze tablet bearing the names of the Alumni and Students of this Institution who died in the service of the Confederacy”; and


WHEREAS, the location chosen for erecting two tablets honoring the deceased Confederate soldiers was either side of the door of the Rotunda facing the Lawn, where they are now located; and


WHEREAS, in recent years the University has undertaken a substantial effort to expand the known history of the University and to recognize all persons including enslaved workers who helped build and maintain the University; and


WHEREAS, the University’s Nau Center on Civil War History is conducting research on those affiliated with the University who fought on behalf of the United States in the Civil War, and they have catalogued the names of more than fifty University students and alumni, and one faculty member, who served in the Union Army or Navy during the Civil War and who are not recognized in any way on Grounds; and


WHEREAS, the tablets on the Rotunda do not recognize or reflect the complete history of the University related to the Civil War;


RESOLVED, consistent with the original resolution authorizing the tablets honoring the deceased Confederate soldiers to be erected “at some suitable place at the University”, the Board of Visitors finds that the Rotunda is no longer a suitable place for the tablets in their current form; and


RESOLVED FURTHER, the Board supports relocating the current Civil War tablets to a more suitable location at the University where they may be preserved as artifacts of the era in which they were erected, and utilized to provide context to the history of the University; and


RESOLVED FURTHER, the Board encourages the Deans Working Group, led by Dean Goluboff, to consider the appropriateness of memorializing all who participated in the Civil War in a tablet on the Rotunda or in other ways that tell the University’s history more fully.


_ _ _ _ _ _ _ _ _ _


Mr. Macfarlane said Dr. Shannon gave the first gift to the Memorial for Enslaved Laborers, and he thanked him for the gift.


President’s Report


The President gave an overview of the Bicentennial Launch Weekend, which is scheduled for October 5 to 7, 2017. She said this is going to be a big weekend in Charlottesville, but the Bicentennial Celebration will extend far beyond the Grounds. Festivities will take place in UVA Clubs in cities across the country and around the world. Clubs as nearby as Richmond and Washington D.C., and as far away as India and Shanghai, are planning bicentennial celebrations in October and November.


The Launch Weekend is just the beginning of the programming for the Bicentennial Commemoration. Later in October, the University will host a symposium titled Universities, Slavery, Public Memory, & the Built Landscape. The symposium will consider the history, preservation, and memorialization of sites of enslavement, and highlight the work of universities that have begun to grapple with their own histories, including UVA. In November, the University will host the Women’s Global Leadership Forum, bringing together 200 women from the University and around the world to discuss the role of women in 21st century democracy. The forum will focus on topics such as education and health; economic access and innovation; and equality and political empowerment.


President Sullivan said she was very grateful to the members of the Bicentennial Commission, chaired by Tom Farrell and Dr. Bobby Battle, as well as the Commission’s steering committee. A great deal of hard work has gone into planning this celebration, and she believes everyone will be impressed with the results next month.


She said the Bicentennial reminds us that the University has thrived for 200 years largely because of its commitment to student learning and an excellent student experience. With that in mind, the President gave each Visitor a UVA Dining gift card that will allow them to eat with students in the dining halls.


Comments by the Student Representative to the Board


Ms. Bryanna Miller provided a “laundry list” of student activities on Grounds, and a preview of items she will bring to the Board in December, which include a substance abuse and alcohol awareness initiative, a student dining advisory committee in partnership with Aramark, and developing a connection with the students at the College at Wise through exchanges of students, faculty, and staff. The fourth initiative is to get more involved in the admissions process. She said she was grateful that the Board passed a resolution to remove the tablets memorializing Confederate soldiers—the Board has shown a great deal of moral courage. Students came together in the vigil after the events of August 11 and 12, and there have been other events and actions to process those events, culminating in the upcoming concert in Scott Stadium. She said in the future she will be asking the Board to consider some context around the Jefferson statue in front of the Rotunda—not to take it down, but to educate people about Mr. Jefferson’s life and views.


Comments by the Faculty Senate Chair


Mr. Alf Weaver spoke about the impact of the events of August 11 and 12 on faculty. A Senate meeting included President Sullivan and Dean Goluboff as well as a number of senators talking about next steps. He reviewed the work of each of the Senate committees.


In response to a discussion in June about a dearth of computer science classes, he explained that his department continues to make strides toward the goal of providing computer science classes to all who want to take them. He said by adding new lectures and new lab courses, the wait list was cleared for this fall, with 809 students enrolled in these courses.


Comments by the Staff Senate Co-Chairs


Mr. Michael Phillips, current co-chair of the Staff Senate, and Ms. Maggie Stein, one of the past co-chairs, gave some background information on what the Staff Senate does for the University. The Staff Senate was formed in 2014 by merging three separate employee councils and consists of 80 members, elected by colleagues in 24 major budgeting units, and represent over 5,000 staff members. Their mission is threefold: 1) to serve as a representative voice for staff in matters relating to the University; 2) to support staff members in the realization of their full potential at the University; and 3) to advance University excellence through their efforts.


They reinforced to the Board that staff assist the Board and the administration in implementing the mission and values of the University. They offered to serve on any committees in which the Board needs staff input. They invited the Board members to attend any of their staff meetings or any executive committee meetings.


_ _ _ _ _ _ _ _ _ _ _


On motion, the following resolutions were approved unanimously by voice vote:


ELECTION OF THE EXECUTIVE COMMITTEE FOR 2017-2018


RESOLVED, in addition to the Rector and the Vice Rector, L.D. Britt, M.D., Whittington W. Clement, Barbara J. Fried, John A. Griffin, and Babur B. Lateef, M.D., are elected to the Executive Committee for the 2017-2018 year. John G. Macfarlane III is also elected as an advisor.


SETTING THE DATE OF THE 2018 ANNUAL MEETING OF THE BOARD


RESOLVED, the first meeting of the Board of Visitors in the fall of 2018 shall be designated the 2018 Annual Meeting of the Board.

SETTING THE DATES OF THE 2020 AND 2021 BOARD MEETINGS


RESOLVED, the following dates for the 2020 and 2021 Board meetings are approved:


2020 BOARD MEETING DATES




2021 BOARD MEETING DATES



RESOLUTION FOR EXCLUSION OF CERTAIN DIRECTORS AND OFFICERS — SEPTEMBER 2017


WHEREAS, current Department of Defense Regulations contain a provision making it mandatory that the Chair of the Board, a Senior Management Official, and a Facility Security Officer meet the requirements for eligibility for access to classified information established for a contractor facility security clearance; and


WHEREAS, said Department of Defense Regulations permit the exclusion from the personnel of the requirements for access to classified information of certain members of the Board of Directors and other officers, provided that this action is recorded in the public Minutes;


RESOLVED, the Rector as Chair of the Board, Senior Management Official, and Facility Security Officer at the present time do possess, or will be processed for, the required eligibility for access to classified information; and


RESOLVED FURTHER, in the future, when any individual enters upon any duties as Rector of the Board, Senior Management Official, and Facility Security Officer, such individual shall immediately make application for the required eligibility for access to classified information; and


RESOLVED FURTHER, the following members of the Board of Visitors and other officers shall not require, shall not have, and can be effectively and formally excluded from access to all CLASSIFIED information disclosed to the University and shall not affect adversely Board and University policies or practices in the performance of classified contracts for the Department of Defense or the Government contracting activities (User Agencies) of the National Industrial Security Program.


Robert M. Blue

Member, University of Virginia Board of Visitors

Mark T. Bowles

Member, University of Virginia Board of Visitors

L.D. Britt, M.D.

Member, University of Virginia Board of Visitors

Whittington W. Clement

Member, University of Virginia Board of Visitors

Elizabeth M. Cranwell

Member, University of Virginia Board of Visitors

Thomas A. DePasquale

Member, University of Virginia Board of Visitors

Barbara J. Fried

Member, University of Virginia Board of Visitors

John A. Griffin

Member, University of Virginia Board of Visitors

Robert D. Hardie

Member, University of Virginia Board of Visitors

Maurice A. Jones

Member, University of Virginia Board of Visitors

Babur B. Lateef, M.D.

Member, University of Virginia Board of Visitors

John G. Macfarlane III

Member, University of Virginia Board of Visitors

Tammy S. Murphy

Member, University of Virginia Board of Visitors

James B. Murray Jr.

Member, University of Virginia Board of Visitors

James V. Reyes

Member, University of Virginia Board of Visitors

Jeffrey C. Walker

Member, University of Virginia Board of Visitors

Roscoe C. Roberts

General Counsel to the University of Virginia

Susan G. Harris

Special Assistant to the President and Secretary to the BOV

Patrick D. Hogan

Executive Vice President and Chief Operating Officer

Thomas C. Katsouleas

Executive Vice President and Provost

Richard P. Shannon, M.D.

Executive Vice President for Health Affairs


ADDITION TO THE MANUAL OF THE BOARD OF VISITORS ON APPOINTING A NONVOTING FACULTY REPRESENTATIVE AND AMENDMENT TO PROVISION ON APPOINTING A NONVOTING STUDENT REPRESENTATIVE


WHEREAS, currently, there is a provision in the Manual of the Board of Visitors (the Manual) for electing a student representative to the Board, and there has been a student representative for many years; and


WHEREAS, in 2015 the Board added a faculty representative to the Board; however, the Board did not add a section to the Manual similar to the one on the student representative; and


WHEREAS, appointing nonvoting student and faculty representatives to the Board is authorized by state law (Code of Virginia § 23.1-1300); and


WHEREAS, the section of the Manual on appointing a nonvoting student representative requires some minor language changes to conform to the requirements of the authorizing provision of the Code of Virginia;

       

RESOLVED, the Board of Visitors amends the Manual of the Board of Visitors to add a new section on appointing a nonvoting faculty representative as follows:


SECTION 2.22 FACULTY NONVOTING MEMBER — In addition to those members appointed by the Governor and referred to in Section 2.2, the Board of Visitors at its late spring meeting may appoint a nonvoting, advisory faculty representative to the Board of Visitors for a term of one year commencing July 1.  Such representative shall be chosen from individuals elected by the faculty or by the faculty senate. The faculty member may attend and participate in a nonvoting capacity in all deliberations and meetings, in Open and Closed Session, of the standing and special committees of the Board as well as meetings of the Board of Visitors itself unless the Board has deemed it appropriate to exclude the faculty member from discussions of faculty grievances, faculty or staff disciplinary matters or salaries, or any other matter.

 

RESOLVED FURTHER, the Board of Visitors amends and replaces in its entirety Section 2.21 of the Manual of the Board of Visitors on appointing a nonvoting student representative to the Board of Visitors as follows:


SECTION 2.21 STUDENT NONVOTING MEMBER — In addition to those members appointed by the Governor and referred to in Section 2.2, the Board of Visitors at the first regular meeting of the second semester of the academic session each year shall appoint for a term of one year, on recommendation of the Executive Committee, a full-time student at the University of Virginia as a nonvoting, advisory representative to the Board of Visitors.  The student member may attend and participate in a nonvoting capacity in all deliberations and meetings, in Open and Closed Session, of the standing and special committees of the Board as well as meetings of the Board of Visitors itself unless the Board has deemed it appropriate to exclude the student member from discussions of faculty grievances, faculty or staff disciplinary matters or salaries, or any other matter.


_ _ _ _ _ _ _ _ _ _


NCAA Orientation

Mr. Eric Baumgartner educated the Visitors on NCAA rules. Visitors are boosters and must avoid any activity that could violate the athlete recruiting rules. He said boosters may not provide extra benefits to student athletes, i.e. benefits provided to student athletes or their family members that are not provided to the general public. The bottom line is, “ask before you act.”

ACC Certification

The Rector read the annual ACC certification statement that designates the chief executive officer of the University as the individual responsible for the athletic program at the University.

Commending Resolutions


On motion, the Board approved the following commending resolutions:


RESOLUTION COMMENDING KEVIN J. FAY


WHEREAS, Kevin J. Fay took a Bachelor of Arts degree with distinction from the University of Virginia and a Juris Doctor degree from American University; and


WHEREAS, Mr. Fay serves as the Vice Chairman and Chief Executive Officer of Alcalde & Fay, as well as the Executive Director of the International Climate Change Partnership, where he advises Fortune 100 industries and is consulted by governments, industry, nongovernmental organizations, and media representatives on the global climate change process; and


WHEREAS, Mr. Fay’s service to the University has included the National Committee on University Resources (NCOUR) and guest lecturer at the Darden School and the Batten School; and


WHEREAS, Mr. Fay’s service to the University continues with his recent appointment as chair of the Board of Directors of the University of Virginia Foundation; and


WHEREAS, Mr. Fay was appointed to the Board of Visitors by Governor McDonnell in 2013; and


WHEREAS, Mr. Fay led the Buildings and Grounds Committee for two years as chair; and


WHEREAS, Kevin Fay played an integral role in developing the University’s multi-year capital program, and guiding key physical planning studies that set the framework for future development along Ivy Road, Brandon Avenue, and North Grounds; and


WHEREAS, Mr. Fay’s sage advice on myriad matters, and his nationally recognized expertise in climate change and energy resources have been invaluable; and


WHEREAS, Mr. Fay completed his term on the Board of Visitors on June 30, 2017;


RESOLVED, the Board thanks Kevin J. Fay for his service to the Board and to the University, considers him a friend and valued colleague, and hopes he will remain actively involved; and


RESOLVED FURTHER, the Board wishes Mr. Fay and his wife, Nancy, continued success and happiness in all of their future endeavors.


RESOLUTION COMMENDING FRANK E. GENOVESE


WHEREAS, Frank E. Genovese took a Bachelor of Science degree in Finance from the University of Connecticut and a M.B.A. from the Darden School of Business; and


WHEREAS, Mr. Genovese has been chairman, president, chief operating officer, majority owner, and co-owner of nine corporations, four of which were considered turnaround successes; and


WHEREAS, Mr. Genovese is an active alumnus of the Darden School of Business, serving as a trustee on the foundation board, including as chair of the Building and Finance Committee. He was a visiting professor at the Darden School and taught “Acquisition of Closely Held Enterprises;” and


WHEREAS, Mr. Genovese was awarded the 1998 Charles C. Abbott Award by the Darden School for his dedication and service; and


WHEREAS, Mr. Genovese was appointed to the Board of Visitors by Governor McDonnell in 2013; and


WHEREAS, Mr. Genovese was chair of the Audit, Compliance, and Risk Committee for three years; and


WHEREAS, Frank Genovese was instrumental in restructuring the Audit, Compliance, and Risk Committee to include risk management, and encouraging a more proactive risk management program at the University; and


WHEREAS, his business savvy and sage advice was sought by other members of the Board as well as the University administration; and


WHEREAS, Mr. Genovese completed his term on the Board of Visitors on June 30, 2017;


RESOLVED, the Board thanks Frank E. Genovese for his service to the Board and to the University, considers him a friend and valued colleague, and hopes he will remain actively involved; and


RESOLVED FURTHER, the Board wishes Mr. Genovese and his wife, Susan, continued success and happiness in all of their future endeavors.


RESOLUTION COMMENDING WILLIAM H. GOODWIN JR.

WHEREAS, William H. Goodwin Jr. took a Bachelor of Science degree in Mechanical Engineering from Virginia Tech and a M.B. A. from the Darden Graduate School of Business. In 2005, he was the recipient of the Virginia Tech Alumni Distinguished Achievement Award; and


WHEREAS, Mr. Goodwin is the retired chair and president of CCA Industries, Inc. and The Riverstone Group, LLC; and


WHEREAS, Mr. Goodwin’s service to his community and higher education in the Commonwealth includes the Virginia Business Higher Education Council; the Richmond Performing Arts Corporation; chairman emeritus and founding trustee on the Board of Trustees for the Virginia Commonwealth University School of Engineering Foundation; and trustee emeritus of the Medical College of Virginia Foundation. Mr. Goodwin and his wife Alice are known for their support of cancer research at cancer institutions and hospitals across the country, including the University; and


WHEREAS, Mr. Goodwin has been very active as a volunteer for the University. As a member and chair of the Board of Trustees for the Darden Graduate School of Business, he was directly involved in the innovative financing and bold thinking that led to the new Darden School; and


WHEREAS, Mr. Goodwin was an engaged member in his first two terms on the Board of Visitors, from 1996 to 2004, during which time he served as chair of the Finance Committee and the University of Virginia Investment Management Company; and


WHEREAS, Governor McDonnell appointed Mr. Goodwin to the Board of Visitors in July 2012, first as a Senior Advisor and then as a voting member in January 2013; and


WHEREAS, Mr. Goodwin is the longest serving member of the Board of Visitors over the last fifty years, completing three full terms and an additional year, including two years as Rector; and


WHEREAS, through his Board service and his work with the Darden Graduate School of Business, the Department of Athletics, and the Health System, Bill Goodwin has shaped the University in profound and lasting ways. He was involved in developing the financial model that supported the John Paul Jones Arena project, he played a key role in establishing and building the University of Virginia Investment Management Company, and he conceived of and implemented the Strategic Investment Fund, among many other contributions of his time and talents; and


WHEREAS, in its first year, the Strategic Investment Fund provided significant funding for cutting-edge research, crucial research infrastructure, financial support for graduate and undergraduate students, and programs that enhance the academic experience; and


WHEREAS, Mr. Goodwin completed his term on the Board of Visitors on June 30, 2017;


RESOLVED, the Board thanks William H. Goodwin Jr. for instilling a culture of thinking bold and big but always within a framework of excellence, and considers him a valued colleague and friend; and


RESOLVED FURTHER, the Board wishes Mr. Goodwin and his wife, Alice, continued success and happiness in all of their future endeavors.


_ __ _ _ _ _ _ _ _ _


The Board approved the following Gift and Grants Report, which was provided as a written report in the advance materials.


Gifts and Grants Report


Summary of Fiscal Year 2017 through June 30, 2017:


Total fundraising progress for the University of Virginia and its related foundations was $359,387,829 through June 30, 2017. Gifts and commitments to the School of Architecture, McIntire School of Commerce, School of Continuing & Professional Studies, Darden School of Business, Curry School of Education, Law School, Batten School of Leadership & Public Policy, Medical Center, School of Nursing, Athletics, Jefferson Scholars Foundation, Center for Politics, Jeffersonian Grounds Initiative, Women’s Center, Alumni Association, and College at Wise saw increases over the previous fiscal year.

Significant Gifts Received Since the Last Meeting:





































Significant Pledges Received Since the Last Meeting:



















Final Session, Friday, September 15, 2017

All voting members, save Dr. Britt, Mr. Jones, Mr. Griffin, and Ms. Murphy were present. Mr. Conner reminded the members of the Board that the resolutions were presented in committee. On motion, the Board approved unanimously the following resolutions by voice vote:



CONSENT ITEMS


REVISED ENTERPRISE RISK MANAGEMENT CHARTER

(approved by the Audit, Compliance, and Risk Committee on September 14, 2017 – see also Attachment A)


WHEREAS, the Board of Visitors originally approved the University’s Enterprise Risk Management (“ERM”) charter in February 2016; and


WHEREAS, the ERM charter is periodically reviewed to determine necessary updates; and


WHEREAS, changes and enhancements have been made to the ERM program since the ERM charter was first adopted by the Board in February 2016;

RESOLVED, the Board of Visitors approves the revised ERM Charter as recommended by the Audit, Compliance, and Risk Committee.


ATHLETICS COMPLIANCE CHARTER

(approved by the Audit, Compliance, and Risk Committee on September 14, 2017 – see also Attachment B)


WHEREAS, the University President is appointed by the Board of Visitors, and through the Board’s delegation of authority, the President has ultimate responsibility and accountability for the Athletics Department; and

WHEREAS, the Athletics Department is responsible for ensuring the intercollegiate athletics program is operated within the rules and regulations of the University, the Atlantic Coast Conference (ACC), and the National Collegiate Athletic Association (NCAA); and


WHEREAS, compliance with these rules and regulations is the shared responsibility of everyone associated with the University, as documented in the Athletics Compliance Charter;


RESOLVED, the Board of Visitors approves the Athletics Compliance Charter as recommended by the Audit, Compliance, and Risk Committee.


NAMING OF THE TOTAL ADVISING CENTER AS DATHEL AND JOHN GEORGES STUDENT CENTER

(approved by the Buildings and Grounds Committee on September 14, 2017)


WHEREAS, Dathel and John Georges of New Orleans, Louisiana are the parents of a current student and an alumna of the University of Virginia College of Arts & Sciences; and


WHEREAS, Mr. and Mrs. Georges have been active volunteers, serving on the UVA Parents Fund Committee and hosting and sponsoring events for students and families; and


WHEREAS, Mr. and Mrs. Georges are generous donors to the University, and supported in particular the construction of the Total Advising Center in Clemons Library;


RESOLVED, the Board of Visitors names the Total Advising Center in Clemons Library the Dathel and John Georges Student Center.


RENAMING LEWIS HOUSE AS YEN HOUSE

(approved by the Buildings and Grounds Committee on September 14, 2017)


WHEREAS, Yan Huiqing, also known as W.W. Yen, was the first student from China to graduate from the University of Virginia, and the first international student to receive a Bachelor of Arts from the University; and


WHEREAS, Mr. Yen was a highly accomplished diplomat whose exemplary political career included service as China's Minister of Foreign Affairs, first ambassador to the Soviet Union, delegate in the League of Nations, Premier, and acting President; and


WHEREAS, Mr. Yen serves as a distinguished example of a true global scholar committed to cross-cultural exchange, peace, and goodwill;


RESOLVED, the Board of Visitors renames Lewis House as Yen House.


DEMOLITION OF 1939 IVY ROAD

(approved by the Buildings and Grounds Committee on September 14, 2017)


WHEREAS, the redevelopment of property fronting Ivy Road will require the demolition of 1939 Ivy Road (#3480); and


WHEREAS, pursuant to the Management Agreement dated November 15, 2005, by and between the Commonwealth of Virginia and The Rector and Visitors of the University of Virginia, the Board of Visitors is authorized to approve the demolition of buildings, subject to such other laws as may be applicable;


RESOLVED, the demolition of 1939 Ivy Road is approved by the Board of Visitors, pending approval by the Art and Architectural Review Board and the Department of Historic Resources and in compliance with such other laws as may be applicable; and

RESOLVED FURTHER, the Executive Vice President and Chief Operating Officer is authorized, on behalf of the University, to approve and execute such documents and to take such other actions as deemed necessary and appropriate in connection with the demolition of the building; and


RESOLVED FURTHER, all prior acts performed by the Executive Vice President and Chief Operating Officer, and other officers and agents of the University, in connection with this demolition, are in all respects approved, ratified, and confirmed.


AMENDMENT TO THE CAPITAL PROJECT PROCUREMENT PROCESS

(approved by the Buildings and Grounds Committee on September 14, 2017 – see also Attachment C)

WHEREAS, pursuant to § 2.2-4381 of the Code of Virginia, the University amended its capital project procurement process originally required by Item 4-4.01 of the 2016‑2018 biennial budget; and


WHEREAS, § 2.2-4381 of the Code of Virginia further provides that the University seek approval of the process by the Board of Visitors after review by the Department of General Services (DGS);


RESOLVED, the Board of Visitors approves the University’s Amended Capital Project Procurement Process.


ACTION ITEMS

SIGNATORY AUTHORITY RELATED TO CHANGE IN GROUP PURCHASING ORGANIZATION

(approved by the Health System Board on September 13, 2017 and by the Finance Committee on September 14, 2017)


RESOLVED, the Board of Visitors authorizes the Executive Vice President for Health Affairs to execute all contracts as necessary for the Medical Center to transfer contracts in effect under the Vizient group purchasing arrangement to the Premier group purchasing arrangement.

PLAQUE COMMEMORATING THE UNIVERSITY’S BICENTENNIAL

(approved by the Buildings and Grounds Committee on September 14, 2017)


WHEREAS, the University of Virginia will mark the 200th anniversary of the laying of the University’s cornerstone at Pavilion VII on October 6, 2017; and


WHEREAS, the commemoration will continue through the 200th anniversary of the University’s charter on January 25, 2019; and


WHEREAS, the Bicentennial will celebrate the achievements of the University’s first two centuries while articulating aspirations for its next two centuries;


RESOLVED, the Board of Visitors authorizes the placement of a plaque at Pavilion VII to commemorate the University’s Bicentennial.


REVISION TO THE 2017 CAPITAL PLAN – BASEBALL STADIUM EXPANSION, REVISED SCOPE

(approved by the Buildings and Grounds Committee and the Finance Committee on September 14, 2017)


WHEREAS, the University recommends a revision in the originally approved scope for the Baseball Stadium Expansion to include an administrative office area and pitching development center, planned as part of phase 2, located on the ground floor below the new grandstand at a projected cost of $2 million;


RESOLVED, the Board of Visitors approves expanding the scope of the Baseball Stadium Expansion by adding 8,820 GSF to the project bringing the total project cost to $18.16 million.


SIGNATORY AUTHORITY FOR CONTRACTS RELATED TO SECURITY RECOMMENDATIONS

(approved by the Finance Committee on September 14, 2017)


WHEREAS, the University will negotiate contracts as needed to address identified institutional security recommendations;

RESOLVED, the Board of Visitors authorizes the Executive Vice President and Chief Operating Officer to execute these contracts as needed to address identified institutional security recommendations; and


RESOLVED, the Executive Vice President and Chief Operating Officer will inform the Board of Visitors of any such contracts at its December 2017 meeting.


DISPOSITION OF REAL PROPERTY – DAVIS ESTATE LOCATED AT 700 EDWIN DRIVE, VIRGINIA BEACH, VIRGINIA

(approved by the Finance Committee on September 14, 2017)


WHEREAS, by Last Will and Testament dated, December 3, 2004, and as amended, Lawrence Davis, Jr. devised to The Rector and Visitors of the University of Virginia real property located at 700 Edwin Drive, Virginia Beach, Virginia (the “Property”); and


WHEREAS, Lawrence Davis, Jr. is now deceased such that title to the Property is vested free and clear in the name of The Rector and Visitors of the University of Virginia; and


WHEREAS, the Board of Visitors finds it to be in the best interest of the University of Virginia to sell the Property, and use the proceeds as agreed in the Lawrence Davis, Jr. and Geraldine M. Davis Scholarship Fund (the “Fund”) gift agreement, and to create and administer the Fund;


RESOLVED, the Board of Visitors approves the conveyance of the Property subject to (i) such terms as are approved by the Executive Vice President and Chief Operating Officer and the Chair of the Finance Committee, and (ii) the net proceeds shall be administered in accordance with the instructions contained in the Lawrence Davis, Jr. and Geraldine M. Davis Scholarship Fund agreement; and


RESOLVED FURTHER, the Executive Vice President and Chief Operating Officer is authorized, on behalf of the University, to approve and execute agreements and related documents, to incur reasonable and customary expenses, and to take such other actions as deemed necessary and appropriate to consummate such property conveyance and to facilitate the maintenance, sale, and marketing activities associated with the Property; and


RESOLVED FURTHER, all prior acts performed by the Executive Vice President and Chief Operating Officer, and other officers and agents of the University, in connection with such property conveyance, are in all respects approved, ratified and confirmed.


2018-2024 SIX-YEAR INSTITUTIONAL PLANS FOR THE ACADEMIC DIVISION AND THE COLLEGE AT WISE

(approved by the Finance Committee on September 14, 2017)


WHEREAS, the Virginia Higher Education Opportunity Act of 2011, § 23.1-306 of the Code of Virginia, requires the governing boards of all public institutions of higher education to develop and adopt biennially an institutional six-year plan and submit that plan to the State Council of Higher Education for Virginia (SCHEV); the General Assembly; the Governor; and the Chairs of the House Committee on Appropriations, House Committee on Education, Senate Committee on Education and Health, and Senate Committee on Finance; and


WHEREAS, the University submitted its preliminary plans for the Academic Division and the College at Wise as required on June 30, 2017, outlining general strategies to advance the priorities of the Commonwealth and to enhance teaching, research, and service consistent with the strategies of the Cornerstone Plan and the College at Wise’s Strategic Plan, Envisioning 2020; and


WHEREAS, final institutional plans must be approved by the Board of Visitors and submitted to SCHEV, the General Assembly; the Governor; and the Chairs of the House Committee on Appropriations, House Committee on Education, Senate Committee on Education and Health, and Senate Committee on Finance no later than October 1;


RESOLVED, the Board of Visitors approves the 2018-2024 six-year institutional plans for the Academic Division and the College at Wise; and


RESOLVED FURTHER, the President is authorized to transmit the six-year plans as required by § 23.1-306 of the Code of Virginia.


STATE OPERATING BUDGET REQUESTS FOR THE 2018-20 BIENNIUM FOR THE ACADEMIC DIVISION AND THE UNIVERSITY OF VIRGINIA’S COLLEGE AT WISE

(approved by the Finance Committee on September 14, 2017)


WHEREAS, the proposed biennial budget requests represent the University’s highest priority initiatives and are aligned with the Cornerstone Plan and the Six Year Institutional Plan submitted to the Commonwealth on July 1, 2017;


RESOLVED, the Board of Visitors of the University of Virginia approves the 2018-2020 biennial budget General Fund operating requests; and


RESOLVED FURTHER, the Board of Visitors understands that to the extent these initiatives are not included in the Governor’s 2018-2020 biennial budget, the University may want to pursue similar requests to the General Assembly; and

RESOLVED FURTHER, the President or her designee is authorized to transmit to the General Assembly any request not funded by the Governor as long as there are no material differences from the items already endorsed by the Board of Visitors.


ISSUANCE OF GENERAL REVENUE PLEDGE BONDS

(approved by the Finance Committee on September 14, 2017 – See also Attachment D)


WHEREAS, Chapter 22, Title 23.1 of the Code of Virginia of 1950, as amended (the "Virginia Code"), establishes a public corporation under the name and style of The Rector and Visitors of the University of Virginia (the "University") which is governed by a Board of Visitors (the "Board"); and


WHEREAS, Title 23.1 of the Virginia Code classifies the University as an educational institution of the Commonwealth of Virginia; and


WHEREAS, by Chapter 10, Title 23.1 of the Virginia Code (the "Act"), the University entered into a management agreement with the Commonwealth of Virginia which was enacted as Chapter 3 of Chapter 933 of the 2006 Virginia Acts of Assembly, pursuant to which the University is empowered with the authority to undertake and implement the acquisition of any interest in land, including improvements on the acquired land at the time of acquisition, new construction, improvements or renovations and to borrow money and make, issue and sell bonds of the University for such purposes, including the refinancing of any such facilities; and


WHEREAS, in order for the University to more efficiently access the capital markets, the Board desires to authorize a multi-year capital project financing program (the "Program") that may be used by the University from time to time to finance or refinance the costs of capital and other projects, including capitalized interest, financing costs, working capital, general corporate purposes and the refunding of prior obligations of the University (collectively, the "Projects"), subject to the limitations and parameters set forth in this resolution; and


WHEREAS, the Board anticipates that the Program will be secured by a general revenue pledge of the University and not be in any way a debt of the Commonwealth of Virginia (the "Commonwealth") and shall not create or constitute any indebtedness or

obligation of the Commonwealth, either legal, moral, or otherwise; and


WHEREAS, on June 9, 2017, the Board provided its initial approval of the Program; and


WHEREAS, the Board desires to authorize the establishment of the Program of up to $500,000,000 of taxable or tax-exempt bonds (the "Bonds") that may be issued by the University from time to time to finance one or more Projects, all subject to the limitations and parameters described below; and


WHEREAS, the Board desires, that with any taxable proceeds of the Bonds, the University create two new investment accounts, one account to fund the maturity of the taxable Bonds’ principal and a second to fund current and future capital expenditures of the University.


RESOLVED, that the Board hereby implements the plan of finance described in the recitals hereto by authorizing the establishment of the Program, by adopting a master program resolution in substantially the form attached as Exhibit A with such amendments, revisions and final terms as provided herein and in Section 11.7 thereof (the "Program Resolution"); and


RESOLVED FURTHER, that as described in Section 11.7 of the Program Resolution, the President of the University or the Executive Vice President and Chief Operating Officer of the University, in consultation with the Chair of the Board's Finance Committee, is authorized to approve the final terms of the Program Resolution; and


RESOLVED FURTHER, the President of the University or the Executive Vice President and Chief Operating Officer of the University are each hereby authorized to negotiate, execute and deliver certain documents related to the Program Resolution as described therein; and


RESOLVED FURTHER, under the Program, the Board hereby authorizes the issuance of the Bonds in one or more series, and for the purpose of providing for the terms thereof, by adopting one or more series resolutions in substantially the form attached as Exhibit B with such amendments, revisions and final terms as provided herein and in Section 7.5 thereof (each a "Series Resolution"); and


RESOLVED FURTHER, that the President of the University or the Executive Vice President and Chief Operating Officer of the University, in consultation with the Chair of the Board's Finance Committee, is authorized to approve the final terms of each series of the Bonds, including, without limitation, their original principal amounts and the specific Projects to be financed or refinanced, their maturity dates and amounts, redemption provisions and prices and interest rates, and tax status of interest on each series of the Bonds, provided that (i) the maximum aggregate principal amount of the Bonds to be issued hereunder shall not exceed $500,000,000; (ii) the Bonds shall be issued at fixed or variable rates with a maximum yield on any fixed rate series, and the maximum initial yield on any variable rate series, not to exceed five and one-half percent (5.50%) per annum; (iii) the final maturity of each series of Bonds shall not exceed 101 years beyond their respective issuance dates; and (iv) the Bonds shall be issued within one year from the date of this Resolution; and


RESOLVED FURTHER, that with any taxable proceeds of the Bonds, the President of the University or the Executive Vice President and Chief Operating Officer of the University are each hereby authorized to create two new investment accounts, one account to be funded and invested in a manner that provides sufficient funds to pay the principal of the taxable Bonds’ upon their maturity, and a second account to fund current and future capital expenditures; and


RESOLVED FURTHER, that President of the University or the Executive Vice President and Chief Operating Officer of the University are each hereby authorized to negotiate, execute and deliver all documents related to the Series Resolution and the Bonds; and


RESOLVED FURTHER, that, as provided in the Program Resolution, no bonds other than the Bonds shall be issued under the Program Resolution unless the Board adopts a subsequent resolution authorizing those subsequent bonds; and


RESOLVED FURTHER, that all officers of the University are authorized and directed to take all such further actions, including without limitation the designation of underwriters, paying agents, remarketing agents, trustees and liquidity providers for the Bonds, and to execute all such instruments, agreements, documents, and certificates as they shall deem necessary or desirable to carry out the terms of the financing plans presented to this meeting, including without limitation any liquidity facilities, swap or other interest rate management agreements associated with the Bonds; and


RESOLVED FURTHER, pursuant to the Section 147(f) of the Internal Revenue Code of 1986, as amended, and applicable regulations thereunder, the University designates the Executive Vice President and Chief Operating Officer of the University as the public hearing officer to hold any public hearings required in order to ensure the tax-exempt status of interest on all or a portion of the Bonds; and


RESOLVED FURTHER that all acts of all officers of the University which are in conformity with the purposes and intent of this Resolution and in carrying out the financing plans presented to this meeting are ratified, approved and affirmed; and


RESOLVED FURTHER that, upon approval, this action shall take effect immediately.


ESTABLISHMENT OF THE KENNETH G. ELZINGA PROFESSORSHIP IN ECONOMICS AND THE LAW

(approved by the Academic and Student Life Committee on September 15, 2017)


WHEREAS, Professor Kenneth G. Elzinga, Robert C. Taylor Professor of Economics, has been a member of the faculty since 1967; and


WHEREAS, Mr. Elzinga has taught more than 45,000 students and has been honored many times as an excellent teacher and engaged member of the faculty, including receiving the Thomas Jefferson Award in 1992, the highest honor bestowed by the University; and


WHEREAS, more than 500 alumni, students, parents, and friends contributed to a fund to establish a professorship in honor of Professor Elzinga;


RESOLVED, the Board of Visitors establishes the Kenneth G. Elzinga Professorship in Economics and the Law in the Department of Economics of the College and Graduate School of Arts & Sciences to enhance the Department of Economics; and


RESOLVED FURTHER, the Board thanks the many donors for their generosity to the Department of Economics and the University, and congratulates Professor Elzinga on a long and distinguished academic career.


ESTABLISHMENT OF A SECOND JAMES R. SCHLESINGER DISTINGUISHED PROFESSORSHIP AT THE MILLER CENTER OF PUBLIC AFFAIRS

(approved by the Academic and Student Life Committee on September 15, 2017)


WHEREAS, James R. Schlesinger was a member of the faculty of the Economics Department from 1955 to 1963, first as an Assistant Professor and then as an Associate Professor; and


WHEREAS, Mr. Schlesinger was a distinguished figure in American life, having been Chairman of the Atomic Energy Commission, Director of the Central Intelligence Agency, Secretary of Defense, and the first Secretary of Energy, as well as having been an advisor to a number of government agencies; and


WHEREAS, Mr. Schlesinger’s career embodied the ideals of public service in this country; and


WHEREAS, Mr. Schlesinger made a generous gift to establish a professorship at the Miller Center, whose occupant should offer expertise in foreign policy or national security;


RESOLVED, the Board of Visitors establishes a second James R. Schlesinger Distinguished Professorship at the Miller Center and pays tribute to Mr. Schlesinger’s exemplary public service.

POLICY ON THE ADMINISTRATION OF ATHLETICS AND THE ATHLETICS ADVISORY COUNCIL

(approved by the Academic and Student Life Committee on September 15, 2017)


WHEREAS, the Board of Visitors approved a revised "Standing Policy on Administration of Athletics and the Advisory Council on Athletics" on June 13, 1997; and


WHEREAS, current administrative practices and terms are not consistent with those outlined in the June 13, 1997 policy;


RESOLVED, the policy of June 13, 1997 is hereby rescinded and replaced by the following policy:


Policy on the Administration of Athletics and the Athletics Advisory Council


The responsibility for administration of the Department of Athletics shall be placed on a Director of Intercollegiate Athletics Programs, who shall be appointed by the President of the University, subject to the approval of the Board of Visitors.


The faculty shall, as heretofore, have the responsibility of setting the standards required for the maintenance of acceptable academic standing for students in general. That students who maintain such standards shall be eligible to represent the University in athletic competition, subject to such regulations as may be established by the administrative authorities of the University, including the Board of Visitors, regarding eligibility in respects other than that of acceptable academic standing. The policy of the University concerning scholarships which may be awarded to students who participate in intercollegiate athletics is reserved for decision by the Board of Visitors, which may act with the benefit of recommendations from the administration and the Athletics Advisory Council hereinafter mentioned.


An Athletics Advisory Council is established, consisting of representatives selected by the President of the University from the faculty, the Alumni Association, the Virginia Athletics Foundation, administration, and student body. The Chair of the Athletics Advisory Council shall be designated by the President of the University. At least one of the members should be a student-athlete.


FORMATION OF A STATEWIDE PEDIATRIC CLINICALLY INTEGRATED NETWORK

(approved by the Health System Board on September 13, 2017 and the Finance Committee on September 14, 2017)


WHEREAS, the University of Virginia Medical Center desires to create a statewide pediatric clinically integrated network (the “Pediatric Network”) in order to coordinate, standardize, and improve care provided to children in the Commonwealth of Virginia; and


WHEREAS, the Medical Center believes that the Pediatric Network will result in, inter alia, less fragmented care for children, increased physician and other provider alignment, a potential reduction in the cost of pediatric care, and positioning the participants in the Network for value-based reimbursement; and


WHEREAS, the Children’s Hospital of Kings Daughters or its affiliate (“CHKD”) has expressed an interest in co-founding and jointly operating the Pediatric Network with the Medical Center, subject to approval by its governing board; and


WHEREAS, the Pediatric Network is expected initially to be a 50-50 partnership between the Medical Center and CHKD, but other health care entities may join as members in the Pediatric Network in the future; and


WHEREAS, the Health System Board finds it to be in the best interest of the University of Virginia and its Medical Center for the Medical Center to form and be a member of the Pediatric Network;


RESOLVED, pending the Health System Financial Working Group’s review of a financial pro forma, the University, on behalf of the Medical Center, is authorized to create and participate in the Pediatric Network with the Children’s Hospital of Kings Daughters or its affiliate and/or any other parties determined to be necessary; and


RESOLVED FURTHER, the Executive Vice President for Health Affairs of the University, with the concurrence of the Chair of the Health System Board, is authorized to negotiate the terms of such Pediatric Network transaction, including but not limited to, the execution of contracts and all other documents necessary for the formation, capitalization, and operation of the Pediatric Network, on such terms as the Executive Vice President for Health Affairs deems appropriate, and to take such other action as the Executive Vice President for Health Affairs deems necessary and appropriate to consummate the foregoing.


USE OF PRIVATE FUNDS TO DEFRAY CONCERT FOR CHARLOTTESVILLE EXPENSES

(approved by the Finance Committee on September 14, 2017)


WHEREAS, the Concert for Charlottesville will be held in Scott Stadium on Sunday, September 24th for residents of the City of Charlottesville and Albemarle county, UVA students and staff, and residents of the counties adjacent to Albemarle County to help heal and unify the Charlottesville community after the violence incurred in Charlottesville on August 11 and 12;

RESOLVED, the Board of Visitors directs the University administration to use resources from private funds to help defray the expenses associated with the Concert for Charlottesville event.


FACULTY PERSONNEL ACTIONS


1. ELECTIONS


RESOLVED, the following persons are elected to the faculty:


Mr. Huiwang Ai, as Associate Professor of Molecular Physiology and Biological Physics, without term, and Associate Professor of Chemistry, for three years, effective August 1, 2017, at an annual salary of $140,000.


Ms. Christina Amspaugh, as Assistant Professor of Education, General Faculty, for three years, effective June 25, 2017, at an annual salary of $83,000.


Ms. Alice M. Bailey, as Assistant Professor of Art, General Faculty, for the period July 25, 2017 through May 24, 2018, at a salary of $36,000.


Dr. Rita Basu, as Professor of Medicine, effective August 1, 2017, at an annual salary of $210,000.


Dr. Derek Bauer, as Assistant Professor of Neurology, for three years, effective August 1, 2017, at an annual salary of $100,000.


Dr. Taison D. Bell, as Assistant Professor of Medicine, for three years, effective July 1, 2017, at an annual salary of $100,000.


Ms. Barbara A. Blythe, as Assistant Professor of Classics, General Faculty, for the period July 25, 2017 through May 24, 2018, at a salary of $36,000.


Mr. Bradford J. Campbell, as Assistant Professor of Computer Science, for three academic years, effective August 25, 2017, at an academic year salary of $140,000.


Mr. Bradley E. Cantrell, as Professor of Landscape Architecture, effective June 25, 2017, at an annual salary of $128,600.


Mr. Adrian L. Carson, as Assistant Professor of Music, for four academic years, effective July 25, 2017, at an academic year salary of $69,000.


Mr. Graham Casey, as Professor of Public Health Sciences, effective September 1, 2016, at an annual salary of $250,000.


Dr. Carla L. Chavez-Mayorga, as Assistant Professor of Dentistry, for three years, effective July 1, 2017, at an annual salary of $100,000.


Ms. Kyong Mi Choi, as Associate Professor of Education, General Faculty, for three academic years, effective August 25, 2017, at an academic year salary of $84,000.


Mr. Philip I-Fon Chow, as Assistant Professor of Psychiatry and Neurobehavioral Sciences, for three years, effective August 1, 2017, at an annual salary of $85,000.


Ms. Meredith D. Clark, as Assistant Professor of Media Studies, for four academic years, effective July 25, 2017, at an academic year salary of $85,000.


Mr. John J. Comazzi, as Associate Professor of Architecture, effective July 25, 2017, at an academic year salary of $93,000.


Dr. Meghan N. Cooper, as Assistant Professor of Medicine, for three years, effective July 1, 2017, at an annual salary of $100,000.


Mr. Ashon T. Crawley, as Assistant Professor of Religious Studies and Assistant Professor of African American and African Studies, for four academic years, effective July 25, 2017, at an academic year salary of $92,000.


Mr. Federico Cuatlacuatl, as Assistant Professor of Art, for four academic years, effective July 25, 2017, at an academic year salary of $75,000.


Dr. Beth Ellen Davis, as Professor of Pediatrics, for three years, effective August 14, 2017, at an annual salary of $100,000.


Dr. Brent DeGeorge, as Assistant Professor of Plastic Surgery, for three years, effective August 14, 2017, at an annual salary of $100,000.


Dr. Matthew Elliott, as Assistant Professor of Neurology, for three years, effective July 1, 2017, at an annual salary of $100,000.


Ms. Jill H. Esquivel, as Associate Professor of Nursing, effective June 25, 2017, at an annual salary of $145,000.


Mr. Jinbo Fan, as Assistant Professor of Pathology, for one year, effective July 1, 2017, at an annual salary of $100,000.


Mr. Jeremy Foster, as Associate Professor of Landscape Architecture, General Faculty, for three academic years, effective August 25, 2017, at an academic year salary of $87,000.


Mr. Robert J. Gilliard, as Assistant Professor of Chemistry, for four academic years, effective June 25, 2017, at an academic year salary of $90,000.


Ms. Kaiama L. Glover, as Visiting Associate Professor of French, General Faculty, for the period July 25, 2017 through May 24, 2018, at a salary of $140,000.


Mr. Michael B. Goetz, as Assistant Professor of Architecture, General Faculty, for one academic year, effective July 25, 2017, at an academic year salary of $55,000.

Mr. Hudson F. Golino, as Assistant Professor of Psychology, for four academic years, effective July 25, 2017, at an academic year salary of $84,000.


Dr. Nagesh Gollahalli-Shivaramaiah, as Assistant Professor of Medicine, for three years, effective July 1, 2017, at an annual salary of $100,000.


Dr. Olubusola Gomes, as Assistant Professor of Medicine, for three years, effective May 1, 2017, at an annual salary of $100,000.


Mr. Christopher R. Gratien, as Assistant Professor of History, for four academic years, effective July 25, 2017, at an academic year salary of $75,000.


Ms. Fiona Greenland, as Assistant Professor of Sociology, for four academic years, effective July 25, 2017, at an academic year salary of $82,000.


Ms. Brenda Gunn, as Associate Professor, General Faculty, University Library, for three years, effective August 28, 2017, at an annual salary of $135,000.


Dr. Drew A. Harris, as Assistant Professor of Medicine, for three years, effective August 1, 2017, at an annual salary of $100,000.


Mr. Benjamin R. Hayes, as Assistant Professor of Mathematics, for four academic years, effective July 25, 2017, at an academic year salary of $88,000.


Ms. Jasmin Herz, as Assistant Professor of Neuroscience, for three years, effective May 1, 2017, at an annual salary of $65,000.


Mr. Youjia Hua, as Associate Professor of Education, effective August 25, 2017, at an academic year salary of $93,000.


Mr. Jon F. Ihlefeld, as Associate Professor of Materials Sciences & Engineering and Electrical & Computer Engineering, effective August 10, 2017, at an annual salary of $165,400.


Dr. Patrick E. H. Jackson, as Assistant Professor of Medicine, for three years, effective July 1, 2017, at an annual salary of $100,000.


Dr. Ashkan Karimi, as Assistant Professor of Medicine, for one year, effective July 1, 2017, at an annual salary of $100,000.


Dr. James K. Kim, as Assistant Professor of Anesthesiology, for three years, effective July 17, 2017, at an annual salary of $100,000.


Ms. Tami Kim, as Assistant Professor of Business Administration, for three academic years, effective August 25, 2017, at an academic year salary of $172,000.


Dr. Meghan E. Klavans, as Assistant Professor of Obstetrics and Gynecology, for one year, effective July 17, 2017, at an annual salary of $100,000.


Dr. Alexander S. Krupnick, as Associate Professor of Surgery, effective September 19, 2016, at an annual salary of $100,000.

Dr. Paul R. Kunk, as Assistant Professor of Medicine, for three years, effective July 1, 2017, at an annual salary of $100,000.


Ms. Jessie R. Labadie, as Assistant Professor of French, General Faculty, for the period July 25, 2017 through May 24, 2018 at a salary of $36,000.


Dr. Daniel E. Levin, as Assistant Professor of Surgery, for three years, effective August 1, 2017, at an annual salary of $125,000.


Ms. Melissa A. Little, as Assistant Professor of Public Health Sciences, for three years, effective May 1, 2017, at an annual salary of $180,200.


Ms. Christi L. Lockwood, as Assistant Professor of Commerce, for three academic years, effective August 25, 2017, at an academic year salary of $172,000.


Mr. Lee M. Lockwood, as Assistant Professor of Economics, for four academic years, effective July 25, 2017, at an academic year salary of $180,000.


Dr. David N. Loy, as Assistant Professor of Radiology and Medical Imaging, for three years, effective August 1, 2017, at an annual salary of $100,000.


Dr. Amanda Lusa, as Assistant Professor of Medicine, for three years, effective July 17, 2017, at an annual salary of $100,000.


Dr. Louise M. Man, as Assistant Professor of Medicine, for three years, effective July 17, 2017, at an annual salary of $100,000.


Dr. Jose L. Mattos, as Assistant Professor of Otolaryngology, for three years, effective August 1, 2017, at an annual salary of $100,000.


Ms. Meghan K. Mattos, as Assistant Professor of Nursing, for three academic years, effective August 25, 2017, at an academic year salary of $83,000.


Mr. Christopher J. Mazurek, as Professor of Education, General Faculty, for three academic years, effective August 25, 2017, at an academic year salary of $83,000.


Ms. Micah Mazurek, as Associate Professor of Education, effective August 25, 2017, at an academic year salary of $111,000.


Dr. Michael McCulloch, as Associate Professor of Pediatrics, for three years, effective June 1, 2017, at an annual salary of $100,000.


Ms. Katie E. McDermott, as Assistant Professor of Commerce, General Faculty, for two academic years, effective August 25, 2017, at an academic year salary of $130,000.


Ms. Elena C. McGrath, as Assistant Professor of History, General Faculty, for the period July 25, 2017 through May 24, 2018, at a salary of $47,500.


Dr. Kathleen A. McManus, as Assistant Professor of Medicine, for three years, effective July 1, 2017, at an annual salary of $100,000.


Dr. Melissa McShane, as Assistant Professor of Medicine, for three years, effective July 1, 2017, at an annual salary of $100,000.


Mr. Marcus J. Meade, as Assistant Professor of English, General Faculty, for three academic years, effective July 25, 2017, at an academic year salary of $50,000.


Dr. Pooja Mehra, as Assistant Professor of Medicine, for three years, effective July 1, 2017, at an annual salary of $100,000.


Mr. Clint Miller, as Assistant Professor of Public Health Sciences, for three years, effective July 1, 2017, at an annual salary of $122,500.


Dr. Matthew M. Miller, as Assistant Professor of Radiology and Medical Imaging, for three years, effective July 31, 2017, at an annual salary of $100,000.


Ms. Mirabella Mitchell, as Assistant Professor of English, General Faculty, for the period July 25, 2017 through May 24, 2018, at a salary of $36,000.


Mr. Golam Mohi, as Professor of Biochemistry and Molecular Genetics, effective September 1, 2017, at an annual salary of $180,000.


Dr. Willie J. Moore, as Assistant Professor of Medicine, for three years, effective August 14, 2017, at an annual salary of $100,000.


Ms. Stephanie Morano, as Assistant Professor of Education, for three academic years, effective August 25, 2017, at an academic year salary of $77,000.


Mr. Andrew D. Morgan, as Assistant Professor of Philosophy, General Faculty, for the period July 25, 2017 through May 24, 2018, at a salary of $40,500.


Dr. Benjamin A. Moses, as Assistant Professor of Anesthesiology, for three years, effective August 1, 2017, at an annual salary of $100,000.


Ms. Amanda Nguyen, as Research Assistant Professor of Education, for three years, effective July 1, 2017, at an annual salary of $74,000.


Mr. Frederic R. Padilla, as Associate Professor of Radiation Oncology, for one year, effective August 7, 2017, at an annual salary of $101,700.


Mr. Robert Parham, as Assistant Professor of Commerce, for three academic years, effective August 25, 2017, at an academic year salary of $220,000.


Dr. Michael T. Perry, as Assistant Professor of Radiology and Medical Imaging, for three years, effective July 1, 2017, at an annual salary of $100,000.


Ms. Dana G. Popescu, as Associate Professor of Business Administration, for five academic years, effective August 25, 2017, at an academic year salary of $175,000.


Dr. Francesco U. Prada, as Assistant Professor of Neurosurgery, for one year, effective July 1, 2017, at an annual salary of $101,700.


Ms. Beth A. Quatrara, as Assistant Professor of Nursing, General Faculty, for three academic years, effective August 25, 2017, at an academic year salary of $85,000.


Dr. Cody Quirk, as Assistant Professor of Radiology and Medical Imaging, for three years, effective July 1, 2017, at an annual salary of $100,000.


Sketch:

Texas A&M University: B.S., 2007; M.D., 2011; Fellow, Oregon Health and Science University: 2016-2017; Resident, Intern, Baylor University Medical Center: 2011-2016.


Mr. Tyson F. Reeder, as Research Assistant Professor, The Papers of James Madison, for three years, effective July 25, 2017, at an annual salary of $72,000.


Sketch:

Utah State University: B.A., 2008; George Mason University: M.A., 2010; University of California: Ph.D., 2016; Historian, Joseph Smith Papers: 2016-2017; Teaching Assistant, University of California: 2012-2016.


Ms. Leah C. Reid, as Assistant Professor of Music, General Faculty, for three academic years, effective July 25, 2017, at an academic year salary of $50,000.


Sketch:

McGill University: B.A., 2008; Stanford University: M.A., 2010; D.M.A., 2013; Adjunct Faculty, Cogswell Polytechnical College: 2014-2017; Visiting Lecturer, University of the Pacific: 2014-2015; Fellow, Teaching Assistant, Research Assistant, Stanford University: 2008-2013.


Dr. Matthew J. Reilley, as Assistant Professor of Medicine, for three years, effective July 17, 2017, at an annual salary of $100,000.


Sketch:

Washington & Lee University: B.S., 2006; Dartmouth College: M.D., 2008; Brown University: M.D., 2011; Chief Fellow, Anderson Cancer Center: 2016-2017; Fellow, Anderson Cancer Center, Houston: 2014-2016; Resident, Intern, University of Pennsylvania: 2011-2014.


Dr. Amanda D. Renaghan, as Assistant Professor of Medicine, for three years, effective August 1, 2017, at an annual salary of $100,000.


Mr. Jordan S. Rodu, as Assistant Professor of Statistics, for four academic years, effective August 25, 2017, at an academic year salary of $94,000.


Dr. Alan Ropp, as Assistant Professor of Radiology & Medical Imaging, for three years, effective July 1, 2017, at an annual salary of $100,000.


Mr. Benjamin W. Rous, as Associate Professor of Music, General Faculty, for three academic years, effective July 25, 2017, at an academic year salary of $90,000.


Ms. Rebecca M. Rush, as Assistant Professor of English, for four academic years, effective July 25, 2017, at an academic year salary of $74,000.


Dr. Amy M. Salerno, as Assistant Professor of Medicine, for three years, effective August 1, 2017, at an annual salary of $100,000.


Ms. April S. Salerno, as Assistant Professor of Education, General Faculty, for three academic years, effective August 25, 2017, at an academic year salary of $65,000.


Dr. Daniel P. Sheeran, as Assistant Professor of Radiology & Medical Imaging, for three years, effective July 1, 2017, at an annual salary of $100,000.


Ms. Crystal Shin, as Assistant Professor of Law, General Faculty, for three years, effective July 1, 2017, at an annual salary of $104,000.


Mr. Nikolaos D. Sidiropoulos, as Professor of Electrical and Computer Engineering, effective August 15, 2017, at an annual salary of $300,000.


Mr. Benjamin T. Skinner, as Research Assistant Professor of Education, for three years, effective August 1, 2017, at an annual salary of $80,000.


Dr. Anna R. Smith, as Assistant Professor of Medicine, for three years, effective July 1, 2017, at an annual salary of $100,000.


Dr. Brynne A. Sullivan, as Assistant Professor of Pediatrics, for three years, effective August 1, 2017, at an annual salary of $100,000.


Dr. Hasan R. Syed, as Assistant Professor of Neurosurgery, for three years, effective August 1, 2017, at an annual salary of $100,000.


Mr. Xiwei Tang, as Assistant Professor of Statistics, for four academic years, effective July 25, 2017, at an academic year salary of $90,000.


Dr. Nicholas Teman, as Assistant Professor of Surgery, for three years, effective July 15, 2017, at an annual salary of $130,000.


Mr. Douglas J. Thomas, as Professor of Business Administration, effective August 25, 2017, at an academic year salary of $245,000.


Mr. Christopher Yoichi Ito Tibbetts, as Research Assistant Professor of Education, for three years, effective May 25, 2017, at an annual salary of $72,000.


Dr. Christina Tieu, as Assistant Professor of Medicine, for three years, effective July 1, 2017, at an annual salary of $100,000.


Mr. Davide Tomio, as Assistant Professor of Business Administration, for three academic years, effective August 25, 2017, at an academic year salary of $220,000.


Ms. Luzita Vela, as Assistant Professor of Education, General Faculty, for three years, effective June 15, 2017, at an annual salary of $90,000.


Ms. Jennifer A. Wales, as Associate Professor of Practice in Drama, General Faculty, for three years, effective July 25, 2017, at an annual salary of $103,900.


Ms. Ginger Watson Papelis, as Associate Professor of Education, effective August 10, 2017, at an annual salary of $142,700.


Mr. Joseph R. Wiencek, as Assistant Professor of Pathology, for three years, effective July 24, 2017, at an annual salary of $100,000.


Dr. Carlin A. Williams, as Assistant Professor of Surgery, for three years, effective August 14, 2017, at an annual salary of $100,000.


Mr. Joseph M. Williams, as Associate Professor of Education, effective August 25, 2017, at an academic year salary of $95,000.


Mr. Ting Xu, as Assistant Professor of Business Administration, for three academic years, effective August 25, 2017, at an academic year salary of $220,000.

Ms. Joanna S. Yost, as Assistant Professor of Psychiatry and Neurobehavioral Sciences, for one year, effective August 1, 2017, at an annual salary of $80,000.


Dr. Yiyu Zhao, as Assistant Professor of Anesthesiology, for two years, effective August 1, 2017, at an annual salary of $100,000.


2. CORRECTION TO THE ELECTION OF MR. MELUR K. RAMASUBRAMANIAN


RESOLVED, the election of Mr. Melur K. Ramasubramanian, as Professor of Mechanical Engineering effective August 8, 2017, at an annual salary of $340,000, as shown in the Minutes of the meeting of the Board of Visitors dated June 9, 2017, is corrected to read as follows:


      1. Mr. Melur K. Ramasubramanian, as Professor of Mechanical Engineering,

effective August 1, 2017, at an annual salary of $340,000.


3. ACTIONS RELATING TO CHAIRHOLDERS


RESOLVED, the actions relating to the Chairholders are approved as shown below:


(a) Election of Chairholders


Dr. Karen K. Ballen, as Cancer Center Distinguished Professor, for five years, effective January 1, 2017, at an annual salary of $310,000. Dr. Ballen will continue as Professor of Medicine, without term.


Mr. Lawrence E. Band, as Ernest H. Ern Professor of Environmental Sciences, effective August 25, 2017, at an academic year salary of $225,000. Mr. Band will continue as Professor of Environmental Sciences, without term.


Dr. Ananda Basu, as Harrison Distinguished Teaching Professor of Medicine, for five years, effective August 1, 2017, at an annual salary of $259,700. Dr. Basu will continue as Professor of Medicine, without term.


Mr. Anthony Corbeill, as Basil L. Gildersleeve Professor of Classics, effective August 25, 2017, at an academic year salary of $150,000. Mr. Corbeill will continue as Professor of Classics, without term.


Mr. Quinn Curtis, as Albert Clark Tate, Jr., Professor of Law, for three academic years, effective August 25, 2017. Mr. Curtis will continue as Professor of Law, without term.


Mr. Scott C. Doney, as Joe D. and Helen J. Kington Professor of Environmental Sciences, effective August 25, 2017, at an academic year salary of $240,000. Mr. Doney will continue as Professor of Environmental Sciences, without term.


Dr. Camilo Fadul, as Jean and Ronald Butcher, MD, Eminent Scholars Professor of Neurology, for five years, effective May 25, 2017. Dr. Fadul will continue as Professor of Neurology, without term.


Dr. John D. Ferguson, as Julian Ruffin Beckwith Professor of Medicine, for five years, effective May 25, 2017. Dr. Ferguson will continue as Professor of Medicine, without term.


Mr. Kim A. Forde-Mazrui, as Earle K. Shawe Professor of Employment Law, for three academic years, effective August 25, 2017. Mr. Forde-Mazrui will continue as Mortimer M. Caplin Professor of Law, without term.


Mr. Michael B. Froman, as James R. Schlesinger Distinguished Professor at the Miller Center of Public Affairs, for one academic year, effective August 25, 2017, at an academic year salary of $75,000.


Ms. Laura F. Galloway, as Commonwealth Professor of Biology, effective August 25, 2017. Ms. Galloway will continue as Professor of Biology, without term.


Mr. Brandon L. Garrett, as White Burkett Miller Professor of Law and Public Affairs, effective August 25, 2017. Mr. Garrett will continue as Justice Thurgood Marshall Distinguished Professor of Law, until August 24, 2018, and as Professor of Law, without term.


Mr. George S. Geis, as Thomas F. Bergin Teaching Professor of Law, for three academic years, effective August 25, 2017. Mr. Geis will continue as William S. Potter Professor of Law, without term.


Mr. Thomas B. Gunnoe, as Commonwealth Professor of Chemistry, effective August 25, 2017. Mr. Gunnoe will continue as Professor of Chemistry, without term.


Ms. Deborah Hellman, as Roy L. and Rosamond Woodruff Morgan Professor of Law, for three academic years, effective August 25, 2017. Ms. Hellman will continue as David Lurton Massee, Jr., Professor of Law, without term.


Mr. A. E. D. Howard, as Warner-Booker Distinguished Professor of International Law, effective August 25, 2017. Mr. Howard will continue as Professor of Law, without term.


Mr. Jason S. Johnston, as Armistead M. Dobie Professor of Law, for three academic years, effective August 25, 2017. Mr. Johnston will continue as Henry L. and Grace Doherty Charitable Foundation Professor of Law, without term.


Dr. Tracey L. Krupski, as Jay Y. Gillenwater Associate Professor of Urology, for five years, effective May 25, 2014. Dr. Krupski will continue as Associate Professor of Urology, without term.

Mr. Melvyn P. Leffler, as Compton Visiting Professor of World Politics at the White Burkett Miller Center of Public Affairs, for one year, effective May 25, 2017. Mr. Leffler will continue as Edward R. Stettinius Professor of History, without term.


Ms. Elena Loutskina, as Bank of America Research Associate Professor of Business Administration, for three academic years, effective August 25, 2017. Ms. Loutskina will continue as Associate Professor of Business Administration, without term.


Ms. Julia D. Mahoney, as Class of 1963 Research Professor of Law in honor of Graham C. Lilly and Peter W. Low, for three academic years, effective August 25, 2017. Ms. Mahoney will continue as John S. Battle Professor of Law, without term.


Mr. Roger D. Martin, as KPMG Peat Marwick Professor of Professional Accounting, for four academic years, effective August 25, 2017. Mr. Martin will continue as Professor of Commerce, without term.


Ms. Ruth Mason, as Class of 1957 Research Professor of Law, for three academic years, effective August 25, 2017. Ms. Mason will continue as Professor of Law, without term.


Mr. Pedro M. Matos, as Macfarlane Family Professor of Business Administration, for five academic years, effective August 25, 2017. Mr. Matos will continue as Professor of Business Administration, without term.


Ms. Dayna B. Matthew, as William L. Matheson and Robert M. Morgenthau Distinguished Professor of Law, without term, and F. Palmer Weber Research Professor of Civil Liberties and Human Rights, for three academic years, effective August 25, 2017, at an academic year salary of $238,000. Ms. Matthew will continue as Professor of Law, without term.


Mr. Jeffrey K. Olick, as William R. Kenan, Jr., Professor of Sociology, effective August 25, 2017. Mr. Olick will continue as Professor of Sociology, without term.


Mr. David M. Parichy, as Pratt-Ivy Foundation Distinguished Professor of Morphogenesis of Biology, effective July 25, 2017, at an academic year salary of $216,000. Mr. Parichy will continue as Professor of Biology, without term.


Mr. Saikrishna B. Prakash, as Paul G. Mahoney Research Professor of Law, for three academic years, effective August 25, 2017. Mr. Prakash will continue as James Monroe Distinguished Professor of Law, without term.


Mr. Lee M. Ritterband, as Jean and Ronald Butcher, MD, Eminent Scholars Professor of Behavioral Medicine and Psychiatry, for five years, effective May 25, 2017. Mr. Ritterband will continue as Professor of Psychiatry and Neurobehavioral Sciences, without term.


Ms. Saonee Sarker, as Rolls-Royce Commonwealth Professor of Commerce, effective August 25, 2017. Ms. Sarker will continue as Professor of Commerce, without term.


Mr. Suprateek Sarker, as Rolls-Royce Commonwealth Professor of Commerce, effective August 25, 2017. Mr. Sarker will continue as Professor of Commerce, without term.


Mr. Micah J. Schwartzman, as Joseph W. Dorn Research Professor of Law, for three academic years, effective August 25, 2017. Mr. Schwartzman will continue as Professor of Law, without term.


Mr. Thomas J. Steenburgh, as Richard S. Reynolds Professor of Business Administration, effective August 25, 2017. Mr. Steenburgh will continue as Professor of Business Administration, without term.


Mr. Patrick H. Tolan, as Charles S. Robb Professor of Education, for five academic years, effective August 25, 2017. Mr. Tolan will continue as Professor of Education, without term.


Ms. Emiliana Versteeg, as Class of 1941 Research Professor of Law, for three academic years, effective August 25, 2017. Ms. Versteeg will continue as Professor of Law, without term.


Mr. Jarrett Zigon, as H. William Porterfield, M.D., and Linda Obenauf Porterfield Professor of Biomedical Ethics, effective July 25, 2017, at an annual salary of $180,000. Mr. Zigon will continue as Professor of Anthropology, without term.


Mr. Robert B. Zoellick, as James R. Schlesinger Distinguished Professor at the Miller Center of Public Affairs, for the period September 25, 2017 through May 24, 2018, at an academic year salary of $75,000.


(b) Promotion of Chairholder


Dr. Jim B. Tucker, from Priscilla Bonner and Margerie Bonner Lowry Associate Professor in the Division of Personality Studies, and Associate Professor of Psychiatry and Neurobehavioral Sciences, to Priscilla Bonner and Margerie Bonner Lowry Professor in the Division of Personality Studies, for five years, and Professor of Psychiatry and Neurobehavioral Sciences, for three years, effective July 1, 2017.


(c) Change of Title of Chairholder


Dr. Susan M. Pollart, from Ruth E. Murdaugh Professor of Family Practice, to Walter M. Seward Professor of Family Medicine, effective July 10, 2017. Dr. Pollart will continue as Professor of Family Medicine, without term.


(d) Special Salary Action of Chairholders


Dr. Richard L. Guerrant, Thomas Harrison Hunter Professor of International Medicine, effective May 1, 2017, at an annual salary of $185,100.


Mr. Barry M. Horowitz, Walter N. Munster Professor of Research in Intelligence Enhancement, effective May 25, 2017, at an annual salary of $271,600.


(e) Resignation of Chairholder


Dr. Robert G. Sawyer, C. Bruce Morton Professor of Surgery, effective September 14, 2017.


(f) Retirements of Chairholders


Dr. Robert S. Gibson, Lockhart B. McGuire Professor of Internal Medicine, effective July 4, 2017. Dr. Gibson had been a member of the faculty since July 1, 1981.


Dr. Anthony L. McCall, James M. Moss Professor of Diabetes and Professor of Medicine, effective July 1, 2017. Dr. McCall had been a member of the faculty since October 1, 2001.


4. PROMOTIONS


RESOLVED, the following persons are promoted:


Ms. Kristin M. Behfar, from Associate Professor of Business Administration, with term, to Associate Professor of Business Administration, without term, effective August 25, 2017.


Ms. Margarita Jover Biboum, from Professor of Practice in Architecture, to Associate Professor of Architecture, effective August 25, 2017.


5. SPECIAL SALARY ACTIONS


RESOLVED, the following persons shall receive the salary indicated:


Mr. Peter A. Beling, Associate Professor of Systems and Information Engineering, effective May 25, 2017, at an annual salary of $181,000.


Dr. Leigh A. Cantrell, Associate Professor of Obstetrics and Gynecology, effective April 25, 2017, at an annual salary of $137,500.


Dr. James J. Gangemi, Associate Professor of Surgery, effective January 1, 2017, at an annual salary of $300,000.


Ms. Linda A. Gonder-Frederick, Associate Professor of Psychiatry and Neurobehavioral Sciences, effective June 1, 2017, at an annual salary of $83,300.


Mr. Jeffrey K. Olick, William R. Kenan, Jr., Professor of Sociology, effective August 25, 2017, at an academic year salary of $204,100.


6. RESIGNATIONS


The President announced the following resignations:


Dr. Kenneth I. Barron, Assistant Professor of Obstetrics and Gynecology, effective August 4, 2017.


Ms. Erin C. Berenz, Assistant Professor of Pediatrics, effective July 2, 2017.


Mr. Kai-Wei Chang, Assistant Professor of Computer Science, effective June 30, 2017.


Dr. Lucia F. Flors Blasco, Assistant Professor of Radiology and Medical Imaging, effective August 2, 2017.


Ms. Chloe R. Gibbs, Assistant Professor of Public Policy and Education, effective May 24, 2017.


Dr. Jose G. Gurrola II, Assistant Professor of Otolaryngology, effective June 30, 2017.


Dr. Surovi Hazarika, Assistant Professor of Medicine, effective July 30, 2017.


Dr. Sandra M. Johnson, Associate Professor of Ophthalmology, effective August 25, 2017.


Ms. Susie J. Kim, Assistant Professor of East Asian Languages, Literatures and Cultures, effective May 24, 2017.


Dr. John Kwock, Assistant Professor of Anesthesiology, effective August 18, 2017.


Dr. Carlos Leiva Salinas, Assistant Professor of Radiology and Medical Imaging, effective July 28, 2017.


Dr. Jessica D. Lewis, Assistant Professor of Medicine, effective December 28, 2017.


Ms. Jessica K. Lowe, Associate Professor of Law, effective August 20, 2017.


Dr. Kelly B. Mahaney, Assistant Professor of Neurosurgery, effective July 17, 2017.


Dr. William P. McCullough, Jr., Assistant Professor of Pediatric Imaging, effective December 31, 2017.


Ms. Lisa R. Messeri, Assistant Professor of Engineering and Society, effective June 30, 2017.


Ms. Pamela J. Pecchio, Associate Professor of Art, effective June 11, 2017.


Mr. Michael L. Reed, Professor of Electrical & Computer Engineering, effective August 24, 2017.


Mr. Robert J. Swap, Research Professor of Environmental Sciences, effective April 16, 2017.


Ms. Melissa C. Thomas-Hunt, Associate Professor of Business Administration, effective June 24, 2017.


Ms. Yuenan Wang, Assistant Professor of Radiation Oncology, effective June 23, 2017.


Mr. Benjamin T. Webster, Associate Professor of Mathematics, effective July 11, 2017.


Ms. Meredith Jung-En Woo, Professor of Politics, effective August 24, 2017.


7. RETIREMENTS


The President announced the following retirements:


Mr. J. David Castle, Professor of Cell Biology, effective September 1, 2017. Mr. Castle had been a member of the faculty since November 1, 1987.


Mr. Philip N. Geiger, Professor of Art, effective May 24, 2017. Mr. Geiger had been a member of the faculty since September 1, 1983.


Mr. John G. Papovich, Professor, General Faculty, effective August 24, 2017. Mr. Papovich had been a member of the faculty since August 1, 1985.

Ms. Vivian E. Thomson, Professor of Environmental Sciences & Politics, General Faculty, effective June 30, 2017. Ms. Thomson had been a member of the faculty since January 16, 1997.


Dr. Amy L. Tucker, Associate Professor of Medicine, effective April 6, 2017. Dr. Tucker had been a member of the faculty since September 1, 1994.


8. ELECTION OF PROFESSOR EMERITI


RESOLVED, the following persons are elected Professor Emeritus:


Mr. J. David Castle, Professor of Cell Biology, effective September 1, 2017.


Mr. Philip N. Geiger, Professor of Art, effective May 25, 2017.


Dr. Robert S. Gibson, Lockhart B. McGuire Professor of Internal Medicine, effective July 4, 2017.


Dr. Anthony L. McCall, James M. Moss Professor of Diabetes and Professor of Medicine, effective July 1, 2017.


9. ELECTION OF ASSOCIATE PROFESSOR EMERITI


RESOLVED, the following person is elected Associate Professor Emeritus:


Dr. Amy L. Tucker, Associate Professor of Medicine, effective April 6, 2017.


10. DEATHS


The president will announce the following deaths:


Mr. George J. Stukenborg, Professor of Public Health Sciences, died July 21, 2017. Mr. Stukenborg had been a member of the faculty since November 3, 1997.


Mr. Phillip A. Parrish, Interim Vice President for Research, died July 13, 2017. Mr. Parrish has been with the University since May 1, 1996.



UNIVERSITY OF VIRGINIA’S COLLEGE AT WISE


11. ELECTION


RESOLVED, the following person is elected to the faculty:


Mr. Joseph J. Kern, as Assistant Professor of Spanish, The University of Virginia's College at Wise, for one year, effective August 25, 2017, at an annual salary of $55,000.


Sketch:

University of Louisville: B.A., 2010; University of Arizona: M.A., 2012; Ph.D., 2017; Graduate Associate, Graduate Assistant, University of Arizona: 2010-2017.


12. PROMOTIONS


RESOLVED, the following persons are promoted:


Mr. John M. Adrian, from Associate Professor of English, The University of Virginia's College at Wise, to Professor of English, The University of Virginia's College at Wise, effective August 25, 2017.


Mr. Jan Fiala, from Assistant Professor of Physics, The University of Virginia's College at Wise, to Associate Professor of Physics, The University of Virginia's College at Wise, effective August 25, 2017.


- - - - - - - - - -


On motion, the meeting was adjourned at 4:00 p.m.

Respectfully submitted,

Susan G. Harris

Secretary



SGH:ddr

These minutes have been posted to the University of Virginia’s Board of Visitors website.

http://www.virginia.edu/bov/publicminutes.html

ADDENDUM TO THE OFFICIAL MINUTES OF THE MEETING OF

THE BOARD OF VISITORS OF THE UNIVERSITY OF VIRGINIA



Meeting Date: September 14-15, 2017



CERTIFICATION OF CLOSED MEETING



The Board of Visitors, sitting in Open Session, adopted a resolution certifying that while meeting in Closed Session – as permitted by the relevant provisions of the Code of Virginia – only public business authorized by its motion and lawfully exempted from consideration in open session were discussed in closed session.

Respectfully submitted,

Susan G. Harris

Secretary




RESOLUTIONS NOT REQUIRING ACTION BY THE FULL BOARD


The following resolutions were adopted in a Board committee and do not require approval by the full Board; they are enumerated below as a matter of record.


HEALTH SYSTEM BOARD/TRANSITIONAL CARE HOSPITAL – September 13, 2017


AMENDED AND RESTATED BYLAWS OF THE CLINICAL STAFF OF THE TRANSITIONAL CARE HOSPITAL (see Attachment E)


RESOLVED, the Health System Board approves the Amended and Restated Bylaws of the Clinical Staff of the Transitional Care Hospital. These amendments, which are appended as an Attachment, shall be effective as of September 13, 2017.


CREDENTIALING AND RECREDENTIALING ACTIONS – HEALTH SYSTEM BOARD/ TRANSITIONAL CARE HOSPITAL – APPROVED September 13, 2017


The following resolutions were adopted in a Board committee and do not require approval by the full Board; they are enumerated below as a matter of record.


1. APPOINTMENTS TO THE CLINICAL STAFF


RESOLVED, the recommendations of the Clinical Staff Executive Committee for appointment to the Clinical Staff of the University of Virginia Transitional Care Hospital and the granting of specific privileges to the following practitioners are approved:

Ashburn, Frank, M.D., Ophthalmologist in the Department of Ophthalmology; Consulting Staff Status; Period of Appointment: July 17, 2017, through July 16, 2018; Privileged in Ophthalmology.



Bauer, Derek, M.D., Neurologist in the Department of Neurology; Consulting Staff Status; Period of Appointment: August 1, 2017, through July 31, 2018; Privileged in Neurology.


Brown, Jacqueline, M.D., Physician in the Department of Medicine; Consulting Staff Status; Period of Appointment: July 31, 2017, through July 30, 2018; Privileged in Medicine.


Gollahalli Shivaramaih, Nagesh, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 13, 2017, through July 12, 2018; Privileged in Medicine.


Guerrero, Kathleen, M.D., Ophthalmologist in the Department of Ophthalmology; Consulting Staff Status; Period of Appointment: July 11, 2017, through July 10, 2018; Privileged in Ophthalmology.


Lusa, Amanda, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 18, 2017, through July 17, 2018; Privileged in Medicine.


McManus, Kathleen, M.D., Physician in the Department of Medicine; Consulting Staff Status; Period of Appointment: July 26, 2017, through July 25, 2018; Privileged in Medicine.


Natov, Nikola, M.D., Gastroenterologist in the Department of Medicine; Consulting Staff Status; Period of Appointment: July 10, 2017, through July 9, 2018; Privileged in Medicine.


Ropp, Alan, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Appointment: July 1, 2017, through June 30, 2018; Privileged in Radiology and Medical Imaging.


Teman, Nicholas, M.D., Cardiothoracic Surgeon in the Department of Surgery; Consulting Staff Status; Period of Appointment: July 18, 2017, through July 17, 2018; Privileged in Surgery.


Tieu, Christina, M.D., Geriatrician in the Department of Medicine; Consulting Staff Status; Period of Appointment: July 11, 2017, through July10, 2018; Privileged in Medicine.


2. REAPPOINTMENTS TO THE CLINICAL STAFF


RESOLVED, the recommendations of the Clinical Staff Executive Committee for reappointment to the Clinical Staff of the University of Virginia Transitional Care Hospital and the granting of specific privileges to the following practitioners are approved:


Bajo, Stephanie, Psy.D., Psychologist in the Department of Psychiatry and Neurobehavioral Sciences; Consulting Staff Status; Period of Reappointment: September 6, 2017, through February 27, 2019; Privileged in Psychology.


Chhabra, Abhinav, M.D., Orthopedic Surgeon in the Department of Orthopedic Surgery; Consulting Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Orthopedic Surgery.


Chiota-McCollum, Nicole, M.D., Neurologist in the Department of Neurology; Consulting Staff Status; Period of Reappointment: September 14, 2017, through June 30, 2019; Privileged in Neurology.


Duska, Linda, M.D., Obstetrician and Gynecologist in the Department of Obstetrics and Gynecology; Consulting Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Obstetrics and Gynecology.


Gadrey, Shrirang, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: September 5, 2017, through March 30, 2019; Privileged in Medicine.


Hall, Joseph, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: September 5, 2017, through January 30, 2019; Privileged in Medicine.


Jain, Vishal, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Medicine.


Park, Joseph, M.D., Orthopedic Surgeon in the Department of Orthopedic Surgery; Consulting Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Orthopedic Surgery.


Platts-Mills, James, M.D., Physician in the Department of Medicine; Consulting Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Medicine.


Kronfol, Richard, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Medicine.


Mehta, Ambereen, M.D., M.P.H, Physician in the Department of Medicine; Consulting Staff Status; Period of Reappointment: August 30, 2017, through May 30, 2019; Privileged in Medicine.


Rosner, Mitchell, M.D., Nephrologist in the Department of Medicine; Consulting Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Medicine.


Rustin, Rudolph, M.D., Surgeon in the Department of Surgery; Consulting Staff Status; Period of Reappointment: September 1, 2017, through May 30, 2018; Privileged in Surgery.


Warbarton, Karen, M.D., Nephrologist in the Department of Medicine; Consulting Staff Status; Period of Reappointment: September 29, 2017, through October 30, 2018; Privileged in Medicine.


3. RESIGNATIONS OF CLINICAL STAFF


RESOLVED, the recommendations of the Clinical Staff Executive Committee for the resignation and expiration of privileges to the following Clinical Staff are approved:

Adams, Peter D., M.D., Surgeon in the Departments of Surgery; Consulting Staff Status; Effective Date of Resignation: July 31, 2017.


Esau, Sharon A., M.D., Pulmonologist in the Departments of Medicine; Attending Staff Status; Effective Date of Resignation: July 15, 2017.


Hazarika, Surovi, M.D., Ph.D., Cardiologist in the Departments of Medicine; Consulting Staff Status; Effective Date of Resignation: July 30, 2017.

Mahaney, Kelly B., M.D., Neurosurgeon in the Departments of Neurology; Consulting Staff Status; Effective Date of Resignation: July 17, 2017.


Mehrad, Borna., M.D., Pulmonologist in the Departments of Medicine; Attending Staff Status; Effective Date of Resignation: July 14, 2017.


Salinas, Carlos L., M.D., Radiologist in the Departments of Radiology & Medical Imaging; Consulting Staff Status; Effective Date of Resignation: July 31, 2017.


4. RENEWAL OF PRIVILEGES FOR ALLIED HEALTH PROFESSIONALS


RESOLVED, the recommendation of the Clinical Staff Executive Committee for the renewal of privileges to the following Allied Health Professional is approved:


Battle, Molly R.N., N.P., Adult Gerontology Nurse Practitioner in the Department of Surgery; Period of Privileging: September 11, 2017 through September 10, 2019; Privileged as an Adult Gerontology Nurse Practitioner.


Beuscher, Tara, R.N., N.P., Adult Nurse Practitioner in the Department of Medicine; Period of Privileging: September 18, 2017 through September17, 2019; Privileged as an Adult Nurse Practitioner.


Floyd, Shawn, R.N., N.P., Acute Care Nurse Practitioner in the Department of Medicine; Period of Privileging: September 27, 2017 through September 26, 2019; Privileged as an Acute Care Nurse Practitioner.


George, Katie L., R.N., N.P., Adult Gerontology Nurse Practitioner in the Department of Surgery; Period of Privileging: September 29, 2017 through September 28, 2019; Privileged as an Adult Gerontology Nurse Practitioner.


Porreca, Anthony, P.A., Physician Assistant in the Department of Radiology and Medical Imaging; Period of Privileging: September 6, 2017 through September 5, 2019; Privileged as a Physician Assistant.



HEALTH SYSTEM BOARD – September 13, 2017


AMENDED AND RESTATED BYLAWS OF THE CLINICAL STAFF OF THE MEDICAL CENTER (see Attachment F)


RESOLVED, the Health System Board approves the Amended and Restated Bylaws of the Clinical Staff of the Medical Center. These amendments, which are appended as an Attachment, shall be effective as of September 13, 2017.



REAFFIRMATION OF MEDICAL CENTER LEVEL I TRAUMA STATUS:


RESOLVED, the Health System Board supports the Medical Center’s continued designation as a Level I Trauma Center by the Commonwealth and the American College of Surgeons; and


RESOLVED FURTHER, the Medical Center commits to maintain the high standards needed to provide optimal care to all trauma patients.


CREDENTIALING AND RECREDENTIALING ACTIONS – HEALTH SYSTEM BOARD – APPROVED September 13, 2017


The following resolutions were adopted in a Board committee and do not require approval by the full Board; they are enumerated below as a matter of record.


1. APPOINTMENTS TO THE CLINICAL STAFF


RESOLVED, the recommendations of the Clinical Staff Executive Committee for appointment to the Clinical Staff of the University of Virginia Medical Center and the granting of specific privileges to the following practitioners are approved:

Abu Libdeh, Amal, M.D., Neurologist in the Department of Neurology; Attending Staff Status; Period of Appointment: July 24, 2017, through July 23, 2018; Privileged in Neurology.


Ashburn, Frank, M.D., Ophthalmologist in the Department of Ophthalmology; Attending Staff Status; Period of Appointment: July 17, 2017, through July 16, 2018; Privileged in Ophthalmology.


Bauer, Derek, M.D., Neurologist in the Department of Neurology; Attending Staff Status; Period of Appointment: August 1, 2017, through July 31, 2018; Privileged in Neurology.


Bell, Taison, M.D., Pulmonologist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 10, 2017, through July 9, 2018; Privileged in Medicine.



Brown, Jacqueline, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Appointment: July 31, 2017, through July 30, 2018; Privileged in Medicine.


Cooper, Meghan, M.D., Pulmonologist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 19, 2017, through October 3, 2017; Privileged in Medicine.


Fink, Nathan, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Appointment: July 1, 2017, through June 30, 2018; Privileged in Radiology and Medical Imaging.


Gollahalli Shivaramaih, Nagesh, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 13, 2017, through July 12, 2018; Privileged in Medicine.


Guerrero, Kathleen, M.D., Ophthalmologist in the Department of Ophthalmology; Attending Staff Status; Period of Appointment: July 11, 2017, through July 10, 2018; Privileged in Ophthalmology.


Hartman, Stephanie, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Appointment: July 18, 2017, through July 17, 2018; Privileged in Pediatrics.


Kim, James, M.D., Anesthesiologist in the Department of Anesthesiology; Attending Staff Status; Period of Appointment: July 19, 2017, through July 18, 2018; Privileged in Anesthesiology.


Klavans, Meghan, M.D., Obstetrician and Gynecologist in the Department of Obstetrics and Gynecology; Attending Staff Status; Period of Appointment: July 18, 2017, through July 17, 2018; Privileged in Obstetrics and Gynecology.


Khourdaji, Ayed, M.D., Urologist in the Department of Urology; Attending Staff Status; Period of Appointment: July 10, 2017, through July 9, 2018; Privileged in Urology.


Lusa, Amanda, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 18, 2017, through July 17, 2018; Privileged in Medicine.


McManus, Kathleen, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Appointment: July 26, 2017, through July 25, 2018; Privileged in Medicine.


Natov, Nikola, M.D., Gastroenterologist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 10, 2017, through July 9, 2018; Privileged in Medicine.


Pena, Laura, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Appointment: July 17, 2017, through July 16, 2018; Privileged in Pediatrics.


Reilley, Matthew, M.D., Hematologist Oncologist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 26, 2017, through July 25, 2018; Privileged in Medicine.


Ropp, Alan, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Appointment: July 1, 2017, through June 30, 2018; Privileged in Radiology and Medical Imaging.


Smith, Phillip, M.D., Ph.D, Cardiothoracic Surgeon in the Department of Surgery; Attending Staff Status; Period of Appointment: August 16, 2017, through August 15, 2018; Privileged in Surgery.


Sturek, Jeffrey, M.D., Pulmonologist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 10, 2017, through July 9, 2018; Privileged in Medicine.


Syed, Hasan, M.D., Neurosurgeon in the Department of Neurosurgery; Attending Staff Status; Period of Appointment: August 1, 2017, through July 31, 2018; Privileged in Neurosurgery.


Teman, Nicholas, M.D., Cardiothoracic Surgeon in the Department of Surgery; Attending Staff Status; Period of Appointment: July 18, 2017, through July 17, 2018; Privileged in Surgery.


Tieu, Christina, M.D., Geriatrician in the Department of Medicine; Attending Staff Status; Period of Appointment: July 11, 2017, through July10, 2018; Privileged in Medicine.


2. REAPPOINTMENTS TO THE CLINICAL STAFF


RESOLVED, the recommendations of the Clinical Staff Executive Committee for reappointment to the Clinical Staff of the University of Virginia Medical Center and the granting of specific privileges to the following practitioners are approved:

Ambati, Jayakrishn, M.D., Ophthalmologist in the Department of Ophthalmology; Attending Staff Status; Period of Reappointment: September 14, 2017, through June 30, 2019; Privileged in Ophthalmology.


Babbott, Stewart, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Reappointment: August 30, 2017, through September 29, 2018; Privileged in Medicine.


Bachmann, Keith, M.D., Orthopedic Surgeon in the Department of Orthopedic Surgery; Attending Staff Status; Period of Reappointment: September 2, 2017, through July 30, 2019; Privileged in Orthopedic Surgery.


Bajo, Stephanie, Psy.D., Psychologist in the Department of Psychiatry and Neurobehavioral Sciences; Attending Staff Status; Period of Reappointment: September 6, 2017, through February 27, 2019; Privileged in Psychology.


Castrodale, Brett, M.D., Physician in the Department of Family Medicine; Attending Staff Status; Period of Reappointment: September 15, 2017, through September 14, 2019; Privileged in Family Medicine.


Chhabra, Abhinav, M.D., Orthopedic Surgeon in the Department of Orthopedic Surgery; Attending Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Orthopedic Surgery.


Chiota-McCollum, Nicole, M.D., Neurologist in the Department of Neurology; Attending Staff Status; Period of Reappointment: September 14, 2017, through June 30, 2019; Privileged in Neurology.

Dengel, Lynn, M.D., Surgeon in the Department of Surgery; Attending Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Surgery.


Duska, Linda, M.D., Obstetrician and Gynecologist in the Department of Obstetrics and Gynecology; Attending Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Obstetrics and Gynecology.


Flors Blasco, Lucia, M.D., Radiologist in the Department of Radiology and Medical Imaging; Administrative Staff Status; Period of Reappointment: September 8, 2017, through March 30, 2019.


Gadrey, Shrirang, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: September 5, 2017, through March 30, 2019; Privileged in Medicine.


Hall, Joseph, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: September 5, 2017, through January 30, 2019; Privileged in Medicine.


Jain, Vishal, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Medicine.


Kaur, Varinder, M.D., Hematologist Oncologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: September 26, 2017, through May 30, 2019; Privileged in Medicine.


Kirzhner, Maria, M.D., Ophthalmologist in the Department of Ophthalmology; Attending Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Ophthalmology.


Kronfol, Richard, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Medicine.


Kyin, Timothy, M.D., Allergist and Immunologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Medicine.


Leiva Salinas, Carlos, M.D., Radiologist in the Department of Radiology and Medical Imaging; Administrative Staff Status; Period of Reappointment: September 29, 2017, through April 29, 2019.


Lewis, Jessica, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Medicine.


Mehta, Ambereen, M.D., M.P.H, Physician in the Department of Medicine; Attending Staff Status; Period of Reappointment: August 30, 2017, through May 30, 2019; Privileged in Medicine.


Mendoza, Joanne, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: September 15, 2017, through October 30, 2018; Privileged in Pediatrics.


Mor, Lavika, D.D.S., Dentist in the Department of Dentistry; Attending Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Dentistry.


Murphy, Jessica, M.D., Obstetrician and Gynecologist in the Department of Obstetrics and Gynecology; Attending Staff Status; Period of Reappointment: August 4, 2017, through August 3, 2019; Privileged in Obstetrics and Gynecology.


Park, Joseph, M.D., Orthopedic Surgeon in the Department of Orthopedic Surgery; Attending Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Orthopedic Surgery.


Platts-Mills, James, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Medicine.


Politis, George, M.D., Anesthesiologist in the Department of Anesthesiology; Attending Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Anesthesiology.


McGahren, Eugene, M.D., Pediatric Surgeon in the Department of Surgery; Attending Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Surgery.


Mason, Kelly, M.D., Pediatric Endocrinologist in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: September 23, 2017, through August 30, 2019; Privileged in Pediatrics.


Mendoza, Joanne, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: September 15, 2017, through October 30, 2018; Privileged in Pediatrics.


Mendoza, Michael, M.D., Pediatric Gastroenterologist in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: September 14, 2017, through October 30, 2018; Privileged in Pediatrics.


Raval, Gauri, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: September 09, 2017, through February 27, 2019; Privileged in Pediatrics.


Riegler, Lara, M.D., Pediatric Hematologist Oncologist in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: September 2, 2017, through October 30, 2018; Privileged in Pediatrics.


Roberson, Porsche, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: August 30, 2017, through November 29, 2018; Privileged in Pediatrics.

Rosner, Mitchell, M.D., Nephrologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Medicine.


Rustin, Rudolph, M.D., Surgeon in the Department of Surgery; Attending Staff Status; Period of Reappointment: September 1, 2017, through May 30, 2018; Privileged in Surgery.


Sacco, Melissa, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Pediatrics.


Sanders, David, M.D., Anesthesiologist in the Department of Anesthesiology; Attending Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Anesthesiology.


Schenkman, Noah, M.D., Urologist in the Department of Urology; Attending Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Urology.


Shepard, Jaclyn, Psy.D., Psychologist in the Department of Psychiatry and Neurobehavioral Sciences; Attending Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Psychology.


Schoelwer, Melissa, M.D., Pediatric Endocrinologist in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: September 7, 2017, through July 30, 2019; Privileged in Pediatrics.


Titus, Brian, M.D., Anesthesiologist in the Department of Anesthesiology; Attending Staff Status; Period of Reappointment: September 7, 2017, through April 29, 2019; Privileged in Anesthesiology.


Vinton, Deborah, M.D., Physician in the Department of Emergency Medicine; Attending Staff Status; Period of Reappointment: September 9, 2017, through December 30, 2019; Privileged in Emergency Medicine.


Warbarton, Karen, M.D., Nephrologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: September 29, 2017, through October 30, 2018; Privileged in Medicine.

3. SECONDARY REAPPOINTMENTS TO THE CLINICAL STAFF


RESOLVED, the recommendations of the Clinical Staff Executive Committee for the secondary reappointment to the clinical staff of the University of Virginia Medical Center and the granting of specific privileges to the following practitioner are approved:

Politis, George, M.D., Anesthesiologist in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: August 31, 2017, through August 30, 2019; Privileged in Pediatrics.


4. RESIGNATIONS OF CLINICAL STAFF


RESOLVED, the recommendations of the Clinical Staff Executive Committee for the resignation and expiration of privileges to the following Clinical Staff are approved:

Adams, Peter D., M.D., Surgeon in the Departments of Surgery; Attending Staff Status; Effective Date of Resignation: July 31, 2017.


Barron, Kenneth I., M.D., Obstetrician and Gynecologist in the Departments of Obstetrics and Gynecology; Attending Staff Status; Effective Date of Resignation: August 4, 2017.


Calhoun, Alice O., M.D., Physician in the Departments of Family Medicine; Attending Staff Status; Effective Date of Resignation: July 20, 2017.


Desmett, Ashley L., M.D., Pulmonologist in the Departments of Medicine; Attending Staff Status; Effective Date of Resignation: June 30, 2017.


Duke, Duane S., M.D., Surgeon in the Departments of Surgery; Attending Staff Status; Effective Date of Resignation: June 30, 2017.


Esau, Sharon A., M.D., Pulmonologist in the Departments of Medicine; Attending Staff Status; Effective Date of Resignation: July 15, 2017.


Gosche, John R., M.D., Surgeon in the Departments of Surgery; Attending Staff Status; Effective Date of Resignation: June 30, 2017.


Hazarika, Surovi, M.D., Ph.D., Cardiologist in the Departments of Medicine; Attending Staff Status; Effective Date of Resignation: July 30, 2017.


Jeyanandarajan, Dhiraj R., M.D., Neurologist in the Departments of Neurology; Attending Staff Status; Effective Date of Resignation: July 25, 2017.


Keeley, Ellen C., M.D., Cardiologist in the Departments of Medicine; Attending Staff Status; Effective Date of Resignation: July 14, 2017.


Mahaney, Kelly B., M.D., Neurosurgeon in the Departments of Neurology; Attending Staff Status; Effective Date of Resignation: July 17, 2017.


Mehrad, Borna., M.D., Pulmonologist in the Departments of Medicine; Attending Staff Status; Effective Date of Resignation: July 14, 2017.


Oliver, M. Norman, M.D., Physician in the Departments of Family Medicine; Attending Staff Status; Effective Date of Resignation: July 9, 2017.


Palac, Susan M., M.D., Neurologist in the Departments of Neurology; Attending Status; Effective Date of Resignation: November 18, 2016.


Simmons, Lisa, M.D., Hematologist Oncologist in the Departments of Medicine; Attending Staff Status; Effective Date of Resignation: July 31, 2017.


Waterhouse, Stephanie G., M.D., Pediatrician in the Departments of Pediatrics; Attending Staff Status; Effective Date of Resignation: April 17, 2017.


5. PRIVILEGES FOR NEW ALLIED HEALTH PROFESSIONALS



RESOLVED, the recommendations of the Clinical Staff Executive Committee for the granting of privileges to the following Allied Health Professionals are approved:

Burgamy, Annely E., R.N., N.P., Pediatric Nurse Practitioner in the Department of Pediatrics; Period of Privileging: July 25, 2017 through July 24, 2018; Privileged as a Pediatric Nurse Practitioner.


Cleaves, Christine, R.N., N.P., Certified Nurse Anesthetist in the Department of Anesthesiology; Period of Privileging: July 31, 2017 through July30, 2018; Privileged as a Certified Nurse Anesthetist.


Comerzan, Katelyn, R.N., N.P., Acute Care Nurse Practitioner in the Department of Medicine; Period of Privileging: July 17, 2017 through July16, 2018; Privileged as an Acute Care Nurse Practitioner.



Dunbar, Catherine P., R.N., N.P., Family Nurse Practitioner in the Department of Anesthesiology; Period of Privileging: July 30, 2017 through July 29, 2018; Privileged as a Family Nurse Practitioner.


Dunivan, Kevin, R.N., N.P., Adult Gerontology Acute Care Nurse Practitioner in the Department of Neurology; Period of Privileging: July 16, 2017 through July15, 2018; Privileged as an Adult Gerontology Acute Care Nurse Practitioner.


Frank, Nicole, P.A., Physician Assistant in the Department of Pediatrics; Period of Privileging: July 31, 2017 through July 30, 2018; Privileged as a Physician Assistant.


Hove, Mary, R.N., N.P., Certified Nurse Anesthetist in the Department of Anesthesiology; Period of Privileging: July 31, 2017 through July30, 2018; Privileged as a Certified Nurse Anesthetist.


LeRoy, Susan, R.N., N.P., Pediatric Nurse Practitioner in the Department of Urology; Period of Privileging: July 31, 2017 through July 30, 2018; Privileged as a Pediatric Nurse Practitioner.

Rush-Evans, Shelly L, R.N., N.P., Adult Gerontology Acute Care Nurse Practitioner in the Department of Neurology; Period of Privileging: July 30, 2017 through July29, 2018; Privileged as an Adult Gerontology Acute Care Nurse Practitioner.


Schneiderman, Emily, R.N., N.P., Adult Gerontology Acute Care Nurse Practitioner in the Department of Surgery; Period of Privileging: July 30, 2017 through July29, 2018; Privileged as an Adult Gerontology Acute Care Nurse Practitioner.


6. RENEWAL OF PRIVILEGES FOR ALLIED HEALTH PROFESSIONALS


RESOLVED, the recommendations of the Clinical Staff Executive Committee for lthe renewal of privileges to the following Allied Health Professionals are approved:


Alvarez, Elizabeth, R.N., N.P., Adult Gerontology Nurse Practitioner in the Department of Surgery; Period of Privileging: September 9, 2017 through September 8, 2019; Privileged as an Adult Gerontology Nurse Practitioner.


Bailey, Pamela K., R.N., N.P., Pediatric Nurse Practitioner in the Department of Pediatrics; Period of Privileging: September 18, 2017 through September 17, 2019; Privileged as a Pediatric Nurse Practitioner.


Battle, Molly R.N., N.P., Adult Gerontology Nurse Practitioner in the Department of Surgery; Period of Privileging: September 11, 2017 through September 10, 2019; Privileged as an Adult Gerontology Nurse Practitioner.


Cross, Shelby T., R.N., N.P., Family Nurse Practitioner in the Department of Pediatrics; Period of Privileging: September 11, 2017 through September 10, 2019; Privileged as a Family Nurse Practitioner.


Floyd, Shawn, R.N., N.P., Acute Care Nurse Practitioner in the Department of Medicine; Period of Privileging: September 27, 2017 through September 26, 2019; Privileged as an Acute Care Nurse Practitioner.


Foster, Lisa W., P.A.., Physician Assistant in the Department of Medicine; Period of Privileging: September 9, 2017 through September 8, 2019; Privileged as a Physician Assistant.


George, Katie L., R.N., N.P., Adult Gerontology Nurse Practitioner in the Department of Surgery; Period of Privileging: September 29, 2017 through September 28, 2019; Privileged as an Adult Gerontology Nurse Practitioner.


Hamby, Jenny, R.N., N.P., Adult Gerontology Nurse Practitioner in the Department of Medicine; Period of Privileging: September 11, 2017 through September 10, 2019; Privileged as an Adult Gerontology Nurse Practitioner.


Hart, Jennifer A., P.A., Physician Assistant in the Department of Orthopedic Surgery; Period of Privileging: September 15, 2017 through September 14, 2019; Privileged as an Physician Assistant.


Kahler, Nicole, R.N., N.P., Adult Gerontology Nurse Practitioner in the Department of Medicine; Period of Privileging: September 8, 2017 through August 8, 2019; Privileged as an Adult Gerontology Nurse Practitioner.


Longley, Michelle, R.N., N.P., Geriatric Nurse Practitioner in the Department of Surgery; Period of Privileging: September 12, 2017 through September 11, 2019; Privileged as a Geriatric Nurse Practitioner.


Marshall, Michelle E., R.N., N.P., Adult Gerontology Nurse Practitioner in the Department of Surgery; Period of Privileging: September 25, 2017 through September 24, 2019; Privileged as an Adult Gerontology Nurse Practitioner.


Porreca, Anthony, P.A., Physician Assistant in the Department of Radiology and Medical Imaging; Period of Privileging: September 6, 2017 through September 5, 2019; Privileged as a Physician Assistant.


Roman, Amy, R.N., N.P., Acute Care Nurse Practitioner in the Department of Surgery; Period of Privileging: August 28, 2017 through August 27, 2019; Privileged as an Acute Care Nurse Practitioner.


Sites, Lindsey W., R.N., N.P., Certified Nurse Anesthetist in the Department of Anesthesiology; Period of Privileging: September 20, 2017 through September 19, 2019; Privileged as a Certified Nurse Anesthetist.


Viars, Ashley, R.N., N.P., Adult Gerontology Nurse Practitioner in the Department of Medicine; Period of Privileging: September 25, 2017 through September 24, 2019; Privileged as an Adult Gerontology Nurse Practitioner.


Walton, Drew H., R.N., N.P., Acute Care Nurse Practitioner in the Department of Surgery; Period of Privileging: September 3, 2017 through September 2, 2019; Privileged as an Acute Care Nurse Practitioner.


7. RESIGNATIONS OF ALLIED HEALTH PROFESSIONALS


RESOLVED, the recommendations of the Clinical Staff Executive Committee for the resignation and expiration of privileges to the following Allied Health Professionals are approved:

Argetsinger, Debora S., R.N., N.P., Adult Gerontology Acute Care Nurse Practitioner in the Department of Surgery; Effective Date of Resignation: June 29, 2017.


Hanson, Suzanne, R.N., N.P., Certified Nurse Anesthetist in the Department of Anesthesiology; Effective Date of Resignation: June 23, 2017.


Lee, Kathleen D, P.A., Physician Assistant in the Department of Urology; Effective Date of Resignation: July 7, 2017.


Madden, Krista, R.N., N.P., Certified Nurse Anesthetist in the Department of Anesthesiology; Effective Date of Resignation: June 23, 2017.


Miller, Jane, R.N., N.P., Family Nurse Practitioner in the Department of Medicine; Effective Date of Resignation: July 1, 2017.



Subudhi, Courtney M., R.N., N.P., Certified Nurse Midwife in the Department of Obstetrics and Gynecology; Effective Date of Resignation: July 22, 2017.


8. New Privileges to allied health professionals


RESOLVED the recommendations of the Clinical Staff Executive Committee for new procedural privileges to the following Allied Health Professional are approved:

Logan, Jenna, R.N., N.P., Adult Gerontology Acute Care Nurse Practitioner in the Department of Medicine. Additional Privileges for Bone Marrow Aspirations. Effective Date: August 1, 2017, through March 12, 2018.



CREDENTIALING AND RECREDENTIALING ACTIONS – HEALTH SYSTEM BOARD – APPROVED July 18, 2017


RECOMMENDED CREDENTIALING AND RECREDENTIALING ACTIONS


RESOLVED, pursuant to the delegation of authority contained in the September 15, 2011 Resolution of the Medical Center Operating Board, the undersigned hereby approve the following Credentialing and Recredentialing Actions as specifically set forth below:


1. APPOINTMENTS TO THE CLINICAL STAFF


RESOLVED, the recommendations of the Clinical Staff Executive Committee for appointment to the Clinical Staff of the University of Virginia Medical Center and the granting of specific privileges to the following practitioners are approved:



Abdelmalek, Cherif, M.D., Hematologist Oncologist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 7, 2017, through July 6, 2018; Privileged in Medicine.


Allen, Douglas, M.D., Pediatric Cardiologist in the Department of Pediatrics; Attending Staff Status; Period of Appointment: August 1, 2017, through July 31, 2018; Privileged in Pediatrics.


Beesley, Sharon, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Appointment: June 27, 2017, through June 26, 2018; Privileged in Radiology and Medical Imaging.


Berthaud, Jimmy, M.D., Neurologist in the Department of Neurology; Attending Staff Status; Period of Appointment: July 6, 2017, through July 5, 2018; Privileged in Medicine.


Chalian, Majid, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Appointment: June 29, 2017, through June 28, 2018; Privileged in Radiology and Medical Imaging.


Chavez-Mayorga, Cara, D.D.S., Dentist in the Department of Dentistry; Attending Staff Status; Period of Appointment: July 6, 2017, through July 5, 2018; Privileged in Dentistry.


Culver, Silas, M.D., Endocrinologist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 6, 2017, through July 5, 2018; Privileged in Medicine.


DeBerry, Jason, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Appointment: July 1, 2017, through June 30, 2018; Privileged in Radiology and Medical Imaging.


Derry, William, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Appointment: July 1, 2017, through June 30, 2018; Privileged in Radiology and Medical Imaging.


Elliott, Matthew, M.D., Neurologist in the Department of Neurology; Attending Staff Status; Period of Appointment: July 1, 2017, through June 30, 2018; Privileged in Neurology.


Fan, Jinbo, Ph.D., Pathologist in the Department of Pathology; Attending Staff Status; Period of Appointment: July 7, 2017, through July 6, 2018; Privileged in Pathology.


Fite, Jordan, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Appointment: June 29, 2017, through June 28, 2018; Privileged in Radiology and Medical Imaging.


Gupta, Shakun, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Appointment: June 21, 2017, through June 20, 2018; Privileged in Pediatrics.


Hsu, Johann, M.D., M.PH, Hematologist Oncologist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 1, 2017, through June 30, 2018; Privileged in Medicine.


Karimi, Ashkan, M.D., Cardiologist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 6, 2017, through July 5, 2018; Privileged in Medicine.


Kim, Su, M.D., Endocrinologist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 6, 2017, through July 5, 2018; Privileged in Medicine.


Kongkatong, Matthew, M.D., Physician in the Department of Emergency Medicine; Attending Staff Status; Period of Appointment: July 1, 2017, through June 30, 2018; Privileged in Emergency Medicine.


Kunk, Paul, M.D., Hematologist Oncologist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 1, 2017, through June 30, 2018; Privileged in Medicine.


Lapides, David, M.D., Neurologist in the Department of Neurology; Attending Staff Status; Period of Appointment: July 6, 2017, through July 5, 2018; Privileged in Neurology.


McCulloch, Michael, M.D., Pediatric Cardiologist in the Department of Pediatrics; Attending Staff Status; Period of Appointment: July 5, 2017, through July 4, 2018; Privileged in Pediatrics.


McEachern, Rachel, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Appointment: July 1, 2017, through June 30, 2018; Privileged in Radiology and Medical Imaging.


Mahjoub, Ali, M.D., Hematologist Oncologist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 1, 2017, through June 30, 2018; Privileged in Medicine.


Man, Louise, M.D., Hematologist Oncologist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 17, 2017, through July 16, 2018; Privileged in Medicine.


Mao, Lisa, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Appointment: June 29, 2017, through June 28, 2018; Privileged in Radiology and Medical Imaging.


McShane, Melissa, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 6, 2017, through July 5, 2018; Privileged in Medicine.


Mehra, Pooja, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 6, 2017, through July 5, 2018; Privileged in Medicine.


Mills, Ryan, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Appointment: July 3, 2017, through July 2, 2018; Privileged in Radiology and Medical Imaging.


Odrich, Marc, M.D., Ophthalmologist in the Department of Ophthalmology; Attending Staff Status; Period of Appointment: June 26, 2017, through June 25, 2018; Privileged in Ophthalmology.


Pace, Maria, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Appointment: July 1, 2017, through June 30, 2018; Privileged in Radiology and Medical Imaging.


Perry, Michael, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Appointment: July 6, 2017, through July 5, 2018; Privileged in Radiology and Medical Imaging.


Quirk, Cody, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Appointment: July 7, 2017, through July 6, 2018; Privileged in Radiology and Medical Imaging.


Sheeran, Daniel, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Appointment: July 1, 2017, through June 30, 2018; Privileged in Radiology and Medical Imaging.


Smith, Anna, M.D., Allergist and Immunologist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 7, 2017, through July 6, 2018; Privileged in Medicine.


Smith, Joshua, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Appointment: July 1, 2017, through June 30, 2018; Privileged in Radiology and Medical Imaging.



2. REAPPOINTMENTS TO THE CLINICAL STAFF


RESOLVED, the recommendations of the Clinical Staff Executive Committee for reappointment to the Clinical Staff of the University of Virginia Medical Center and the granting of specific privileges to the following practitioners are approved:

Archbald-Pannone, Laurie, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.


Ashraf, Mohammed, M.D., Nephrologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.


Bahl, Alisa, Ph.D., Psychologist in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Psychology.


Bauman, Kimberley, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.


Boyle, Annelee, M.D., Obstetrician and Gynecologist in the Department of Obstetrics and Gynecology; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Obstetrics and Gynecology.


Bergin, James, M.D., Cardiologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.


Brady, William, M.D., Physician in the Department of Emergency Medicine; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Emergency Medicine.


Brenner, Laurie, Ph.D., Psychologist in the Department of Neurology; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Psychology.


Browne, James, M.D., Orthopedic Surgeon in the Department of Orthopedic Surgery; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Orthopedic Surgery.


Brumfield, Sara, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.


Cagnina, Rebecca, M.D., Pulmonologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: August 1, 2017, through December 30, 2018; Privileged in Medicine.


Charlton, Jennifer, M.D., Pediatric Nephrologist in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Pediatrics.


Chiao, Sunny, M.D., Anesthesiologist in the Department of Anesthesiology; Attending Staff Status; Period of Reappointment: August 3, 2017, through March 30, 2019; Privileged in Anesthesiology.


Chisholm, Christian, M.D., Obstetrician and Gynecologist in the Department of Obstetrics and Gynecology; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Obstetrics and Gynecology.


Cohee, Mark, M.D., Physician in the Department of Family Medicine; Attending Staff Status; Period of Reappointment: August 5, 2017, through January 30, 2019; Privileged in Family Medicine.


Diamond-Myrsten, M.D., Physician in the Department of Family Medicine; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Family Medicine.


Domson, Gregory, M.D., Orthopedic Surgery in the Department of Orthopedic Surgery; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Orthopedic Surgery.


Forkin, Katherine, M.D., Anesthesiologist in the Department of Anesthesiology; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Anesthesiology.


Fu, Shu-Man, M.D., Rheumatologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.


Frazier, Katheryn, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: August 8, 2017, through February 27, 2019; Privileged in Pediatrics.


Glass, George, M.D., Physician in the Department of Emergency Medicine; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2018; Privileged in Emergency Medicine.


Gomez-Sanchez, Miriam, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.


Hallowell, Peter, M.D., Surgeon in the Department of Surgery; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Surgery.


Heinan, Kristen, M.D., Neurologist in the Department of Neurology; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Neurology.


Hixson, Harry, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Reappointment: July 1, 2017, through July 30, 2018; Privileged in Radiology and Medical Imaging.


Hulse, Matthew, M.D., Anesthesiologist in the Department of Anesthesiology; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Anesthesiology.


Janowski, Einsley-Marie, M.D., Ph.D., Radiation Oncologist in the Department of Radiation Oncology; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Radiation Oncology.


Jones, Sarah, M.D., Neurologist in the Department of Neurology; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Neurology.


Kelly, Heather, M.D., Anesthesiologist in the Department of Anesthesiology; Attending Staff Status; Period of Reappointment: August 12, 2017, through January 30, 2019; Privileged in Anesthesiology.


Khurana, Gitanjali, M.D., Rheumatologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: August 4, 2017, through August 3, 2019; Privileged in Medicine.


Landesman, Barbara, M.D., Neurologist in the Department of Neurology; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Neurology.


Larner, James, M.D., Radiation Oncologist in the Department of Radiation Oncology; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Radiation Oncology.


Latimer, Katherine, M.D., Obstetrician and Gynecologist in the Department of Obstetrics and Gynecology; Attending Staff Status; Period of Reappointment: August 4, 2017, through September 29, 2018; Privileged in Obstetrics and Gynecology.


L’Ecuyer, Thomas, M.D., Pediatric Cardiologist in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Pediatrics.


Leiner, John, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.


Luna, Max, M.D., Cardiologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: August 4, 2017, through August 3, 2019; Privileged in Medicine.


McGowan, Emily, M.D., Allergist and Immunologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: August 18, 2017, through January 30, 2019; Privileged in Medicine.


Mannem, Hannah, M.D., Pulmonologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: August 3, 2017, through August 30, 2019; Privileged in Medicine.


Manson, William, M.D., Anesthesiologist in the Department of Anesthesiology; Attending Staff Status; Period of Reappointment: August 8, 2017, through April 29, 2019; Privileged in Anesthesiology.


Mason, Pamela, M.D., Cardiologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.


Miller, Mark, M.D., Orthopedic Surgery in the Department of Orthopedic Surgery; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Orthopedic Surgery.


Moonah, Shannon, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Reappointment: August 3, 2017, through May 30, 2019; Privileged in Medicine.


Norwood, Victoria, M.D., Pediatric Nephrologist in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Pediatrics.


Okusa, Mark, M.D., Nephrologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.


Patel, Aarat, M.D., Pediatric Immunologist and Rheumatologist in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2018; Privileged in Pediatrics.


Ring, Kari, M.D., Obstetrician and Gynecologist in the Department of Obstetrics and Gynecology; Attending Staff Status; Period of Reappointment: August 18, 2017, through March 30, 2019; Privileged in Obstetrics and Gynecology.


Salajegheh, Reza, M.D., Anesthesiologist in the Department of Anesthesiology; Attending Staff Status; Period of Reappointment: September 30, 2017, through September 29, 2018; Privileged in Anesthesiology.


Scott, Chantal, M.D., Obstetrician and Gynecologist in the Department of Obstetrics and Gynecology; Attending Staff Status; Period of Reappointment: August 8, 2017, through January 30, 2019; Privileged in Obstetrics and Gynecology.


Schneider, Daniel, M.D., Pediatric Cardiologist in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Pediatrics.


Sharma, Arjun, M.D., Nephrologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: August 2, 2017, through February 27, 2019; Privileged in Medicine.


Sheeran, Jessica, M.D., Anesthesiologist in the Department of Anesthesiology; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Anesthesiology.


Shildkrot, Yevgeniy, M.D., Ophthalmologist in the Department of Ophthalmology; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Ophthalmology.


Showalter, Timothy, M.D., Radiation Oncologist in the Department of Radiation Oncology; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Radiation Oncology.


Sussdorf, Claudia, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Pediatrics.


Stone, James, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Radiology and Medical Imaging.


Swaminathan, Sundararaman, M.D., Nephrologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.


Thomas, Tania, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.


Tribble, Curtis, M.D., Surgeon in the Department of Surgery; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Surgery.


Upchurch, Gilbert, M.D., Surgeon in the Department of Surgery; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Surgery.


Weder, Max, M.D., Pulmonologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.


Werner, Brian, M.D., Orthopedic Surgeon in the Department of Orthopedic Surgery; Attending Staff Status; Period of Reappointment: August 18, 2017, through December 30, 2018; Privileged in Orthopedic Surgery.


William, Michael, M.D., Hematologist Oncologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.


3. RESIGNATIONS OF CLINICAL STAFF


RESOLVED, the recommendations of the Clinical Staff Executive Committee for the resignation and expiration of privileges to the following Clinical Staff are approved:

Alson, Amy R., M.D., Psychiatrist in the Departments of Medicine and Psychiatry and Neurobehavioral Sciences and Medicine; Effective Date of Resignation: June 30, 2017.


Berenz, Erin C., Ph.D., Psychologist in the Department of Pediatrics; Effective Date of Resignation: July 2, 2017.


Boyer, James E., M.D., Physician in the Department of Family Medicine; Effective Date of Resignation: July 2, 2017.


Bradley, Bradley M., M.D., Surgeon in the Department of Surgery; Effective Date of Resignation: July 1, 2017.


Buerlein, Ross C., M.D., Physician in the Department of Medicine; Effective Date of Resignation: June 30, 2017.


Burstein, Eitan S., M.D., Ophthalmologist in the Department of Ophthalmology; Effective Date of Resignation: June 30, 2017.


Collins, Andrew S., M.D., Ophthalmologist in the Department of Ophthalmology; Effective Date of Resignation: June 30, 2017.


Gabriel, Ryan T., M.D., Radiologist in the Department of Radiology and Medical Imaging; Effective Date of Resignation: June 30, 2017.


Geeslin, Matthew G., M.D., Radiologist in the Department of Radiology and Medical Imaging; Effective Date of Resignation: June 30, 2017.


Gumuscu, Burak., M.D., Pediatric Hematologist Oncologist in the Department of Pediatrics; Effective Date of Resignation: June 5, 2017.


Gurrola, Jose G., II., M.D., Otolaryngologist in the Department of Otolaryngology; Effective Date of Resignation: June 30, 2017.


Haley, Elliott C., Jr., M.D., Neurologist in the Department of Neurology; Effective Date of Resignation: July 1, 2017.


Hansen, Benjamin P., M.D., Physician in the Department of Family Medicine; Effective Date of Resignation: June 30, 2017.


Hass, Mark J., M.D., Radiologist in the Department of Radiology and Medical Imaging; Effective Date of Resignation: June 30, 2017.


Hill, Andrew J., M.D., Radiologist in the Department of Radiology and Medical Imaging; Effective Date of Resignation: June 30, 2017.

Hilton, Ebony J., M.D., Anesthesiologist in the Department of Anesthesiology; Effective Date of Resignation: June 30, 2017.


Holt, Harry R., M.D., Physician in the Department of Family Medicine; Effective Date of Resignation: June 23, 2017.


Jahann, Darius A.., M.D., Gastroenterologist in the Department of Family Medicine; Effective Date of Resignation: June 30, 2017.


LaFond, Sarah E., M.D., Radiologist in the Department of Radiology and Medical Imaging; Effective Date of Resignation: June 30, 2017.


Lazo, Christoher R., M.D., Radiologist in the Department of Radiology and Medical Imaging; Effective Date of Resignation: June 30, 2017.


Lin, Albert L., M.D., Ophthalmologist in the Department of Ophthalmology; Effective Date of Resignation: June 30, 2017.


Liu, Peter W., M.D., Physician in the Department of Medicine; Effective Date of Resignation: June 30, 2017.


McCall, Anthony L., M.D., Endocrinologist in the Department of Medicine; Effective Date of Retirement: July 1, 2017.


McCarter, Daniel F., M.D., Physician in the Department of Family Medicine; Effective Date of Retirement: June 30, 2017.


Macik, B. Gail, M.D., Hematologist Oncologist in the Departments of Medicine and Pathology; Effective Date of Retirement: June 30, 2017.


McCrum, Erin C., M.D., Radiologist in the Department of Radiology and Medical Imaging; Effective Date of Resignation: June 30, 2017.


McLoughlin, Erin M., M.D., Physician in the Department of Medicine; Effective Date of Resignation: June 30, 2017.


Naik, Roopa G., M.D., Physician in the Department of Medicine; Effective Date of Resignation: June 30, 2017.


Pace, Emma J.., M.D., Physician in the Department of Family Medicine; Effective Date of Resignation: June 30, 2017.


Palacios-Kibler, Thamiris V., D.O., Allergist and Immunologist in the Department of Medicine; Effective Date of Resignation: June 30, 2017.


Paladino, Walter P., M.D., Cardiologist in the Department of Medicine; Effective Date of Resignation: July 3, 2017.


Pooja J., M.D., Radiologist in the Department of Radiology and Medical Imaging; Effective Date of Resignation: June 30, 2017.


Ramirez-Montealegre, Denia, M.D., Neurologist in the Department of Neurology; Effective Date of Resignation: July 1, 2017.


Rosas, Edwin I., M.D., Hospitalist in the Department of Medicine; Effective Date of Resignation: June 30, 2017.


Sabri, Saher S., M.D., Radiologist in the Department of Radiology and Medical Imaging; Effective Date of Resignation: June 20, 2017.


Simpson, Allan G., M.D., Cardiologist in the Department of Medicine; Effective Date of Retirement: May 24, 2017.


Smith, Andrea R., M.D., Physician in the Department of Medicine; Effective Date of Resignation: June 30, 2017.


Starke Nathan R., M.D., Urologist in the Department of Urology; Effective Date of Resignation: June 30, 2017.


Stein, Kim M., M.D., Physician in the Department of Family Medicine; Effective Date of Resignation: June 30, 2017.


Sutphen, James L., M.D., Pediatric Gastroenterologist in the Department of Pediatrics; Effective Date of Resignation: July 1, 2017.


4. PRIVILEGES FOR NEW ALLIED HEALTH PROFESSIONALS



RESOLVED, the recommendations of the Clinical Staff Executive Committee for the granting of privileges to the following Allied Health Professionals are approved:

Harrison, Lisa K., R.N., N.P., Acute Care Nurse Practitioner in the Department of Medicine; Period of Privileging: June 18, 2017 through June 17, 2018; Privileged as an Acute Care Nurse Practitioner.


Iorio, Michael, R.N., N.P., Certified Nurse Anesthetist in the Department of Anesthesiology; Period of Privileging: June 19, 2017 through June 18, 2018; Privileged as a Certified Nurse Anesthetist.


Madden, Dana C., R.N., N.P., Pediatric Nurse Practitioner in the Department of Pediatrics; Period of Privileging: July 6, 2017 through July 4, 2018; Privileged as a Pediatric Nurse Practitioner.

Murry, Ann C., R.N., N.P., Adult Nurse Practitioner in the Department of Anesthesiology; Period of Privileging: June 19, 2017 through June 18, 2018; Privileged as an Adult Nurse Practitioner.


Schlieper, Katherine, O.D., Optometrist in the Department of Ophthalmology; Period of Privileging: July 6, 2017 through June 30, 2018; Privileged as an Optometrist.


5. RENEWAL OF PRIVILEGES FOR ALLIED HEALTH PROFESSIONALS


RESOLVED, the recommendations of the Clinical Staff Executive Committee for lthe renewal of privileges to the following Allied Health Professionals are approved:


Adams, Choi-Mei C., R.N., N.P., Family Nurse Practitioner in the Department of Medicine; Period of Privileging: August 20, 2017 through August 19, 2019; Privileged as a Family Nurse Practitioner.


Anzuini, Kayla, R.N., N.P., Adult Gerontology Nurse Practitioner in the Department of Medicine; Period of Privileging: August 15, 2017 through August 14, 2019; Privileged as an Adult Gerontology Nurse Practitioner.


Byrnes, Pamela D., R.N., N.P., Psychiatric Mental Health Nurse Practitioner in the Department of Psychiatry and Neurobehavioral Sciences; Period of Privileging: August 28, 2017 through August 27, 2019; Privileged as a Psychiatric Mental Health Nurse Practitioner.


Chen, Jie, R.N., N.P., Acute Care Nurse Practitioner in the Department of Surgery; Period of Privileging: August 6, 2017 through August 5, 2019; Privileged as an Acute Care Nurse Practitioner.


Charlebois, Donna, R.N., N.P., Acute Care Nurse Practitioner in the Department of Medicine; Period of Privileging: August 15, 2017 through August 14, 2019; Privileged as an Acute Care Nurse Practitioner.


Edwards, Jodie A., R.N., N.P., Certified Nurse Anesthetist in the Department of Anesthesiology; Period of Privileging: August 27, 2017 through August 26, 2019; Privileged as a Certified Nurse Anesthetist.


Forch, Edwina T., R.N., N.P., Geriatric Nurse Practitioner in the Department of Medicine; Period of Privileging: August 21, 2017 through August 20, 2019; Privileged as a Geriatric Nurse Practitioner.


Gott, Kristi K., R.N., N.P., Pediatric Nurse Practitioner in the Department of Pediatrics; Period of Privileging: August 24, 2017 through August 23, 2019; Privileged as a Pediatric Nurse Practitioner.


Johnson, Augustus, R.N., N.P., Certified Nurse Anesthetist in the Department of Anesthesiology; Period of Privileging: August 26, 2017 through August 25, 2019; Privileged as a Certified Nurse Anesthetist.


Long, Brandi J., R.N., N.P., Acute Care Nurse Practitioner in the Department of Neurology; Period of Privileging: August 4, 2017 through August 3, 2019; Privileged as an Acute Care Nurse Practitioner.


O’Connell, Kelly G., R.N., N.P., Pediatric Nurse Practitioner in the Department of Neurology; Period of Privileging: September 1, 2017 through August 31, 2019; Privileged as a Pediatric Nurse Practitioner.


Peluso, Melissa R., R.N., N.P., Acute Care Nurse Practitioner in the Department of Medicine; Period of Privileging: August 28, 2017 through August 27, 2019; Privileged as an Acute Care Nurse Practitioner.


Post, Michelle, P.A., Physician Assistant in the Department of Orthopedic Surgery; Period of Privileging: September 1, 2017 through August 31 2019; Privileged as a Physician Assistant.


Sorensen, Eric, R.N., N.P., Acute Care Nurse Practitioner in the Department of Emergency Medicine; Period of Privileging: August 16, 2017 through August 15, 2019; Privileged as an Acute Care Nurse Practitioner.


Ragsdale, Nancy V., P.A., Physician Assistant in the Department of Radiology and Medical Imaging; Period of Privileging: August 21, 2017 through August 20, 2019; Privileged as a Physician Assistant.


Tyger, Rosemarie L, P.A., Physician Assistant in the Department of Orthopedic Surgery; Period of Privileging: August 6, 2017 through August 5, 2019; Privileged as a Physician Assistant.


Viemeister, Leigh, R.N., N.P., Pediatric Nurse Practitioner in the Department of Neurology; Period of Privileging: August 5, 2017 through August 4, 2019; Privileged as a Pediatric Nurse Practitioner.


6. RESIGNATIONS OF ALLIED HEALTH PROFESSIONALS


RESOLVED, the recommendations of the Clinical Staff Executive Committee for the resignation and expiration of privileges to the following Allied Health Professionals are approved:

Borish, Lorraine M., R.N., N.P., Adult Nurse Practitioner in the Department of Medicine; Effective Date of Resignation: June 30, 2017.


Carrera, Nicole, R.N., N.P., Acute Care Nurse Practitioner in the Department of Medicine; Effective Date of Resignation: June 2, 2017.

Faraz, Asefeh, R.N., N.P., Family Nurse Practitioner in the Department of Medicine; Effective Date of Resignation: June 14, 2017.


Frank, Nicole, P.A., Physician Assistant in the Department of Pediatrics; Effective Date of Resignation: March 6, 2017.


Hunter, Elizabeth L., R.N., N.P., Pediatric Nurse Practitioner in the Department of Urology; Effective Date of Resignation: June 30, 2017.


Phipps, Kristin L., R.N., N.P., Family Nurse Practitioner in the Department of Medicine; Effective Date of Resignation: June 10, 2017.


Walton, Allison P., R.N., N.P., Family Nurse Practitioner in the Department of Neurosurgery; Effective Date of Resignation: June 9, 2017.


Wilson, Karie A., R.N., N.P., Acute Care Nurse Practitioner in the Department of Medicine; Effective Date of Resignation: June 16, 2017.


7. New Privileges to Clinical staff Members


RESOLVED, the recommendations of the Clinical Staff Executive Committee for new procedural privileges to Clinical Staff of the University of Virginia Medical Center and the granting of specific privileges to the following practitioners are approved:

Abuannadi, Mohammad, M.B.B.S., Cardiologist in the Department of Medicine. Additional Privileges for Cardiac Nuclear scan interpretation. Effective Date: June 14, 2017 – January 30, 2019.


Dailey, Tina, D.O., Anesthesiologist in the Department of Anesthesiology. Additional Privileges for Pain Medicine privileges. Effective Date: June 14, 2017 – February 27, 2019.


Dudley, Donald, M.D., Obstetrician and Gynecologist in the Department of Obstetrics and Gynecology. Additional Privileges for Nexplanon placement. Effective Date: June 14, 2017 – April 29, 2019.


Lim, Scott, M.D., Cardiologist in the Department of Medicine. New Privileges for Revivent Ventricular Reduction. Effective Date: June 14, 2017 – December 30, 2018.


Moses, Benjamin, M.D., Anesthesiologist in the Department of Anesthesiology. Additional Privileges for Critical Care Privileges. Effective Date: June 14, 2017 – October 30, 2018.


Pettit, Kate, M.D., Obstetrician and Gynecologist in the Department of Obstetrics and Gynecology. Additional Privileges for Nexplanon placement. Effective Date: June 14, 2017 – June 29, 2018.


Yarboro, Leora, M.D., Surgeon in the Department of Surgery. New Privileges for Revivent Ventricular Reduction. Effective Date: June 14, 2017 – February 27, 2018.


Ragosta, Michael, M.D., Cardiologist in the Department of Medicine. New Privileges for Revivent Ventricular Reduction. Effective Date: June 14, 2017 – November 29, 2018.


8. New Privileges to allied health professionals


RESOLVED, the recommendations of the Clinical Staff Executive Committee for new procedural privileges to the following Allied Health Professional are approved:

Parker, Corrie, R.N., N.P., Family Nurse Practitioner in the Department of Family Medicine. Additional Privileges for IUD placement. Effective Date: July 14, 2017, through June 18, 2018.


Schuman, Elizabeth, R.N., N.P., Family Nurse Practitioner in the Department of Medicine. Additional Privileges for Bone Marrow Aspiration and Biopsy. Effective Date: July 14, 2017, through February 5, 2018.


CREDENTIALING AND RECREDENTIALING ACTIONS – TRANSITIONAL CARE HOSPITAL – Approved July 26, 2017


RECOMMENDED CREDENTIALING AND RECREDENTIALING ACTIONS


RESOLVED, pursuant to the delegation of authority contained in the September 15, 2011 Resolution of the Health System Board, the undersigned hereby approve the following Credentialing and Recredentialing Actions as specifically set forth below:


1. APPOINTMENTS TO THE CLINICAL STAFF


RESOLVED, the recommendations of the Clinical Staff Executive Committee for appointment to the Clinical Staff of the University of Virginia Transitional Care Hospital and the granting of specific privileges to the following practitioners are approved:

Beesley, Sharon, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Appointment: June 27, 2017, through June 26, 2018; Privileged in Radiology and Medical Imaging.


Berthaud, Jimmy, M.D., Neurologist in the Department of Neurology; Consulting Staff Status; Period of Appointment: July 6, 2017, through July 5, 2018; Privileged in Neurology.


Chalian, Majid, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Appointment: June 29, 2017, through June 28, 2018; Privileged in Radiology and Medical Imaging.


Cooper, Meghan, M.D., Pulmonologist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 3, 2017, through July 2, 2018; Privileged in Medicine.

DeBerry, Jason, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Appointment: July 1, 2017, through June 30, 2018; Privileged in Radiology and Medical Imaging.


Derry, William, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Appointment: July 1, 2017, through June 30, 2018; Privileged in Radiology and Medical Imaging.


Elliott, Matthew, M.D., Neurologist in the Department of Neurology; Consulting Staff Status; Period of Appointment: July 1, 2017, through June 30, 2018; Privileged in Neurology.


Fite, Jordan, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Appointment: June 29, 2017, through June 28, 2018; Privileged in Radiology and Medical Imaging.


Karimi, Ashkan, M.D., Cardiologist in the Department of Medicine; Consulting Staff Status; Period of Appointment: July 6, 2017, through July 5, 2018; Privileged in Medicine.


McEachern, Rachel, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Appointment: July 1, 2017, through June 30, 2018; Privileged in Radiology and Medical Imaging.


McShane, Melissa, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 6, 2017, through July 5, 2018; Privileged in Medicine.


Mao, Lisa, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Appointment: June 29, 2017, through June 28, 2018; Privileged in Radiology and Medical Imaging.


Mehra, Pooja, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Appointment: July 6, 2017, through July 5, 2018; Privileged in Medicine.


Mills, Ryan, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Appointment: July 3, 2017, through July 2, 2018; Privileged in Radiology and Medical Imaging.


Pace, Maria, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Appointment: July 1, 2017, through June 30, 2018; Privileged in Radiology and Medical Imaging.


Perry, Michael, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Appointment: July 6, 2017, through July 5, 2018; Privileged in Radiology and Medical Imaging.


Quirk, Cody, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Appointment: July 7, 2017, through July 6, 2018; Privileged in Radiology and Medical Imaging.


Sheeran, Daniel, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Appointment: July 1, 2017, through June 30, 2018; Privileged in Radiology and Medical Imaging.


Smith, Anna, M.D., Allergist and Immunologist in the Department of Medicine; Consulting Staff Status; Period of Appointment: July 7, 2017, through July 6, 2018; Privileged in Medicine.


2. RECOMMENDED CREDENTIALING AND RECREDENTIALING ACTIONS


RESOLVED, the recommendations of the Clinical Staff Executive Committee for appointment to the Clinical Staff of the University of Virginia Transitional Care Hospital and the granting of specific privileges to the following practitioners are approved:


Bergin, James, M.D., Cardiologist in the Department of Medicine; Consulting Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.


Browne, James, M.D., Orthopedic Surgeon in the Department of Orthopedic Surgery; Consulting Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Orthopedic Surgery.


Brumfield, Sara, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.


Cagnina, Rebecca, M.D., Pulmonologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: August 1, 2017, through December 30, 2018; Privileged in Medicine.


Cornella, Scott L., M.D., Physician in the Department of Medicine; Moonlighting Staff Status; Period of Reappointment: July 6, 2017, through June 30, 2018; Privileged in Medicine.


Goldstein, Robert, M.D., Anesthesiologist in the Department of Anesthesiology; Consulting Staff Status; Period of Reappointment: August 5, 2017, through April 29, 2018; Privileged in Anesthesiology.


Gomez-Sanchez, Miriam, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.


Heinan, Kristen, M.D., Neurologist in the Department of Neurology; Consulting Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Neurology.


Hixson, Harry, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Reappointment: July 1, 2017, through July 30, 2018; Privileged in Radiology and Medical Imaging.


Hallowell, Peter, M.D., Surgeon in the Department of Surgery; Consulting Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Surgery.


Jones, Sarah, M.D., Neurologist in the Department of Neurology; Consulting Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Neurology.


King, Joshua, M.D., Nephrologist in the Department of Medicine; Consulting Staff Status; Period of Reappointment: August 1, 2017, through December 30, 2018; Privileged in Medicine.


Luna, Max, M.D., Cardiologist in the Department of Medicine; Consulting Staff Status; Period of Reappointment: August 4, 2017, through August 3, 2019; Privileged in Medicine.


Mannem, Hannah, M.D., Pulmonologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: August 3, 2017, through August 30, 2019; Privileged in Medicine.

Mason, Pamela, M.D., Cardiologist in the Department of Medicine; Consulting Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.


Miller, Mark, M.D., Orthopedic Surgery in the Department of Orthopedic Surgery; Consulting Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Orthopedic Surgery.


Okusa, Mark, M.D., Nephrologist in the Department of Medicine; Consulting Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.


Preston, Devon C., M.D., Physician in the Department of Medicine; Moonlighting Staff Status; Period of Reappointment: July 1, 2017, through June 30, 2018; Privileged in Medicine.


Ring, Kari, M.D., Obstetrician and Gynecologist in the Department of Obstetrics and Gynecology; Consulting Staff Status; Period of Reappointment: August 18, 2017, through March 30, 2019; Privileged in Obstetrics and Gynecology.


Salajegheh, Reza, M.D., Anesthesiologist in the Department of Anesthesiology; Consulting Staff Status; Period of Reappointment: September 30, 2017, through September 29, 2018; Privileged in Anesthesiology.


Shildkrot, Yevgeniy, M.D., Ophthalmologist in the Department of Ophthalmology; Consulting Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Ophthalmology.

Stone, James, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Radiology and Medical Imaging.


Swaminathan, Sundararaman, M.D., Nephrologist in the Department of Medicine; Consulting Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.


Thomas, Tania, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.


Upchurch, Gilbert, M.D., Surgeon in the Department of Surgery; Consulting Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Surgery.


Weder, Max, M.D., Pulmonologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 31, 2017, through July 30, 2019; Privileged in Medicine.

Werner, Brian, M.D., Orthopedic Surgeon in the Department of Orthopedic Surgery; Consulting Staff Status; Period of Reappointment: August 18, 2017, through December 30, 2018; Privileged in Orthopedic Surgery.


3. RENEWAL OF PRIVILEGES FOR ALLIED HEALTH PROFESSIONALS


RESOLVED, the recommendation of the Clinical Staff Executive Committee for the renewal of privileges to the following Allied Health Professional is approved:


Ragsdale, Nancy V., P.A., Physician Assistant in the Department of Radiology and Medical Imaging; Period of Privileging: August 21, 2017 through August 20, 2019; Privileged as a Physician Assistant.


4. RESIGNATIONS OF CLINICAL STAFF


RESOLVED, the recommendations of the Clinical Staff Executive Committee for the resignation and expiration of privileges to the following Clinical Staff are approved:

Buerlein, Ross C., M.D., Physician in the Department of Medicine; Effective Date of Resignation: June 30, 2017.


Gabriel, Ryan T., M.D., Radiologist in the Department of Radiology and Medical Imaging; Effective Date of Resignation: June 30, 2017.


Geeslin, Matthew G., M.D., Radiologist in the Department of Radiology and Medical Imaging; Effective Date of Resignation: June 30, 2017.


Haley, Elliott C., Jr., M.D., Neurologist in the Department of Neurology; Effective Date of Resignation: July 1, 2017.


Hass, Mark J., M.D., Radiologist in the Department of Radiology and Medical Imaging; Effective Date of Resignation: June 30, 2017.


Hill, Andrew J., M.D., Radiologist in the Department of Radiology and Medical Imaging; Effective Date of Resignation: June 30, 2017.


Jahann, Darius A.., M.D., Gastroenterologist in the Department of Family Medicine; Effective Date of Resignation: June 30, 2017.


Lazo, Christoher R., M.D., Radiologist in the Department of Radiology and Medical Imaging; Effective Date of Resignation: June 30, 2017.


Lin, Albert L., M.D., Ophthalmologist in the Department of Ophthalmology; Effective Date of Resignation: June 30, 2017.


Liu, Peter W., M.D., Physician in the Department of Medicine; Effective Date of Resignation: June 30, 2017.


McCrum, Erin C., M.D., Radiologist in the Department of Radiology and Medical Imaging; Effective Date of Resignation: June 30, 2017.


McLoughlin, Erin M., M.D., Physician in the Department of Medicine; Effective Date of Resignation: June 30, 2017.


Naik, Roopa G., M.D., Physician in the Department of Medicine; Effective Date of Resignation: June 30, 2017.


Nataro, James P., M.D., Pediatrician in the Department of Pediatrics; Effective Date of Resignation: June 30, 2017.


Paladino, Walter P., M.D., Cardiologist in the Department of Medicine; Effective Date of Resignation: July 3, 2017.


Rosas, Edwin I., M.D., Hospitalist in the Department of Medicine; Effective Date of Resignation: June 30, 2017.


Sabri, Saher S., M.D., Radiologist in the Department of Radiology and Medical Imaging; Effective Date of Resignation: June 20, 2017.


Sheth, Pooja J., M.D., Radiologist in the Department of Radiology and Medical Imaging; Effective Date of Resignation: June 20, 2017.


Smith, Andrea R., M.D., Physician in the Department of Medicine; Effective Date of Resignation: June 30, 2017.



CREDENTIALING AND RECREDENTIALING ACTIONS – HEALTH SYSTEM BOARD – Approved June 20, 2017


RECOMMENDED CREDENTIALING AND RECREDENTIALING ACTIONS


RESOLVED, pursuant to the delegation of authority contained in the September 15, 2011 Resolution of the Medical Center Operating Board, the undersigned hereby approve the following Credentialing and Recredentialing Actions as specifically set forth below:


1. APPOINTMENTS TO THE CLINICAL STAFF


RESOLVED, the recommendations of the Clinical Staff Executive Committee for appointment to the Clinical Staff of the University of Virginia Medical Center and the granting of specific privileges to the following practitioners are approved:

Gomes, Olubusola, M.D., Pulmonologist in the Department of Medicine; Attending Staff Status; Period of Appointment: May 5, 2017, through May 4, 2018; Privileged in Medicine.


Simmons, Lisa, M.D., Hematologist Oncologist in the Department of Medicine; Attending Staff Status; Period of Appointment: May 22, 2017, through May 21, 2018; Privileged in Medicine.



2. REAPPOINTMENTS TO THE CLINICAL STAFF


RESOLVED, the recommendations of the Clinical Staff Executive Committee for reappointment to the Clinical Staff of the University of Virginia Medical Center and the granting of specific privileges to the following practitioners are approved:

Bergman, Michael, M.D., Pulmonologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 11, 2017, through November 29, 2018; Privileged in Medicine.


Black, Katherine, M.D., Anesthesiologist in the Department of Anesthesiology; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Anesthesiology.


Bourque, Jamieson, M.D., Cardiologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Medicine.


Corbett, Sean, M.D., Urologist in the Department of Urology; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Urology.


Darby, Andrew, M.D., Cardiologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Medicine.


Dirghangi, Arjun, M.D., Ophthalmologist in the Department of Ophthalmologist; Instructor Staff Status; Period of Reappointment: July 6, 2017, through June 29, 2018; Privileged in Ophthalmologist.


Donahue, Joseph, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Reappointment: July 6, 2017, through February 27, 2019; Privileged in Radiology and Medical Imaging.


Doran, Amy, M.D., Gastroenterologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 5, 2017, through September 29, 2018; Privileged in Medicine.


Druzgal, Colleen, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Pediatrics.


Ehtesham, Asad, M.D., Nephrologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Medicine.


Elmer, Donald, M.D., Anesthesiologist in the Department of Anesthesiology; Instructor Staff Status; Period of Reappointment: July 5, 2017, through June 29, 2018; Privileged in Anesthesiology.


Gay, Spencer, M.D., Radiologist in the Department of Radiology and Medical Imaging; Administrative Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Radiology and Medical Imaging.


Hainstock, Lisa, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Pediatrics.


Hauck, Fern, M.D., Physician in the Department of Family Medicine; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Family Medicine.


Herrington, Pamila, M.D., Psychiatrist in the Department of Psychiatry and Neurobehavioral Sciences; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Psychiatry and Neurobehavioral Sciences.


Heymann, Peter, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Pediatrics.


Heysell, Scott, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Medicine.

Hryvniak, David, DO, Physiatrist in the Department of Physical Medicine and Rehabilitation; Attending Staff Status; Period of Reappointment: July 8, 2017, through November 29, 2018; Privileged in Pediatrics.


Irwin, Anna, D.O., Anesthesiologist in the Department of Anesthesiology; Attending Staff Status; Period of Reappointment: July 5, 2017, through October 30, 2018; Privileged in Anesthesiology.


Jane, John, M.D., Neurosurgeon in the Department of Neurosurgery; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Neurosurgery.


Kuo-Bonde, Lyida, M.D., Ph.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Reappointment: July 11, 2017, through March 30, 2019; Privileged in Radiology and Medical Imaging.


Kellams, Ann, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Pediatrics.


Kumral, Abigail, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: July 6, 2017, through June 29, 2019; Privileged in Pediatrics.


Kyaw, Thurein, M.D., Nephrologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 5, 2017, through April 29, 2019; Privileged in Medicine.


Le, Tri, M.D., Hematologist Oncologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 5, 2017, through December 30, 2018; Privileged in Medicine.


Lee, Daniel, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: July 17, 2017, through January 30, 2019; Privileged in Pediatrics.


Leiva Salinas, Carlos, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Reappointment: July 7, 2017, through April 29, 2019; Privileged in Radiology and Medical Imaging.


MacKnight, John, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Medicine.


Matthew, Sheena, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 22, 2017, through October 30, 2018; Privileged in Medicine.

Mills, Stacey, M.D., Pathologist in the Department of Neurosurgery; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Pathology.


Mithqal, Ayman, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Radiology and Medical Imaging.


Moore, Sean, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: July 8, 2017, through May 30, 2019; Privileged in Pediatrics.


Moses, Benjamin, M.D., Anesthesiologist in the Department of Anesthesiology; Attending Staff Status; Period of Reappointment: July 5, 2017, through October 30, 2018; Privileged in Anesthesiology.


Nataro, James, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Pediatrics.


Olazagasti, Juan, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Radiology and Medical Imaging.


Pace, Emma, M.D., Physician in the Department of Family Medicine; Instructor Staff Status; Period of Reappointment: July 15, 2017, through June 29, 2019; Privileged in Family Medicine.


Paget-Brown, Alix, M.D., Pediatrician in the Department of Pediatrics; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Pediatrics.


Pajewski, Thomas, M.D., Anesthesiologist in the Department of Anesthesiology; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Anesthesiology.


Pal, Kavita, M.D., Pulmonologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 1, 2017, through June 30, 2018; Privileged in Medicine.


Parsons, Andrew, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 6, 2017, through April 29, 2019; Privileged in Medicine.


Patel, Sohil, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Reappointment: July 6, 2017, through March 30, 2019; Privileged in Radiology and Medical Imaging.

Peura, David, M.D., Gastroenterologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Medicine.


Rizer, Justin, M.D., Physician in the Department of Emergency Medicine; Attending Staff Status; Period of Reappointment: July 28, 2017, through December 30, 2018; Privileged in Emergency Medicine.


Royer, Regan, M.D., Physiatrist in the Department of Physical Medicine and Rehabilitation; Attending Staff Status; Period of Reappointment: July 6, 2017, through April 29, 2019; Privileged in Physical Medicine and Rehabilitation.


Ruptka, James, M.D., Neurosurgeon in the Department of Neurosurgery; Attending Staff Status; Period of Reappointment: June 15, 2017, through January 30, 2019; Privileged in Neurosurgery.


Schectman, Joel, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Medicine.


Sudhir, Amita, M.D., Physician in the Department of Emergency Medicine; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Emergency Medicine.


Tocchio, Shannon, M.D., Radiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Reappointment: July 6, 2017, through December 30, 2018; Privileged in Radiology and Medical Imaging.


Uppal, Dushant, M.D., Gastroenterologist in the Department of Medicine; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Medicine.


Walters, Dustin, M.D., Surgeon in the Department of Surgery; Attending Staff Status; Period of Reappointment: July 22, 2017, through July 30, 2019; Privileged in Surgery.


Wilder, Robert, M.D., Physiatrist in the Department of Physical Medicine and Rehabilitation; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Physical Medicine and Rehabilitation.


Wolf, Stephen, M.D., Physician in the Department of Emergency Medicine; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Emergency Medicine.


Yen, Chun-Po, M.D., Neurosurgeon in the Department of Neurosurgery; Instructor Staff Status; Period of Reappointment: July 1, 2017, through June 29, 2018; Privileged in Neurosurgery.


3. SECONDARY REAPPOINTMENTS TO THE CLINICAL STAFF


RESOLVED the recommendations of the Clinical Staff Executive Committee for the secondary reappointment to the clinical staff of the University of Virginia Medical Center and the granting of specific privileges to the following practitioner are approved:

Bourque, Jamieson, M.D., Cardiologist in the Department of Radiology and Medical Imaging; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Noninvasive Cardiology Imaging.


Lee, Daniel, M.D., Pediatrician in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 17, 2017, through January 30, 2019; Privileged in Hematology Oncology.


4. RESIGNATIONS OF CLINICAL STAFF


RESOLVED, the recommendations of the Clinical Staff Executive Committee for the resignation and expiration of privileges to the following Clinical Staff are approved:

Michael, Glen E., M.D., Physician in the Department of Emergency Medicine; Effective Date of Resignation: April 1, 2017.


Poler, Joseph, Ph.D., Psychologist in the Department of Psychiatry and Neurobehavioral Sciences; Effective Date of Resignation: May 31, 2017.


Thomas, Mareen E., M.D., Pediatric Endocrinologist in the Department of Pediatrics; Effective Date of Resignation: March 28, 2017.


5. PRIVILEGES FOR NEW ALLIED HEALTH PROFESSIONALS



RESOLVED, the recommendations of the Clinical Staff Executive Committee for the granting of privileges to the following Allied Health Professionals are approved:


Boehling, Megan A., R.N., N.P., Adult Gerontology Acute Care Nurse Practitioner in the Department of Medicine; Period of Privileging: May 21, 2017 through May 20, 2018; Privileged as an Adult Gerontology Nurse Practitioner.



Hertwig, Stephene A., R.N., N.P., Adult Gerontology Acute Care Nurse Practitioner in the Department of Emergency Medicine; Period of Privileging: June 4, 2017 through June 3, 2018; Privileged as an Adult Gerontology Nurse Practitioner.


McDowell, Andrew, P.A., Physician Assistant in the Department of Surgery; Period of Privileging: June 5, 2017 through June 4, 2018; Privileged as a Physician Assistant.



Strobel, Katherine, R.N., N.P., Acute Care Nurse Practitioner in the Department of Surgery; Period of Privileging: June 5, 2017 through June 4, 2018; Privileged as an Acute Care Nurse Practitioner.


6. RENEWAL OF PRIVILEGES FOR ALLIED HEALTH PROFESSIONALS


RESOLVED, the recommendations of the Clinical Staff Executive Committee for the renewal of privileges to the following Allied Health Professionals are approved:


Anderson, Rachel, R.N., N.P., Acute Care Nurse Practitioner in the Department of Surgery; Period of Privileging: July 27, 2017 through July 26, 2019; Privileged as an Acute Care Nurse Practitioner.


Andrus, Sharon, R.N., N.P., Certified Nurse Anesthetist in the Department of Anesthesiology; Period of Privileging: July 23, 2017 through July 22, 2019; Privileged as a Certified Nurse Anesthetist.


Antonio, Anthony, R.N., N.P., Certified Nurse Anesthetist in the Department of Anesthesiology; Period of Privileging: August 1, 2017 through July 31, 2019; Privileged as a Certified Nurse Anesthetist.


Biggerstaff, Caitlin, R.N., N.P., Certified Nurse Anesthetist in the Department of Anesthesiology; Period of Privileging: July 5, 2017 through July 4, 2019; Privileged as a Certified Nurse Anesthetist.


Cole, Shelly, R.N., N.P., Certified Nurse Anesthetist in the Department of Anesthesiology; Period of Privileging: July 5, 2017 through July 4, 2019; Privileged as a Certified Nurse Anesthetist.


Condi, Gina T., R.N., N.P., Psychiatric Mental Health Nurse Practitioner in the Department of Psychiatry and Neurobehavioral Sciences; Period of Privileging: August 1, 2017 through July 31, 2019; Privileged as a Psychiatric Mental Health Nurse Practitioner.


Frame, Chelsea M., P.A., Physician Assistant in the Department of Neurosurgery; Period of Privileging: July 29, 2017 through July 28, 2019; Privileged as a Physician Assistant.


Freed-Pastor, Cassandra G., R.N., N.P., Acute Care Nurse Practitioner in the Department of Neurology; Period of Privileging: July 14, 2017 through July 13, 2019; Privileged as an Acute Care Nurse Practitioner.


Haden, Kathleen, R.N., N.P., Adult Nurse Practitioner in the Department of Surgery; Period of Privileging: July 15, 2017 through July 14, 2019; Privileged as an Adult Nurse Practitioner.



Howard, Naomi, R.N., N.P., Pediatric Nurse Practitioner in the Department of Pediatrics; Period of Privileging: July 22, 2017 through July 21, 2019; Privileged as a Pediatric Nurse Practitioner.


Huyett, Theresa R. R.N., N.P., Acute Care Nurse Practitioner in the Department of Surgery; Period of Privileging: July 18, 2017 through July 17, 2019; Privileged as an Acute Care Nurse Practitioner.


Jackson, Denise L., P.A., Physician Assistant in the Department of Otolaryngology; Period of Privileging: July 28, 2017 through July 27, 2019; Privileged as a Physician Assistant.


Kang, Min-hee, R.N., N.P., Acute Care Nurse Practitioner in the Department of Medicine; Period of Privileging: July 21, 2017 through July 20, 2019; Privileged as an Acute Care Nurse Practitioner.


Kaufman, Evan J., O.D., Optometrist in the Department of Ophthalmology; Period of Privileging: August 1, 2017 through July 31, 2019; Privileged as an Optometrist.


Kearns, James W., P.A., Physician Assistant in the Department of Neurology; Period of Privileging: July 25, 2017 through July 24, 2019; Privileged as a Physician Assistant.


Lohr, Karen M.., R.N., N.P., Adult Gerontology Acute Care Nurse Practitioner in the Department of Neurosurgery; Period of Privileging: July 25, 2017 through July 24, 2019; Privileged as an Adult Gerontology Acute Care Nurse Practitioner.


Loffler, Cynthia, R.N., N.P., Adult Nurse Practitioner in the Department of Medicine; Period of Privileging: July 15, 2017 through July 14, 2019; Privileged as an Adult Nurse Practitioner.


Metsch, Caroline B., P.A., Physician Assistant in the Department of Neurosurgery; Period of Privileging: July 6, 2017 through July 5, 2019; Privileged as a Physician Assistant.


Molnar, Helen, R.N., N.P., Acute Care Nurse Practitioner and Family Nurse Practitioner in the Departments of Medicine and Family Medicine; Period of Privileging: August 1, 2017 through July 31, 2019; Privileged as an Acute Care Nurse Practitioner and Family Nurse Practitioner.


Pandya, Mamta N., R.N., N.P., Acute Care Nurse Practitioner in the Department of Surgery; Period of Privileging: July 22, 2017 through July 21, 2019; Privileged as an Acute Care Nurse Practitioner.


Perry, Kelly, R.N., N.P., Certified Nurse Anesthetist in the Department of Anesthesiology; Period of Privileging: July 23, 2017 through July 22, 2019; Privileged as a Certified Nurse Anesthetist.


Rowell, Robert E., R.N., N.P., Adult Nurse Practitioner in the Department of Surgery; Period of Privileging: July 9, 2017 through July 8, 2019; Privileged as an Adult Nurse Practitioner.


Sturgill, Alison W., R.N., N.P., Pediatric Nurse Practitioner in the Department of Pediatrics; Period of Privileging: July 25, 2017 through July 24, 2019; Privileged as a Pediatric Nurse Practitioner.


Subudhi, Courtney M., R.N., N.P., Certified Nurse Midwife in the Department of Obstetrics and Gynecology; Period of Privileging: July 28, 2017 through July 17, 2019; Privileged as a Certified Nurse Midwife.


Tate, Anna L., R.N., N.P., Acute Care Nurse Practitioner in the Department of Surgery; Period of Privileging: July 31, 2017 through July 30, 2019; Privileged as an Acute Care Nurse Practitioner.


Vincel, Carol L., R.N., N.P., Acute Care Nurse Practitioner in the Department of Surgery; Period of Privileging: August 1, 2017 through July 31, 2019; Privileged as an Acute Care Nurse Practitioner.


White, Douglas N., R.N., N.P., Pediatric Nurse Practitioner in the Department of Pediatrics; Period of Privileging: July 21, 2017 through July 20, 2019; Privileged as a Pediatric Nurse Practitioner.


Wiencek, Clareen, R.N., N.P., Acute Care Nurse Practitioner in the Department of Medicine; Period of Privileging: July 26, 2017 through July 25, 2018; Privileged as an Acute Care Nurse Practitioner.


Wilson, Karie A., R.N., N.P., Acute Care Nurse Practitioner in the Department of Medicine; Period of Privileging: August 1, 2017 through July 31, 2019; Privileged as an Acute Care Nurse Practitioner.


Zhao, Hong, R.N., N.P., Acute Care Nurse Practitioner in the Department of Urology; Period of Privileging: July 17, 2017 through July 16, 2019; Privileged as an Acute Care Nurse Practitioner.


7. STATUS TO ALLIED HEALTH PROFESSIONAL STAFF


RESOLVED the recommendation of the Clinical Staff Executive Committee for the status change in clinical privileges to the following practitioners is approved:


Kirchoff, Lindsey, R.N., N.P., Acute Care Gerontology Nurse Practitioner in the Department of Surgery; Location Change; Period of Privileging: June 5, 2017 through June 4, 2018; Privileged as an Acute Care Gerontology Nurse Practitioner.



8. RESIGNATIONS OF ALLIED HEALTH PROFESSIONALS


RESOLVED, the recommendations of the Clinical Staff Executive Committee for the resignation and expiration of privileges to the following Allied Health Professionals are approved:


Allman, Marietta, R.N., N.P., Certified Nurse Anesthetist in the Department of Anesthesiology; Effective Date of Resignation: April 26, 2017.


Collins, Tami L., R.N., N.P., Acute Care Nurse Practitioner in the Department of Medicine; Effective Date of Resignation: May 4, 2017.


Hunt, Darren, R.N., N.P., Acute Care Nurse Practitioner in the Department of Surgery; Effective Date of Resignation: March 15, 2017.


Thompson, Cynthia A., R.N., N.P., Certified Nurse Anesthetist in the Department of Anesthesiology; Effective Date of Resignation: April 25, 2017.


9. New Privileges to Clinical staff Members


RESOLVED, the recommendations of the Clinical Staff Executive Committee for new procedural privileges to Clinical Staff of the University of Virginia Medical Center and the granting of specific privileges to the following practitioners are approved:


Darby, Andrew, M.D., Cardiologist in the Department of Medicine. New Privileges for Epicardial access for catheter mapping and ablation of ventricular tachycardia. Effective Date: June 9, 2017 – June 29, 2019.


Hryvniak, David, D.O., Physiatrist in the Department of Physical Medicine and Rehabilitation. New Privileges for ultrasound guided injections to peripheral tissues and joints and SI joint; Nerve hydrodissection and denervation with ultrasound guidance; ultrasound guided platlet rich plasm injections. Effective Date: June 9, 2017 – November 29, 2018.


MacKnight, John, M.D., Physician in the Department of Medicine. New Privileges for MSK Ultrasound for diagnosis and injections. Effective Date: June 9, 2017 – June 29, 2019.


Rusmussen, Sara, M.D., Surgeon in the Department of Surgery. New Privileges for Use of Robotic Assisted System for General Surgical Procedures. Effective Date: June 9, 2017 – March 30 2018.




CREDENTIALING AND RECREDENTIALING ACTIONS – TRANSITIONAL CARE HOSPITAL – Approved June 28, 2017


RECOMMENDED CREDENTIALING AND RECREDENTIALING ACTIONS


RESOLVED, pursuant to the delegation of authority contained in the September 15, 2011 Resolution of the Medical Center Operating Board, the undersigned hereby approve the following Credentialing and Recredentialing Actions as specifically set forth below:


1. APPOINTMENTS TO THE CLINICAL STAFF


RESOLVED, the recommendations of the Clinical Staff Executive Committee for appointment to the Clinical Staff of the University of Virginia Transitional Care Hospital and the granting of specific privileges to the following practitioners are approved:

McCade, Michael, M.D., Physician in the Department of Medicine; Moonlighting Staff Status; Period of Appointment: July 18, 2017, through June 30, 2018; Privileged in Medicine.


Sturek, Jeffrey, M.D., Physician in the Department of Medicine; Moonlighting Staff Status; Period of Appointment: August 3, 2017, through June 30, 2018; Privileged in Medicine.


2. REAPPOINTMENTS TO THE CLINICAL STAFF


RESOLVED, the recommendations of the Clinical Staff Executive Committee for appointment to the Clinical Staff of the University of Virginia Transitional Care Hospital and the granting of specific privileges to the following practitioners are approved:


Bergman, Michael, M.D., Pulmonologist in the Department of Medicine; Consulting Staff Status; Period of Reappointment: July 11, 2017, through November 29, 2018; Privileged in Medicine.


Bourque, Jamieson, M.D., Cardiologist in the Department of Medicine; Consulting Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Medicine.


Darby, Andrew, M.D., Cardiologist in the Department of Medicine; Consulting Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Medicine.


Donahue, Joseph, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Reappointment: July 6, 2017, through February 27, 2019; Privileged in Radiology and Medical Imaging.


Doran, Amy, M.D., Gastroenterologist in the Department of Medicine; Consulting Staff Status; Period of Reappointment: July 5, 2017, through September 29, 2018; Privileged in Medicine.

Druzgal, Colleen, M.D., Pediatrician in the Department of Pediatrics; Consulting Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Pediatrics.


Herrington, Pamila, M.D., Psychiatrist in the Department of Psychiatry and Neurobehavioral Sciences; Consulting Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Psychiatry and Neurobehavioral Sciences.


Heymann, Peter, M.D., Pediatrician in the Department of Pediatrics; Consulting Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Pediatrics.


Heysell, Scott, M.D., Physician in the Department of Medicine; Attending Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Medicine.


Hryvniak, David, DO, Physiatrist in the Department of Physical Medicine and Rehabilitation; Consulting Staff Status; Period of Reappointment: July 8, 2017, through November 29, 2018; Privileged in Pediatrics.


Jane, John, Jr., M.D., Neurosurgeon in the Department of Neurosurgery; Consulting Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Neurosurgery.


Kuo-Bonde, Lydia, M.D., Ph.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Reappointment: July 11, 2017, through March 30, 2019; Privileged in Radiology and Medical Imaging.


Leiva Salinas, Carlos, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Reappointment: July 7, 2017, through April 29, 2019; Privileged in Radiology and Medical Imaging.


Matthew, Sheena, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 22, 2017, through October 30, 2018; Privileged in Medicine.


Mills, Stacey, M.D., Pathologist in the Department of Neurosurgery; Consulting Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Pathology.


Mithqal, Ayman, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Radiology and Medical Imaging.


Nataro, James, M.D., Pediatrician in the Department of Pediatrics; Consulting Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Pediatrics.

Olazagasti, Juan, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Radiology and Medical Imaging.


Parsons, Andrew, M.D., Hospitalist in the Department of Medicine; Attending Staff Status; Period of Reappointment: July 6, 2017, through April 29, 2019; Privileged in Medicine.


Patel, Sohil, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Reappointment: July 6, 2017, through March 30, 2019; Privileged in Radiology and Medical Imaging.


Peura, David, M.D., Gastroenterologist in the Department of Medicine; Consulting Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Medicine.


Royer, Regan, M.D., Physiatrist in the Department of Physical Medicine and Rehabilitation; Consulting Staff Status; Period of Reappointment: July 6, 2017, through April 29, 2019; Privileged in Physical Medicine and Rehabilitation.


Tocchio, Shannon, M.D., Radiologist in the Department of Radiology and Medical Imaging; Consulting Staff Status; Period of Reappointment: July 6, 2017, through December 30, 2018; Privileged in Radiology and Medical Imaging.


Walters, Dustin, M.D., Surgeon in the Department of Surgery; Consulting Staff Status; Period of Reappointment: July 22, 2017, through July 30, 2019; Privileged in Surgery.


Wilder, Robert, M.D., Physiatrist in the Department of Physical Medicine and Rehabilitation; Consulting Staff Status; Period of Reappointment: June 30, 2017, through June 29, 2019; Privileged in Physical Medicine and Rehabilitation.


Yen, Chun-Po, M.D., Neurosurgeon in the Department of Neurosurgery; Consulting Staff Status; Period of Reappointment: July 1, 2017, through June 29, 2018; Privileged in Neurosurgery.


3. PRIVILEGES FOR ALLIED HEALTH PROFESSIONALS


RESOLVED, the recommendations of the Clinical Staff Executive Committee privileges to the following Allied Health Professional are approved:

Metsch, Caroline B., P.A., Physician Assistant in the Department of Neurosurgery; Period of Privileging: June 7, 2017, through June 6, 2018; Privileged as a Physician Assistant.


4. RENEWAL OF PRIVILEGES FOR ALLIED HEALTH PROFESSIONALS


RESOLVED, the recommendation of the Clinical Staff Executive Committee for the renewal of privileges to the following Allied Health Professional is approved:


Anderson, Rachel, R.N., N.P., Acute Care Nurse Practitioner in the Department of Surgery; Period of Privileging: July 27, 2017 through July 26, 2019; Privileged as an Acute Care Nurse Practitioner.


COMMITTEE ON THE UNIVERSITY OF VIRGINIA’S COLLEGE AT WISE – September 14, 2017


UVA-WISE COMMITTEE WORK PLAN FOR 2017-2018


RESOLVED, the Committee on The University of Virginia’s College at Wise approves the Fiscal Year 2017-2018 work plan:


  1. Student Recruitment and Retention

  2. Wise Affordability

  3. Regional Economic Development

  4. Collegiate Recovery Program (New)

  5. intra-disciplinary Coordination



BUILDINGS & GROUNDS COMMITTEE – SEPTEMBER 14, 2017


ARCHITECT/ENGINEER SELECTION FOR THE STUDENT HEALTH AND WELLNESS BUILDING


RESOLVED, VMDO of Charlottesville and Duda Paine of Durham, NC are approved for the performance of architectural services for the Student Health and Wellness Building.


ARCHITECT/ENGINEER SELECTION FOR THE THORNTON HALL C WING CLEAN ROOM UPGRADES


RESOLVED, Hodess Construction Corporation of Attleboro Falls, MA is approved for the performance of architectural services for the Thornton Hall C Wing Clean Room Upgrades.


ARCHITECT/ENGINEER SELECTION FOR THE MAIN HEAT PLANT NEW BOILER


RESOLVED, Jacobs Engineering Group of Fort Worth, Texas is approved for the performance of engineering services for the Main Heat Plant New Boiler.


ACADEMIC AND STUDENT LIFE COMMITTEE – SEPTEMBER 15, 2017

MEMORIAL RESOLUTION FOR PHILLIP A. PARRISH

WHEREAS, Phillip A. Parrish, known to everyone as Phil, joined the University of Virginia in 1996 as director of the UVA Intelligent Processing of Materials Lab in the School of Engineering and Applied Science; and

WHEREAS, Mr. Parrish became special assistant to the vice president for research in 2002, assistant vice president for research in 2006, and associate vice president for research in 2009; and

WHEREAS, Mr. Parrish over the years had a significant impact at UVA, including the development of UVA’s Center for Automata Processing, the NanoSTAR Institute, and a joint energy systems collaboration with the Max Planck Society’s Institute for Chemical Energy Conversion; and

WHEREAS, Mr. Parrish also helped establish an initiative focused on science, technology, policy and innovation partnerships with Latin American universities and companies, and recruitment to UVA of top Brazilian graduate students and postdoctoral fellows; and

WHEREAS, Mr. Parrish was appointed interim vice president for research of the University of Virginia on February 1, 2015; and

WHEREAS, in this role Mr. Parrish was responsible for the integration and enhancement of research activities across the University’s 11 schools and multiple research centers; and

WHEREAS, Mr. Parrish played a key role in the establishment of ResearchNet, a cross-University initiative with the objective of assisting faculty in the discovery of opportunities for external funding support and cross-University collaborations; and

WHEREAS Mr. Parrish helped establish UVA’s Pan-University Institutes, in both concept and execution; and

WHEREAS, Mr. Parrish had a significant career in private industry prior to his time at the University, including time at the Defense Advanced Research Projects Agency and the U.S. Office of Naval Research Global in London;

WHEREAS, Mr. Parrish co-held four patents, was the author of numerous journal articles, and received several awards from the U.S. military, having served on government scientific and engineering panels; and

WHEREAS, Mr. Parrish passed away on July 12, 2017;

RESOLVED, the Board of Visitors honors Phil Parrish for twenty-one years of outstanding University leadership.




This page intentionally left blank.



ATTACHMENTS

Attachment A


UNIVERSITY OF VIRGINIA

ENTERPRISE RISK MANAGEMENT CHARTER


  1. Mission


The purpose of the University of Virginia's Enterprise Risk Management (“ERM”) program is to strengthen the University’s ability to achieve its mission and strategic objectives. This is done by effectively managing key risks and seizing opportunities related to the achievement of our strategic objectives. In this context, risk encompasses both negative events (“downside risk”) and opportunities (“upside risk”). An effective ERM program helps the University effectively deploy its resources in pursuit of its objectives.


  1. Scope


The scope of the program includes ERM activities at the Academic Division, Health System, and College at Wise. The ERM function will work closely with the Audit and Compliance functions. Efficiencies are gained through collaboration among the three functions, including:


This collaboration is accomplished while recognizing the distinct roles played by each party. Treasury is responsible for leading ERM within the organization. Compliance is responsible for monitoring and promoting adherence to laws and regulations. Internal Audit is responsible, in part, for examining and evaluating the adequacy and effectiveness of the University’s governance, risk management, and internal controls.


  1. Objectives


In support of the ERM program’s purpose, the objectives of the program include:




  1. Roles and Organization


The President of the University is the owner of the ERM program. Responsibility for administering the program is delegated to the University’s Treasurer. ERM is effected by the University’s Board and leadership and is a collaborative effort at various levels of the organization, including:


Risk Management Networks


Risk Management Networks (“RMN’s”) exist for both the Academic Division and the Health System. Membership consists of higher-level individuals who can (1) provide perspective on industry trends, and (2) have a deep understanding of University operations. Their role is to help identify emerging risks and cascade ERM initiatives into the University’s departments.


Risk Management Council


The Risk Management Council (“RMC”) is comprised of representatives from the major functional areas of the University, including the Health System. The RMC’s objectives are to provide guidance and expertise in helping steer the efforts of the ERM program.  


University Executive Leadership


The RMC will review key risks and mitigation strategies with the University’s executive leadership. Executive leadership will help set the University’s risk appetite, contribute to the assessment of risks, and provide guidance on how to report key risks to the ACR.


The Board of Visitors’ Audit, Compliance, and Risk (“ACR”) Committee


The ACR Committee will:



The Treasurer will communicate and interact directly with the Chair of the ACR committee, including in executive sessions and between ACR committee meetings as appropriate.


  1. Charter Review


The ERM Charter should be annually reviewed and, if necessary, updated to determine if the charter continues to reflect the institution’s risk management priorities.

Attachment B


UNIVERSITY OF VIRGINIA ATHLETICS COMPLIANCE CHARTER


The University of Virginia (the “University”) Athletics Compliance Office is designed to ensure that the intercollegiate athletics program is operated within the rules and regulations of the University, the Atlantic Coast Conference (ACC), and the National Collegiate Athletic Association (NCAA). Compliance with these rules and regulations is the shared responsibility of everyone associated with the University. In order for institutional control to be maintained, the NCAA Committee on Infractions developed principles with the idea of assisting institutions to better understand the efforts and attitudes needed in order to create an atmosphere of compliance and institutional control.


As stipulated by NCAA Bylaw 6.1.1 and requirement for participation within the ACC as indicated in Article XI, Section XI-2 of the ACC Bylaws, the ultimate authority and accountability for the University athletics program rests with the University President. The President is appointed by the University Board of Visitors, and through the Board’s delegation of authority the President has ultimate responsibility for the Athletics Department. To share in the responsibilities of NCAA and ACC oversight, the University President delegates day-to-day administration of the University Athletics Department to the Director of Athletics, who in-turn shares that responsibility with the Athletics Compliance Office. In fulfilling the obligation to exercise institutional control, the Athletics Compliance Office has a direct reporting line to the Director of Athletics and to the University President. The University Athletics Compliance Program will interface with student-athletes, coaches, athletic staff members, other University personnel, as well as the University’s alumni and friends. The Athletics Compliance Office will assist coaches and staff by developing and maintaining a compliance program that will educate, monitor, interpret, and report rules violations, if they occur.


As mentioned above, Compliance is a shared responsibility within the University. To ensure the University maintains institutional control and full compliance with applicable rules, departments outside of the Athletics Department have responsibility for certain NCAA, ACC, and University compliance functions, as outlined below:


Faculty Athletics Representative (FAR): The FAR serves as a liaison for the President between the University Faculty and the Athletics Department; reviews student-athlete grade distribution at the end of each academic term; reviews and approves student-athlete grade changes; serves as the ACC’s voting representative for institutional positioning on NCAA/ACC legislation, and may serve the same role for the NCAA’s voting representative if need be as directed by the President; and assists in review of potential academic misconduct/impermissible academic assistance allegations/violations.


Admissions: The Office of Undergraduate Admission has ultimate responsibility to determine which prospective student-athletes are admitted to the University. The Athletics Department will have designated liaisons who may speak with Admission regarding a prospective student-athlete’s admission.


University Registrar (UREG): The University Registrar is the certifying officer for all student-athlete academic eligibility, including initial, continuing, and transfer eligibility certification; full-time enrollment; and NCAA Academic Performance Review cohort review.


Student Financial Services (SFS): The SFS office is the certifying officer for student-athlete financial aid; responsible for squad list production/completion; outside award certification; and athletic aid renewal/non-renewal notifications.


Athletic Academic Affairs: The Athletic Academic Affairs office collaboratively works with UREG and the Athletics Compliance Office to monitor student-athlete eligibility; and communicates with faculty and staff regarding student-athletes’ academic requirements for NCAA academic purposes since only academic advisors within the University departments can add student-athletes to courses.


Institutional Assessment and Studies: The Office of Institutional Assessment and Studies is responsible for tracking and reporting graduation rate and Graduation Success Rate cohort review.


Executive Vice President and Chief Operating Officer and Assistant Vice President for Institutional Compliance: During quarterly meetings with the Executive Vice President and Chief Operating Officer, the Assistant Vice President for Institutional Compliance, and the University President’s Chief of Staff, the Athletics Compliance Office reviews any compliance concerns, reporting requirements, potential violations, and the results of any external compliance reviews. In addition, the Athletics Compliance Office meets bimonthly with the University’s Compliance Network to share compliance-related concerns, trends, and best-practices.

Attachment C


AMENDED CAPITAL PROJECT PROCUREMENT PROCESS


Executive Summary


Purpose: Pursuant to Chapters 699 and 704 of the 2017 Acts of Assembly, the following updated process is provided to the University’s Board of Visitors for approval. Any subsequent changes to these procedures will be submitted to the Department of General Services (DGS) for review and comment, and to the Board of Visitors for approval.


Procedure: In accordance with Chapters 699 and 704 of the 2017 Acts of Assembly, and subject to Subchapter 3 of the Restructuring Act and the associated Management Agreement between the Commonwealth of Virginia and the University of Virginia, the University shall have and shall exercise all authority relating to the procurement of construction. Documentation adopted by the University and approved by the Board of Visitors identifies procurement procedures for capital construction.


The University of Virginia Associate Vice President and Chief Facilities Officer (AVP & CFO) shall approve construction delivery methods, and any exceptions, in writing on a project specific basis.


A written recommendation for the construction delivery method will be provided to the AVP & CFO through the Director of Facilities Planning & Construction (FP&C) in consultation with the University management team comprised of the University Project Manager, the FP&C Division Director, and the Construction Services and Contract Administration Director. FP&C completes a risk analysis for each project, and if competitive sealed bidding is not selected, the written recommendation will justify why sealed bidding is not practicable and/or fiscally advantageous to the University. Written documentation will be in a Determination and Findings (D&F) format.


Risk Analysis: The following critical components will be considered in recommending the appropriate construction delivery method for each project:



FP&C will submit documentation for the construction delivery method for each project to DGS for a five-day review. Upon receipt of DGS recommendations, UVA will make any amendments to address DGS’ comments, document UVA action in the project file, and submit to DGS.


Related Requirements of Chapter 699 and 704 of the 2017 Acts of Assembly:


Reporting: The University will report on completed capital projects in excess of $2 million in construction cost annually as requested by DGS.


References:

Approval and Revisions:


UVA Policy for Construction Management at Risk (CM at Risk)

In accordance with the provisions of §§ 2.2-4378, 2.2-4379, and 2.2-4381 of the Code of Virginia, UVA has adopted the following Policy for the use of CM at Risk. For convenience of use, UVA will replace SECTION 11.3 of the UVA Higher Education Capital Outlay Manual with this new policy. However, this is a stand-alone policy, approved and recorded by the Board of Visitors, and will not be modified without Board of Visitors’ approval.


  1. Criteria for Use:

    1. Provide a written determination that competitive sealed bidding is not practicable or fiscally advantageous (§ 2.2-4381.C.1). The AVP & CFO is the approving authority for requests to use CM at Risk.

    2. Written determination shall include the basis of determination including one or more of the following:

      1. Construction Cost (§§ 2.2-4381.B.1 and 2.2-4381.D.3)

      2. Project Complexity (§§ 2.2-4381.B.1 and 2.2-4381.D.4)

      3. Building Use (§§ 2.2-4381.B.1 and 2.2-4381.D.3)

      4. Project Timeline (§§ 2.2-4381.B.1 and 2.2-4381.D.3)

      5. Project Phasing (§ 2.2-4381.D.5)

      6. Necessity of Value Management and/or Constructability Analysis Concurrent with Design (§ 2.2-4381.D.5)

      7. Quality Control/ Vendor Prequalification Needs (§ 2.2-4381.D.5)

      8. Cost/ Design Control Needs (§ 2.2-4381.D.5)

    3. A licensed architect or engineer shall be employed or under contract to advise in use of CM at Risk (§ 2.2-4381.C.2).


  1. DGS Review of Procurement Method (§§ 2.2-4381.D through 2.2-4381.F):

    1. Submit the following to DGS for review:

      1. Written determination for each project.

      2. Completed DGS CM at Risk Procurement Review Submittal Form identifying project characteristics relevant to CM at Risk procurement.

    2. Upon receipt of DGS Recommendation within 5 working days, UVA shall:

      1. Address DGS comments as necessary.

      2. Document UVA action in project file and submit to DGS.



  1. Procurement Procedures:

    1. AVP & CFO shall appoint a selection committee consisting of at least three members from UVA, including a licensed design professional, if possible.

    2. Enter into contract no later than the completion of the schematic phase of design unless prohibited by authorization of funding restrictions (§ 2.2-4381.C.4).

    3. Use a two-step RFQ/RFP process (§ 2.2-4381.C.7).

    4. Prepare a RFQ containing UVA’s project overview and justification for use of CM at Risk (§ 2.2-4381.C.1). All offerors shall have a licensed Class “A” Contractor registered in the Commonwealth of Virginia as part of the project team.

    5. RFQ shall include evaluation criteria and be posted in accordance with current Code of Virginia requirements for a minimum of 30 days (§ 2.2-4381.C.3).

    6. Selection committee evaluates the firms’ RFQ responses and any other relevant information and recommends those best qualified with respect to criteria established in RFQ. The AVP & CFO shall approve the best qualified CMs to receive an RFP.

    7. RFQ process shall result in short list of 2-5 offerors to receive RFP
      (§ 2.2-4381.D.5).

    8. RFP shall include evaluation criteria and be posted in accordance with the current requirements in the Code of Virginia.

    9. Offerors who were not selected for the short list shall be provided written notification and the reasons for such decision.

    10. Selection committee shall evaluate and rank the firms’ proposals. Prior CM at Risk or BCOM experience shall not be a prerequisite for award (§ 2.2-4381.C.5).

    11. The AVP & CFO shall approve the CM deemed fully qualified and providing best value in response to the RFP, and the contract shall be awarded to that offeror.

    12. UVA shall notify all offerors who submitted proposals which offeror was selected for the project. When so provided in RFP, awards may be made to more than one offeror.

    13. Upon request, a debriefing of the selection process will be made available to any offeror.


  1. Contracting Requirements:

    1. CM preconstruction/document review phase services shall be contracted as a non-professional service (§ 2.2-4301).

    2. Fixed price of construction will be established at completion of construction drawings based on actual subcontractor pricing (§ 2.2-4381.A). If UVA and the CM cannot agree on a fixed price, UVA may competitively bid the project with the other prequalified CM offerors or enter into competitive negotiations with the other prequalified CM offerors in accordance with the requirements of the Code of Virginia.

    3. Interim fixed prices for early release packages are permitted.

    4. Ninety percent of construction work must be subcontracted through publicly advertised, competitive sealed bidding to the maximum extent practicable (§ 2.2-4381.C.6).



UVA Policy for Design-Build (D/B)

In accordance with the provisions of §§ 2.2-4378, 2.2-4379, and 2.2-4381 of the Code of Virginia, UVA has adopted the following Policy for the use of Design-Build (D/B). For convenience of use, UVA will replace SECTION 11.2 of the UVA Higher Education Capital Outlay Manual with this new policy. However, this is a stand-alone policy, approved and recorded by the Board of Visitors, and will not be modified without Board of Visitors’ approval.


  1. Criteria for Use:

    1. Provide a written determination that competitive sealed bidding is not practicable or fiscally advantageous (§ 2.2-4381.C.1). The AVP & CFO is the approving authority for requests to use D/B procedures.

    2. Written determination shall include the basis of determination including one or more of the following:

      1. Construction Cost (§§ 2.2-4381.B.1 and 2.2-4381.D.3)

      2. Project Complexity (§§ 2.2-4381.B.1 and 2.2-4381.D.4)

      3. Building Use (§§ 2.2-4381.B.1 and 2.2-4381.D.3)

      4. Project Timeline (§§ 2.2-4381.B.1 and 2.2-4381.D.3)

      5. Need for Single Point of Responsibility

    3. A licensed architect or engineer shall be employed or under contract to advise in use of D/B (§ 2.2-4381.C.2).


  1. DGS Review of Procurement Method (§§ 2.2-4381.D through 2.2-4381.F):

    1. Submit the following to DGS for review:

      1. Written determination for each project.

      2. Completed DGS D/B Procurement Review Submittal Form identifying project characteristics relevant to D/B procurement.

    2. Upon receipt of DGS Recommendation within 5 working days, UVA shall:

      1. Address DGS comments as necessary.

      2. Document UVA action in project file and submit to DGS.


  1. Procurement Procedures:

    1. AVP & CFO shall appoint a selection committee consisting of at least three members from UVA, including a licensed design professional, if possible.

    2. Use a two-step RFQ/RFP process (§ 2.2-4381.C.7).

    3. Prepare a RFQ containing UVA’s project overview and justification for use of D/B (§ 2.2-4381.C.1). All offerors shall have a licensed Class “A” Contractor and an architect or engineer registered in the Commonwealth of Virginia as part of the project team.

    4. RFQ will include evaluation criteria and be posted in accordance with current Code of Virginia requirements for a minimum of 30 days (§ 2.2-4381.C.3).

    5. Selection committee evaluates the firms’ RFQ responses and any other relevant information and recommends those best qualified with respect to criteria established for project in RFQ. Prior D/B or BCOM experience shall not be a prerequisite for award (§ 2.2-4381.C.5). The AVP & CFO shall approve the best qualified D/B’s to receive an RFP.

    6. RFQ process shall result in short list of 2-5 offerors to receive RFP
      (§ 2.2-4381.D.5).

    7. RFP shall include evaluation criteria and be posted in accordance with the current requirements in the Code of Virginia. Cost shall be a critical component of selection process.

    8. Offerors who were not selected for the short list shall be provided written notification and the reasons for such decision.

    9. Sealed technical proposals as described in the RFP shall be submitted to the selection committee. Separately sealed cost proposals shall be submitted to UVA’s Virginia Construction Contracting Officer (VCCO), and shall be secured and kept sealed until evaluation of the technical proposals is completed
      (§ 2.2-4381.A).

    10. Selection committee shall evaluate the firms’ technical proposals based upon the criteria contained in the RFP. It shall inform each D/B offeror of any adjustments necessary to make its technical proposal fully comply with the requirements of the RFP. In addition, UVA may require that offerors make design adjustments necessary to incorporate project improvements and/or additional detailed information identified by the selection committee during design development (§ 2.2-4381.A).

    11. Based upon any adjustments requested by the selection committee, the offeror shall provide a revised technical proposal and cost proposal as necessary. In addition, an offeror may submit cost modifications to its original sealed cost proposal which are not based upon revisions to the technical proposals
      (§ 2.2-4381.A).

    12. Selection committee shall evaluate and rank the firms’ technical proposals and open any revised cost proposals and apply the criteria for award as specified in the RFP (§ 2.2-4381.A).

    13. After evaluation and ranking, the Committee may conduct additional negotiations with two or more offerors submitting the highest-ranked proposals and provide their recommendation to the AVP & CFO (§ 2.2-4381.A).

    14. Prior D/B or BCOM experience shall not be a prerequisite for award
      (§ 2.2-4381.C.5).

    15. The AVP & CFO shall approve the D/B deemed fully qualified and providing best value in response to the RFP, and the contract shall be awarded to that offeror.

    16. UVA will notify all offerors who submitted proposals, which offeror was selected for the Project. When so provided in the RFP, awards may be made to more than one offeror.

    17. Upon request, a debriefing of the selection process will be made available to any offeror.

Attachment D









THE RECTOR AND VISITORS OF THE

UNIVERSITY OF VIRGINIA





_____________________________________

Master Bond Resolution (Multi-Year Capital Program)
_____________________________________




AUTHORIZING AND SECURING

GENERAL REVENUE PLEDGE BONDS

ADOPTED __________, 2017


Master Bond Resolution (Multi-Year Capital Program)

ADOPTED ON __________, 2017

THE RECTOR AND VISITORS OF THE
UNIVERSITY OF VIRGINIA
GENERAL REVENUE PLEDGE BONDS


____________________

TABLE OF CONTENTS
____________________

Page

ARTICLE I
DEFINITIONS

Section 1.1 Definitions 2

Section 1.2 Rules of Construction/Use of Words and Phrases 7

ARTICLE II
AUTHORIZATION, FORM, EXECUTION, DELIVERY,
REGISTRATION AND PAYMENT OF THE BondS

Section 2.1 Authorization of the Bonds 7

Section 2.2 Form and Details of Each Series of Bonds 7

Section 2.3 Changes in Mode 7

Section 2.4 Execution of the Bonds 8

Section 2.5 Transfer of the Bonds 8

Section 2.6 Exchange of the Bonds 9

Section 2.7 Bond Register; Notices; Persons Treated as Owners 9

Section 2.8 Temporary Bonds 9

Section 2.9 Bonds Mutilated, Lost, Destroyed, Stolen or Undelivered 10

ARTICLE III
REDEMPTION AND PURCHASE OF THE BondS; liquidity facility; remarketing agent; tender agent

Section 3.1 Redemption of the Bonds 11

Section 3.2 Selection of Bonds for Redemption 11

Section 3.3 Notice of Redemption 11

Section 3.4 Effect of Calling for Redemption 12

Section 3.5 The Bonds Redeemed Not Deemed Outstanding 12

Section 3.6 Remarketing Agent 12

Section 3.7 Tender Agent 13

Section 3.8 Several Capacities 13

ARTICLE IV
ISSUANCE OF BondS

Section 4.1 Issuance of Bonds 13

Section 4.2 Terms and Conditions for Issuance and Delivery of the Bonds 14

Section 4.3 Authentication and Delivery 15

Section 4.4 Application of Bond Proceeds 15

Section 4.5 Items of Cost of the Project 15

ARTICLE V
FUNDS AND REVENUES

Section 5.1 Establishment of Funds 16

Section 5.2 Payments to Bondholders 16

Section 5.3 Pledge of Funds and Accounts 16

Section 5.4 Moneys Held in Trust 16

Section 5.5 Cancellation of the Bonds Upon Payment 16

Section 5.6 No Risk to Paying Agent Funds 17

ARTICLE VI
PARTICULAR COVENANTS

Section 6.1 Payment of Principal and Interest; Pledge of Pledged Revenues 17

Section 6.2 Additional Indebtedness and Encumbrances 17

Section 6.3 Disposition of Assets 19

Section 6.4 Insurance 19

Section 6.5 Rights of Bondholders Not to Be Impaired 19

Section 6.6 Further Instruments and Actions 20

Section 6.7 Accurate Records and Accounts 20

Section 6.8 Recognized Accounting Principles 20

Section 6.9 Security for Deposits 20

Section 6.10 Permitted Investments 20

ARTICLE VII
EVENTS OF DEFAULT AND REMEDIES

Section 7.1 Events of Default 20

Section 7.2 Remedies 21

Section 7.3 Pro Rata Application of Funds 22

Section 7.4 Effect of Discontinuance of Proceedings 23

Section 7.5 Proceedings for Equal Benefit of All Bondholders 23

Section 7.6 No Remedy Exclusive 23

Section 7.7 No Delay or Omission Construed to Be a Waiver 23

ARTICLE VIII
EXECUTION OF INSTRUMENTS BY BONDHOLDERS
AND PROOF OF OWNERSHIP OF THE BondS

Section 8.1 Execution of Instruments; Proof of Ownership 24

ARTICLE IX
SUPPLEMENTAL RESOLUTIONS

Section 9.1 Supplemental Resolutions 24

Section 9.2 Modification of Resolution with Consent of Bondholders 26

Section 9.3 Supplemental Resolutions Part of This Resolution 27

ARTICLE X
DEFEASANCE

Section 10.1 Defeasance 27

Section 10.2 Liability of University Not Discharged 28

Section 10.3 Provision for Payment of Particular Bonds 28

ARTICLE XI
MISCELLANEOUS PROVISIONS

Section 11.1 Effect of Covenants 29

Section 11.2 Successor Paying Agents or Registrars 29

Section 11.3 Manner of Giving Notice 30

Section 11.4 Alternative Notice 30

Section 11.5 Effect of Partial Invalidity 30

Section 11.6 Governing Law 31

Section 11.7 Completion of and Amendments to Resolution; Approval, Execution and Delivery of Necessary and Appropriate Documents 31

Section 11.8 Bond Delivery 31

Section 11.9 Repeal of Inconsistent Provisions 31

Section 11.10 Paying Agent/Registrar/Custodian Reliance and Other Matters 31


A RESOLUTION AUTHORIZING THE ISSUANCE OF THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGINIA GENERAL REVENUE PLEDGE BONDS; PLEDGING TO THE PAYMENT OF THE PRINCIPAL OF AND THE INTEREST ON SUCH BONDS CERTAIN REVENUES OF THE UNIVERSITY AS PROVIDED HEREIN; AND SETTING FORTH THE RIGHTS AND REMEDIES OF THE BONDHOLDERS OF SUCH BONDS.

RECITALS

  1. By Chapter 22, Title 23.1 of the Code of Virginia of 1950, as amended, there is created a corporation under the name and style of The Rector and Visitors of the University of Virginia (the "University"), which is governed by a Board of Visitors (the "Board"), which is vested with the supervision, management and control of the University.

  2. Pursuant to Title 23.1 of the Code of Virginia of 1950, as amended, the University is classified as an educational institution of the Commonwealth.

  3. By Chapter 10, Title 23.1 of the Code of Virginia of 1950, as amended (the "Act"), the University entered into a management agreement with the Commonwealth which was enacted as Chapter 3 of Chapter 933 of the 2006 Virginia Acts of Assembly, as amended, pursuant to which the University is classified as a public institution of higher education and the University is empowered with the authority to undertake and implement the acquisition of any interest in land, including improvements on the acquired land at the time of acquisition, new construction, improvements or renovations and to borrow money and make, issue and sell bonds of the University for such purposes, including the refinancing of any such facilities.

  4. Pursuant to a resolution adopted on September __, 2017 (the "Authorizing Resolution"), the Board determined to finance and refinance the costs of capital and other projects, including capitalized interest, financing costs, working capital, general corporate purposes and the refunding of prior obligations of the University (collectively, the "Projects"), and delegated to certain officers of the University pursuant to the University's Board-approved debt and interest rate risk management policies the power to approve the final terms of such financing, within certain stated parameters.

  5. For the purpose of providing funds to finance or refinance the Projects, the Board has determined to adopt this Master Bond Resolution (Multi-Year Capital Program) authorizing the issuance of general revenue pledge bonds of the University, at one time or on more than one occasion (the "Bonds").

NOW, THEREFORE, BE IT RESOLVED BY THE BOARD:

DEFINITIONS

Definitions. In addition to words and terms elsewhere defined in this Program Resolution, the following words and terms as used in this Program Resolution shall have the following meanings, unless some other meaning is plainly intended:

"Account" means any account established in a Fund with respect to any Series of Bonds or otherwise pursuant to the terms of this Program Resolution or any Supplemental Resolution.

"Act" has the meaning given to it in the Recitals to this Program Resolution.

"Authorized Officer" means (i) in the case of the University, the President of the University, the Chief Operating Officer, or the Chief Financial Officer and, when used with reference to any act or document also means any other person authorized by appropriate action of the Board to perform such act or execute such document on behalf of the University; and (ii) in the case of the Paying Agent or the Custodian, the President, any Vice-President, any Assistant Vice-President, any Corporate Trust Officer or any Assistant Corporate Trust Officer of the Paying Agent or the Custodian, and when used with reference to any act or document also means any other person authorized to perform such act or execute such document by or pursuant to a resolution of the governing body of the Paying Agent or the Custodian.

"Authorizing Resolution" means the resolution of the Board adopted September __, 2017, authorizing general revenue pledge bonds in one or more series and establishing certain other parameters related to such bonds.

"Board" means the Board of Visitors of the University or, if such Board is abolished, the board or body succeeding to the principal functions thereof.

"Bond Counsel" means any firm of attorneys selected by the University and experienced in the issuance of municipal bonds and matters relating to the exclusion of the interest thereon from gross income for federal income tax purposes, which may be an attorney or firm regularly providing services to the University.

"Bondholder" or "Holder" means the registered owner of any Bond and shall mean any Related Liquidity Facility Issuer or its assignee, if appropriate.

"Bonds" means the general revenue pledge bonds of the University issued pursuant to this Program Resolution and one or more Series Resolutions.

"Business Day" except as may be otherwise defined in a Series Resolution, means a day other than (i) a Saturday, Sunday or other day on which banking institutions in the Commonwealth of Virginia or the city in which the Designated Office of the Paying Agent is located are authorized or required by law to close or (ii) a day on which the New York Stock Exchange is closed.

"Chief Financial Officer" means the University's chief financial officer or such other officer of the University having similar duties as may be selected by the Board.

"Chief Operating Officer" means the University's Executive Vice President and Chief Operating Officer or such other officer of the University having similar duties as may be selected by the Board.

"Code" means the Internal Revenue Code of 1986, as amended. Each citation to a Code section shall include the applicable temporary and permanent regulations (and including only such proposed regulations which have proposed effective dates prior to the date the applicable opinion or determination is to be made), revenue rulings and revenue procedures.

"Commercial Paper Rate" means, with respect to any Bonds, an interest rate determined for Interest Periods between 1 and 270 days in duration, as specified in the Related Series Resolution.

"Commercial Paper Rate Bond" means any Bond while in a Commercial Paper Rate Mode.

"Commercial Paper Rate Mode" means the mode during which Bonds bear interest at a Commercial Paper Rate.

"Commonwealth" means the Commonwealth of Virginia.

"Credit Obligation" of the University means any indebtedness incurred or assumed by the University for borrowed money and any other financing obligation of the University that, in accordance with generally accepted accounting principles consistently applied, is shown on the liability side of a balance sheet; provided, however, that Credit Obligation shall not include any portion of any capitalized lease payment directly appropriated from general funds of the Commonwealth or reasonably expected to be so appropriated as certified by an Authorized Officer, but only to the extent such appropriation is restricted by the Commonwealth to the payment of such capitalized lease obligation.

"Custodian" means The Bank of New York Mellon Trust Company, N.A., a national banking association organized under the laws of the United States of America, and its successors, or such other bank or financial institution designated by the University to hold funds under this Program Resolution and each Series Resolution.

"Designated Office" means, when used in reference to the Paying Agent, the corporate trust office of the Paying Agent designated as such, which shall initially be Pittsburgh, Pennsylvania.

"Electronic Means" shall mean the following communications methods: e-mail, facsimile transmission, secure electronic transmission containing applicable authorization codes, passwords and/or authentication keys issued by the Paying Agent, or another method or system specified by the Paying Agent as available for use in connection with its services hereunder.

"Event of Default" has the meaning set forth in Section 7.1.

"Fiscal Year" means the period commencing on the first day of July in any year and ending on the last day of June of the following year.

"Fitch" means Fitch Ratings, and its successors and assigns, except that if such corporation shall be dissolved or liquidated or shall no longer perform the functions of a securities rating agency, then the term "Fitch" shall be deemed to refer to any other nationally recognized securities rating agency selected by the University.

"Fixed Rate" means, with respect to any Bonds, an interest rate fixed to the maturity date of such Bonds.

"Fixed Rate Bonds" means any Bond while in a Fixed Rate Mode.

"Fixed Rate Mode" means the mode during which the Bonds bear interest at a Fixed Rate.

"Fund" means any fund established pursuant to the terms of this Program Resolution or any Supplemental Resolution.

"Government Obligations" means:

Certificates or interest-bearing notes or obligations of the United States, or those for which the full faith and credit of the United States are pledged for the payment of principal and interest, and

Investments in any of the following obligations provided such obligations are backed by the full faith and credit of the United States (i) debentures of the Federal Housing Administration, (ii) certificates of beneficial interest of the Farmers Home Administration or (iii) project notes and local authority bonds of the Department of Housing and Urban Development.

"Index Rate" means, with respect to any Bonds, an interest rate determined pursuant to an index or indexes as specified in the Related Series Resolution.

"Index Rate Bond" means any Bond while in an Index Rate Mode.

"Index Rate Mode" means the mode during which Bonds bear interest at an Index Rate.

"Interest Payment Date" for a given Series of Bonds has the meaning given to it in the Related Series Resolution.

"Interest Period" means, with respect to any Bonds, the period of time that any interest rate remains in effect as specified in the Related Series Resolution.

"Liquidity Facility" except as may be otherwise defined in a Related Series Resolution, means any standby bond purchase agreement, letter of credit or other liquidity enhancement (or replacement or substitution thereof) delivered on or after issuance of a Series of Bonds for the purpose of making payment on such Series of Bonds.

"Liquidity Facility Issuer" except as may be otherwise defined in the Related Series Resolution, means any bank or banks, insurance company or companies, or other financial institution or institutions, or any combination of the foregoing, which is the issuer of a Liquidity Facility.

"Mode" means each of the Commercial Paper Rate Mode, the Index Rate Mode, the Term Rate Mode and the Fixed Rate Mode.

"Mode Change Date" means, with respect to Bonds, the date one Mode ends and with another mode beginning on the next day.

"Moody's" means Moody's Investors Service, Inc., and its successors and assigns, except that if such corporation shall be dissolved or liquidated or shall no longer perform the functions of a securities rating agency, then the term "Moody's" shall be deemed to refer to any other nationally recognized securities rating agency selected by the University.

"Parity Credit Obligation" means any Credit Obligation of the University which may be incurred in accordance with the terms of this Program Resolution or has been incurred that is secured on a parity with the pledge of Pledged Revenues herein.

"Paying Agent" means initially The Bank of New York Mellon Trust Company, N.A., a national banking association organized under the laws of the United States of America, and its successors and any other corporation that may at any time be substituted in its place in accordance with Section 11.2 of this Program Resolution.

"Pledged Revenues" means any or all of the revenues now or hereafter available to the University which are not required by law, by binding contract entered into prior to the date of this Program Resolution or by the provisions of any Qualifying Senior Obligation to be devoted to some other purpose, and shall include, without limitation, all revenues pledged to the payment of any Qualifying Senior Obligation net of amounts necessary to pay it or any operating or other expenses, the payment of which is required or permitted to be made with such revenues prior to the payment of such Qualifying Senior Obligation.

"Principal Payment Date" for a given Series of Bonds has the meaning given to it in the Related Series Resolution.

"Projects" has the meaning given to it in the Recitals to this Program Resolution.

"Program Resolution" or the "Resolution" means this Program Resolution, adopted by the Board on __________, 2017, with respect to the Bonds, as modified, altered, amended and supplemented as herein permitted.

"Purchase Date" except as may otherwise be defined in the Related Series Resolution, means (i) for a Bond in the Commercial Paper Rate Mode or the Term Rate Mode, the Business Day after the last day of each Interest Period applicable thereto and (ii) for a Bond in the Index Rate Mode, any Business Day upon which such Bond may be tendered or deemed tendered for purchase.

"Qualifying Senior Obligation" means any existing Credit Obligation other than a Parity Credit Obligation secured by a pledge of any portion of the University's revenues, and any additional Credit Obligation issued pursuant to Section 6.3(b) or 6.3(c) or to refund any Qualifying Senior Obligation as described in Section 6.3(e).

"Rating Agency" means Moody's, S&P and/or Fitch, if any or all of such rating agencies have provided a rating for any Series of Bonds. If any such corporation ceases to act as a securities rating agency, the University may, with the approval of any applicable Remarketing Agent, appoint any nationally recognized securities rating agency as a replacement.

"Registrar" means initially The Bank of New York Mellon Trust Company, N.A., a national banking association organized under the laws of the United States of America, and any successor Registrar appointed pursuant to Section 11.2.

"Reimbursement Agreement" means with respect to any Liquidity Facility, the agreement providing for such Liquidity Facility and any and all modifications, alterations, amendments and supplements to such agreement.

"Related" means (i) when used with respect to any Fund, Account or Series of Bonds, the Fund, Account or Series of Bonds so authorized, designated and established by this Program Resolution and the Series Resolution authorizing a particular Series of Bonds, (ii) when used with respect to a Series Resolution or other document associated with a Series of Bonds, such document authorizing or related to a particular Series of Bonds, or Supplemental Resolution related thereto.

"Remarketing Agent" means any remarketing agent engaged for a Series of Bonds.

"Remarketing Agreement" means any agreement between the University and any Remarketing Agent.

"Series" means all of the Bonds of a particular series authenticated and delivered pursuant to this Program Resolution and the Related Series Resolution and identified as such pursuant to such Series Resolution, and any Bonds of such Series thereafter authenticated and delivered in lieu of or in substitution for such Bonds pursuant to this Program Resolution and such Series Resolution regardless of variations in lien status, maturity, interest rate, sinking fund installments or other provisions.

"Series Resolution" means a Supplemental Resolution providing for the issuance of a Series of Bonds, as such Series Resolution may be modified, altered, amended and supplemented by a Supplemental Resolution in accordance with the provisions of this Program Resolution.

"S&P" means S&P Global Ratings, and its successors and assigns, except that if such division shall be dissolved or liquidated or shall no longer perform the functions of a securities rating agency, then the term "S&P" shall be deemed to refer to any other nationally recognized securities rating agency selected by the University.

"Short-Term Bond" means any Bond while in a Short-Term Mode.

"Short-Term Mode" means each of the Commercial Paper Rate Mode and the Index Rate Mode.

"State Treasurer" means the State Treasurer of the Commonwealth.

"Supplemental Resolution" means any resolution supplementary to or amendatory of this Program Resolution or any Supplemental Resolution or Series Resolution now or hereafter duly executed and delivered in accordance with the provisions of this Program Resolution, including a Series Resolution.

"Tender Agent" means any Tender Agent engaged for a Series of Bonds.

"Term Rate" means an interest rate fixed to a specified date (other than the final maturity date of the Bond).

"Term Rate Bond" means any Bond while in a Term Rate Mode.

"Term Rate Mode" means the mode during which Bonds bear interest at a Term Rate.

"University" means The Rector and Visitors of the University of Virginia, an educational institution and a public body and governmental instrumentality for the dissemination of education, and its successor or successors.

Rules of Construction/Use of Words and Phrases.  Words of the masculine gender shall be deemed and construed to include correlative words of the feminine and neuter genders. Unless the context shall otherwise indicate, the word "person" shall include corporations and associations, including public bodies, as well as natural persons. Singular words shall connote the plural number as well as the singular and vice versa.

All references in this Program Resolution to particular Articles or Sections are references to Articles or Sections of this Program Resolution unless otherwise indicated.

The headings and table of contents as used in this Program Resolution are solely for convenience of reference and shall not constitute a part of this Program Resolution nor shall they affect its meaning, construction or effect.



AUTHORIZATION, FORM, EXECUTION, DELIVERY,
REGISTRATION AND PAYMENT OF THE BondS

Authorization of the Bonds. For the purpose of providing funds to finance and refinance all or a portion of the costs the Projects, there are hereby authorized to be issued, under the authority of the Act, Bonds of the University. The Bonds shall be designated "The Rector and Visitors of The University of Virginia General Revenue [and Refunding] Pledge Bonds" with an appropriate series designation, as provided in the Related Series Resolution.

Form and Details of Each Series of Bonds. The forms, details and terms of each Series of Bonds, the Funds and Accounts to be established with respect to such Series, the Mode of the Bonds, the federal income tax status of interest on the Bonds, and such other matters as the University may deem appropriate shall be set forth in the Related Series Resolution.

Changes in Mode. Except as may be otherwise provided in the Related Series Resolution:

At the option of the University, all (and not less than all) of the Bonds in any Mode, other than a Fixed Rate Mode, may be changed to any other Mode at the times and in the manner provided in the Related Series Resolution. Subsequent to such change in Mode, the Bonds may again be changed at the option of the University to a different Mode at the times and in the manner hereinafter provided; provided, however, that any Bonds converted to a Fixed Rate Mode shall not be changed to any other Mode.

The option of the University to change the Mode of the Bonds shall be exercised by written notice from the University stating the University's intention to effect a change in the Mode from the Mode then prevailing to another Mode specified in such written notice, together with the proposed Mode Change Date. Such written notice shall be given in accordance with the Related Series Resolution

The Mode Change Date must be a Business Day.

The Mode Change Date from the Commercial Paper Rate Mode shall be the last Purchase Date for the Commercial Paper Rate Bonds with respect to which a change is to be made.

The Mode Change Date from a Term Rate Mode shall be the Purchase Date of the current Interest Period.

No change in Mode will become effective unless funds sufficient to purchase all of the Bonds subject to such change shall be provided on the Mode Change Date as provided in the Related Series Resolution, and all conditions precedent to such change in Mode under the Related Series Resolution have been met.

Execution of the Bonds.  Except as may be otherwise provided in the Related Series Resolution, all of the Bonds of each Series shall be executed in the name and on behalf of the University by an Authorized Officer and the official seal of the University shall be impressed, imprinted, reproduced or lithographed on the Bonds. The signatures on the Bonds may be by facsimile. In case any of the officers who shall have signed or attested any of the Bonds shall cease to be such officer or officers of the University before the Bonds so signed or attested shall have been issued by the University, such Bonds may nevertheless be delivered and issued and, upon such delivery and issue, shall be as binding upon the University as though those who signed and attested the same had continued to be such officers of the University. Any Bonds may be signed and attested on behalf of the University by such persons as at the actual date of execution of such Bonds shall be the proper officers of the University although at the nominal date of such Bonds any such person shall not have been such officer of the University.

Only such of the Bonds as shall bear thereon a certificate of authentication, manually executed by the Registrar, shall be valid or obligatory for any purpose or entitled to the benefits of this Program Resolution, and such certificate of the Registrar shall be conclusive evidence that the Bonds so authenticated have been duly executed, authenticated and delivered hereunder and are entitled to the benefits of this Program Resolution.

Transfer of the Bonds.  Except as may be otherwise provided in the Related Series Resolution, any Bonds may be transferred, upon the books required to be kept pursuant to the provisions of Section 2.7, by the person in whose name it is registered, in person or by his duly authorized attorney, upon surrender of such Bonds for cancellation, accompanied by delivery of a written instrument of transfer, duly executed in a form approved by the Registrar. The Registrar shall not be required to transfer or exchange any Bond selected or called for redemption pursuant to the provisions therein or from a Record Date through the next succeeding Interest Payment Date.

Whenever any Bonds shall be surrendered for registration of transfer, the University shall execute and the Registrar shall authenticate and deliver a new Bonds, of authorized denominations of the same maturity and interest rate and for a like aggregate principal amount. Such transfer shall be without charge to the Bondholder, except that the Registrar shall require the Bondholder requesting such transfer to pay any tax or other governmental charge required to be paid with respect to such transfer.

Exchange of the Bonds. Except as may be otherwise provided in the Related Series Resolution, Bonds may be exchanged at the office of the Registrar for a like aggregate principal amount of the Bonds of other authorized denominations of the same maturity and interest rate. Such exchange shall be without charge to the Bondholder, except that the Registrar shall require the Bondholder requesting such exchange to pay any tax or other governmental charge required to be paid with respect to such exchange.

Bond Register; Notices; Persons Treated as Owners. Except as may be otherwise provided in the Related Series Resolution, the Registrar will keep or cause to be kept sufficient books for the registration and transfer of the Bonds, which shall at all times during regular business hours upon reasonable prior written notice be open to inspection by the University; and, upon presentation for such purpose, the Registrar shall, under such reasonable regulations as it may prescribe, register or cause to be registered, on such books, the transfer or exchange of the Bonds as hereinbefore provided. Notices sent to Bondholders pursuant to this Program Resolution shall be sent to the addresses shown on the registration books maintained by the Registrar or such other address as may be filed with the Registrar for such purpose. All notices required to be given by mail shall be given by first class mail, postage prepaid.

In addition to the other obligations imposed on the Registrar hereunder, the Registrar shall agree to deliver upon request a list of the names and addresses of the registered owners of the Bonds, as follows:

to any Bondholder, if an Event of Default shall have occurred and be continuing; and

to the Bondholders of 25% or more in aggregate principal amount of the Bonds then outstanding, at any time.

Prior to due presentment for registration of transfer of any Bond, the Registrar shall treat the registered owner as the person exclusively entitled to payment of principal, premium, if any, and interest and the exercise of all other rights and powers of the Bondholder, except that interest payments shall be made to the person registered as owner on the registration books of the Registrar on the Record Date.

Temporary Bonds. Any Series of Bonds may be issued in temporary form exchangeable for definitive Bonds when ready for delivery. Any temporary Bond may be printed, lithographed or typewritten, shall be of such denomination as may be determined by the University and may contain such reference to any of the provisions of this Program Resolution as may be appropriate. A temporary Bond may be in the form of a single Bond payable in installments, each on the date, in the amount and at the rate of interest established for the Bonds maturing on such date. Every temporary Bond shall be executed by the University and be authenticated by the Registrar upon the same conditions and in substantially the same manner as the definitive Bonds. If the University issues temporary Bonds it will execute and deliver definitive Bonds as promptly thereafter as practicable, and thereupon the temporary Bonds may be surrendered, for cancellation, in exchange therefor at the Designated Office of the Registrar and the Registrar shall authenticate and deliver in exchange for such temporary Bonds an equal aggregate principal amount of definitive Bonds of authorized denominations of the same maturity or maturities and interest rate. Until so exchanged, the temporary Bonds shall be entitled to the same benefits under this Program Resolution as definitive Bonds authenticated and delivered hereunder.

Bonds Mutilated, Lost, Destroyed, Stolen or Undelivered.

If any Bond shall become mutilated, the University, at the expense of the Bondholder of such Bond, shall execute, and the Registrar shall thereupon authenticate and deliver, a new Bond of like tenor bearing a different number in exchange and substitution for the Bond so mutilated, but only upon surrender to the Registrar of the Bond so mutilated. Every mutilated Bond so surrendered to the Registrar shall be canceled by it and shall be delivered to, or upon the order of, the University. If any Bond shall be lost, destroyed or stolen, evidence of the ownership thereof and of such loss, destruction or theft may be submitted to the University and the Registrar and, if such evidence be satisfactory to both of them and indemnity satisfactory to them shall be given, the University, at the expense of the Bondholder, shall execute, and the Registrar shall thereupon authenticate and deliver, a new Bond of like tenor bearing a different number in lieu of and in substitution for the Bond so lost, destroyed or stolen (or if any such Bond shall have matured or shall be about to mature, instead of issuing a substitute Bond, the Paying Agent may pay the same without surrender thereof). The University may require payment of a sum not exceeding the actual cost of preparing each new Bond issued under this Section and of the related expenses which may be incurred by the University, the Registrar, the State Treasurer and the Paying Agent. Any Bond issued under the provisions of this Section in lieu of any Bond alleged to be lost, destroyed or stolen shall constitute an original additional contractual obligation on the part of the University whether or not the Bond so alleged to be lost, destroyed or stolen be at any time enforceable by anyone, and shall be entitled to the benefits of this Program Resolution and the Related Series Resolution, with all other Bonds secured by this Program Resolution and the Related Series Resolution.

Except as may be otherwise provided in the Related Series Resolution, in the event that any Short-Term Bond or Term Rate Bond purchased pursuant to an optional tender or mandatory repurchase is not delivered by the Bondholder thereof on the date such Short-Term Bond or Term Rate Bond is deemed purchased, the University shall execute (if necessary) and the Paying Agent shall authenticate and deliver a new Short-Term Bond or Term Rate Bond of like aggregate principal amount as the Bond deemed purchased, which Bond shall, for all purposes of this Program Resolution, be deemed to evidence the same debt as the Short-Term Bond or Term Rate Bond deemed purchased and shall be remarketed, delivered and registered in accordance with the Related Series Resolution.

If any Bond is purchased by the Paying Agent with moneys provided by or on behalf of the direction of the University and sufficient for such purchase, the Paying Agent, upon request of the University, shall authenticate a new Bond in any authorized denomination specified by the University and permitted under the Related Series Resolution, registered as the University may direct and deliver it to the University, or to its order, whether or not such Bond is ever delivered.



REDEMPTION AND PURCHASE OF THE BondS;
liquidity facility; remarketing agent; tender agent

Redemption of the Bonds. The Bonds of each Series shall be subject to redemption as specified in the Related Series Resolution.

Selection of Bonds for Redemption. The University or the Paying Agent (as applicable) shall select which Bonds of any Series to call for redemption in accordance with the Related Series Resolution. The University or the Paying Agent (as applicable) shall treat each Bond of a denomination greater than the minimum denomination authorized in the Related Series Resolution as representing the number of separate Bonds that can be obtained by dividing the Bond's actual principal amount by such authorized denomination.

Notice of Redemption.  Except as may be otherwise provided in the Related Series Resolution, whenever any Bonds are to be redeemed, the Paying Agent shall, not less than thirty (30) nor more than sixty (60) days prior to the redemption date, mail notice of redemption to all registered owners of all applicable Bonds to be redeemed at their registered addresses. The Paying Agent shall also mail a copy of any such notice of redemption to any Rating Agency. Any such notice of redemption shall identify the Bonds to be redeemed, shall specify the redemption date and the redemption price, and shall state that on the redemption date the Bonds called for redemption will be payable at the Designated Office of the Paying Agent and that from that date interest will cease to accrue. The Paying Agent may use "CUSIP" numbers in notices of redemption as a convenience to Bondholders, provided that any such notice shall state that no representation is made as to the correctness of such numbers either as printed on the Bonds or as contained in any such notice.

If at the time of mailing of notice of any optional redemption the University shall not have caused to be deposited with the Paying Agent money sufficient to redeem all the Bonds called for redemption, such notice may state that it is conditional in that it is subject to the deposit of such moneys with the Paying Agent not later than the redemption date, and such notice shall be of no effect unless such moneys are so deposited. Failure by the Paying Agent to give any notice of redemption or any defect in such notice as to any particular Bonds shall not affect the validity of the call for redemption of any Bonds in respect of which no such failure or defect has occurred. Any notice mailed as provided in accordance with this Program Resolution or any Series Resolution shall be conclusively presumed to have been given whether or not actually received by any Bondholder.

Effect of Calling for Redemption. Except as may be otherwise provided in the Related Series Resolution, on the date designated for redemption, notice having been mailed in the manner and under the conditions hereinabove provided and moneys for payment of the redemption price being held in separate accounts by the Paying Agent in trust for the Bondholders of the Bonds to be redeemed, all as provided in this Program Resolution, the Bonds so called for redemption shall become and be due and payable at the redemption price provided for redemption of such Bonds on such date, interest on the Bonds so called for redemption shall cease to accrue, such Bonds shall cease to be entitled to any benefit or security under this Program Resolution or the Related Series Resolution and the Bondholders of such Bonds shall have no rights with respect thereto except to receive payment of the redemption price.

The Bonds Redeemed Not Deemed Outstanding. Except as may be otherwise provided in the Related Series Resolution, the Bonds that have been duly called for redemption under the provisions of this Article, or with respect to which irrevocable instructions to call for redemption have been given by an Authorized Officer to the Paying Agent in form satisfactory to him or her, and for the payment of the redemption price of which moneys shall be held in separate accounts by the Paying Agent in trust for the Bondholders of the Bonds to be redeemed, all as provided in this Program Resolution or the Related Series Resolution, shall not thereafter be deemed to be outstanding under the provisions of this Program Resolution and the Related Series Resolution.

Remarketing Agent.  Except as may be otherwise provided in the Related Series Resolution with respect to any Series of Bonds, each Remarketing Agent shall keep such books and records as shall be consistent with prudent industry practice and make such books and records available for inspection by the University, the Paying Agent and any Liquidity Facility Issuer at all reasonable times.

Except as may be otherwise provided in the Related Series Resolution with respect to any Series of Bonds:

The Remarketing Agent may at any time resign and be discharged of the duties and obligations created by this Program Resolution by giving at least sixty (60) days' notice to the Paying Agent, the University, any Liquidity Facility Issuer and the Tender Agent, or otherwise as provided in the Remarketing Agreement.

The Remarketing Agent may be removed at any time by the University, by an instrument filed with the Paying Agent, the Remarketing Agent and the Tender Agent and upon at least thirty (30) days' notice to the Remarketing Agent. Any successor Remarketing Agent shall be selected by the University with the consent of any Liquidity Facility Issuer, such consent not to be unreasonably withheld or delayed, and shall be a member of the Financial Industry Regulatory Authority, shall have a capitalization of at least fifteen million dollars ($15,000,000), and shall be authorized by law to perform all the duties set forth in this Program Resolution.

The University's delivery to the Paying Agent and the Tender Agent of a certificate of an Authorized Officer setting forth the effective date of the appointment of a successor Remarketing Agent and the name, address and telephone number of such successor shall be conclusive evidence that (i) if applicable, the predecessor Remarketing Agent has been removed in accordance with the provisions of this Program Resolution and (ii) such successor has been appointed and is qualified to act as Remarketing Agent under the terms of this Program Resolution.

Tender Agent.  Except as may be otherwise provided in a Related Series Resolution, each Tender Agent shall hold all Bonds of any Series delivered to it hereunder in trust solely for the benefit of the Related Bondholders which shall have so tendered such Bonds until moneys representing the purchase price of such Bonds shall have been delivered to, or for the account of, or to the order of the Related Bondholders; and hold all moneys delivered to it hereunder for the purchase of Bonds in trust solely for the benefit of the person which shall have so delivered such moneys until the Bonds purchased with such moneys shall have been delivered to or for the account of such person.

Except as otherwise may be provided in the Related Series Resolution with respect to any Series of Bonds:

The Tender Agent may at any time resign and be discharged of the duties and obligations set forth herein by giving at least sixty (60) days' notice to the University, each Remarketing Agent, any Liquidity Facility Issuer and the Paying Agent.

The Tender Agent may be removed at any time, by the University, by an instrument filed with the Tender Agent and the Paying Agent. Any successor Tender Agent shall be a commercial bank with trust powers, national banking association with trust powers or trust company doing business and having an office in New York, New York, and shall be appointed by the University with the consent of any Liquidity Facility Issuer, such consent not to be unreasonably withheld or delayed.

In the event of the resignation or removal of the Tender Agent, the Tender Agent shall deliver any Bonds and moneys held by it in such capacity to its successor.

No resignation or removal of the Tender Agent shall be effective unless the rights and obligations of the Tender Agent have been transferred to its successor or the Paying Agent.

Several Capacities. Anything in this Program Resolution to the contrary notwithstanding, the same entity may serve hereunder as the Paying Agent, the Registrar, the Tender Agent and the Remarketing Agent and in any other combination of such capacities, to the extent permitted by law.



ISSUANCE OF BondS

Issuance of Bonds. The University may issue Bonds, subject to the terms and conditions contained in this Program Resolution, for the financing and refinancing of the costs of the Projects, including the refunding of any previously issued and outstanding University obligations. Such Bonds may be issued in any form permitted by law and in any Mode authorized under this Program Resolution or any combination thereof.

Terms and Conditions for Issuance and Delivery of the Bonds. The Bonds authorized by this Program Resolution shall be deposited with the Registrar for delivery as provided in the Related Series Resolution upon delivery to the Registrar the following:

In the case of the initial Series of Bonds issued under this Program Resolution:

a copy, certified by the Secretary of the Board, of this Program Resolution;

an opinion of Bond Counsel (upon which the Registrar can rely) stating that the Program Resolution has been duly adopted and that this Program Resolution constitutes a valid and binding limited obligation of the University.

A copy, certified by the Secretary of the Board, of the Related Series Resolution which may include:

provisions authorizing the issuance, fixing the principal amount and setting forth the details of the Bonds of the Series then to be issued, the interest rate or rates and the manner in which the Bonds are to bear interest, the Principal Payment Dates and Interest Payment Dates,

the purposes for which the Bonds are being issued, the date and the manner of numbering the Bonds, the series designation, the denominations, the maturity dates and amounts, provisions for redemption before maturity;

provisions for Liquidity Facilities for the Series and for the Funds and Accounts to be established with respect to the Series of Bonds as required or authorized under this Program Resolution;

provisions for the application of the proceeds of the Bonds of the Series;

any term or condition necessary or expedient for the issuance of Bonds constituting Commercial Paper Rate Bonds or Index Rate Bonds, including without limitation, tender and remarketing provisions, liquidity facility provisions and provisions for establishing the variable rate and changing Modes; and

such other provisions as the University may deem appropriate.

A certified copy of each resolution adopted by the University authorizing the execution and delivery of any Related Liquidity Facility.

Original executed counterparts of any Related Liquidity Facility.

If the Bonds of the Series then to be issued are to be issued to refund Bonds issued and outstanding under this Program Resolution or other obligations of the University evidence that the University has made provision for the payment or redemption of all of the obligations to be refunded as required by the Series Resolution Related to the Bonds to be issued and (if applicable) the Bonds to be refunded.

An opinion of Bond Counsel (upon which the Registrar can rely) stating that the Bonds have been duly authorized, executed and delivered in accordance with the Act, and this Program Resolution and the Related Series Resolution, that the Bonds and this Program Resolution and the Related Series Resolution constitute valid and binding limited obligations of the University, payable solely from the Pledged Revenues and other property pledged therefor under this Program Resolution.

Any additional document or instrument specified in the Related Series Resolution.

Authentication and Delivery. When the documents mentioned in Section 4.2 shall have been filed with the Registrar and when the Bonds shall have been executed as required by this Program Resolution and the Related Series Resolution, the Registrar shall authenticate and deliver such Bonds as directed in the Related Series Resolution.

Application of Bond Proceeds. The University shall apply the proceeds of any Series of Bonds as provided in the Related Series Resolution.

Items of Cost of the Project. Except as may otherwise be provided in a Related Series Resolution, the costs of the Projects shall include, without intending thereby to limit or restrict or to extend any proper definition of such costs under the Act or this Program Resolution, any or all of the following:

obligations incurred for labor and materials and to contractors, builders and materialmen in connection with the Projects;

the cost of acquiring by purchase, if such purchase shall be deemed expedient, and the amount of any award or final judgment in or any settlement or compromise of any proceeding to acquire by condemnation, such lands, property, rights, rights of way, franchises, easements and other interests as may be deemed necessary or convenient by the Board for the construction and operation of the Projects, options and partial payments thereon, and the amount of any damages incident to or consequent upon such construction and operation;

the cost of furnishing and equipping the Projects;

interest on the Bonds, prior to and during construction of the Projects and for up to one (1) year thereafter;

taxes or other municipal or governmental charges lawfully levied or assessed during construction upon the Projects or any property acquired therefor, and premiums on insurance, if any, in connection with the Projects during construction; fees and expenses of engineers and architects for surveys and estimates and other preliminary investigations, preparation of plans, drawings and specifications and supervising construction, as well as for the performance of all other duties of engineers and architects in relation to the planning and construction of the Projects or the issuance of Bonds therefor;

expenses of administration properly chargeable to the Projects, legal expense and fees, fees and expenses of consultants, financing charges, cost of audits and of preparing and issuing the Bonds, and all other items of expense not elsewhere in this Section specified incident to the planning, construction, development and equipping of the Projects and the placing of the Projects in operation; and

any obligation or expenses heretofore or hereafter incurred by the University, any agent of the University or by any other agency of the Commonwealth of Virginia in connection with the Projects for any of the foregoing purposes.



FUNDS AND REVENUES

Establishment of Funds. One or more of the Funds listed below may be established for a Series of Bonds, as provided in the Related Series Resolution:

Construction Fund;

Cost of Issuance Fund; and

Debt Service Fund.

Payments to Bondholders. The Paying Agent shall, at appropriate times on or before each Interest Payment Date and Principal Payment Date (as applicable), withdraw from the Related Debt Service Fund the amounts needed on such date to pay the principal of and premium, if any, and interest on the Related Bonds and shall pay or cause the same to be paid to the Related Bondholders as such principal, premium and interest become due and payable.

Pledge of Funds and Accounts. The moneys in each Fund shall be held in trust and applied as provided herein and in the Released Series Resolution and, pending such application, shall be pledged to, and subject to a lien and charge in favor, of the Bondholders of the Related Bonds and for the further security of such Bondholders until paid out or transferred as provided herein and in the Released Series Resolution.

Moneys Held in Trust. All moneys from the funds of the University or that the University shall have received from any other source and set aside or deposited with any Paying Agent for the purpose of paying any of the Bonds hereby secured, either at the maturity thereof or upon call for redemption, shall be held in trust for the Bondholders of the Related Bonds. Any moneys which shall be so set aside or deposited and which shall remain unclaimed by the Bondholders of the Related Bonds for the period of five (5) years after the date on which the Related Bonds shall have become due and payable shall be disposed of by the University and the Paying Agent in accordance with The Uniform Disposition of Unclaimed Property Act, Chapter 11.1, Title 55, Code of Virginia of 1950, as amended (the "Unclaimed Property Act"). The Paying Agent shall be entitled to act in good faith in reliance on written direction from the University or its counsel in complying with the Unclaimed Property Act, absent the Paying Agent's negligence or willful misconduct.

Cancellation of the Bonds Upon Payment. All Bonds paid, redeemed or purchased by the University, either at or before maturity, shall be canceled upon the payment, redemption or purchase of such Bonds and shall be delivered to the University when such payment, redemption or purchase is made. All Bonds canceled under any of the provisions of this Program Resolution may be cremated or otherwise destroyed by the University or its designee.

No Risk to Paying Agent Funds. No provision herein shall require the Paying Agent to expend its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder or in the exercise of any of its rights or powers unless the Paying Agent shall have reasonable grounds for believing that repayment of such funds or adequate indemnity against such risk or liability is reasonably assured to it.



PARTICULAR COVENANTS

Payment of Principal and Interest; Pledge of Pledged Revenues. The University covenants that it will promptly pay or cause to be paid from the sources described herein the principal of and the interest on every Bond issued under the provisions of this Program Resolution at the place or places, on the dates and in the manner provided herein and in such Bonds, and any premium required for the retirement of such Bonds by purchase or redemption, according to the true intent and meaning thereof. Except as otherwise provided in this Program Resolution, such principal, interest and premium are payable solely from Pledged Revenues, which Pledged Revenues are hereby pledged to the payment thereof and to the payment of any Parity Credit Obligations issued by the University, which may include any interest rate swaps or other hedge mechanisms and any dedicated line of credit, standby bond purchase agreement or other liquidity facility related to the Bonds, including any Liquidity Facility.

THE UNIVERSITY SHALL NOT BE OBLIGATED TO PAY THE PRINCIPAL OF OR INTEREST ON THE BONDS EXCEPT FROM THE SOURCES NOTED HEREIN AS PLEDGED THEREFOR. THE BONDS AND THE INTEREST THEREON SHALL NOT BE DEEMED TO CONSTITUTE A DEBT OR LIABILITY OF THE COMMONWEALTH, LEGAL, MORAL OR OTHERWISE. NEITHER THE COMMONWEALTH NOR THE UNIVERSITY SHALL BE OBLIGATED TO PAY THE PRINCIPAL OF OR INTEREST ON THE BONDS OR OTHER COSTS INCIDENT THERETO EXCEPT FROM THE SOURCES NOTED HEREIN AS PLEDGED THEREFOR, AND NEITHER THE FAITH AND CREDIT NOR THE TAXING POWER OF THE COMMONWEALTH ARE PLEDGED TO THE PAYMENT OF THE PRINCIPAL OF OR INTEREST ON THE BONDS OR OTHER COSTS INCIDENT THERETO.

Additional Indebtedness and Encumbrances. Except as otherwise provided in this Section, nothing in this Program Resolution shall be construed as prohibiting or limiting in any way the right of the University to incur other Credit Obligations. Notwithstanding the foregoing, however, the University may only incur the following types of Credit Obligations in the event the conditions set forth below are met in each instance:

Limitation on Parity Credit Obligations. The University may incur, assume, guarantee or otherwise become liable on any Parity Credit Obligation, but only if, prior to the incurrence of each such Parity Credit Obligation, an Authorized Officer certifies in writing that (1) taking into account the incurrence of such proposed Parity Credit Obligation (i) the University will have sufficient funds to meet all of its financial obligations, including its obligations to pay principal of and interest on all Credit Obligations, for all Fiscal Years to and including the second full Fiscal Year after the later of (A) the issuance of such Parity Credit Obligation and (B) the completion of any facility financed with the proceeds of such Parity Credit Obligation, and (ii) such Authorized Officer has no reason to believe that the University will not have sufficient funds to pay all amounts due under all indebtedness of the University during the term of such proposed Parity Credit Obligation, and (2) to the best of his or her knowledge, the University is not in default in the performance and observance of any of the provisions of this Program Resolution. Any such Parity Credit Obligation shall be secured by a pledge of Pledged Revenues on a parity with the pledge of Pledged Revenues herein, unless expressly subordinated to the pledge hereof.

Limitation on Section 9(c) Credit Obligations. The University may incur, assume, guarantee or otherwise become liable on any Credit Obligation pursuant to the provisions of Article X, Section 9(c) of the Constitution of Virginia, as such section may be amended from time to time, and may pledge and apply such portion of the Pledged Revenues as may be necessary to provide for the payment of any such Credit Obligation, the funding of reasonable reserves therefor, or the payment of operating and other reasonable expenses of the facilities financed in whole or in part with the proceeds of such Credit Obligation or facilities reasonably related to such facilities, and such pledge shall be senior and superior in all respects to the pledge of Pledged Revenues securing the Bonds and any other Parity Credit Obligations, but only if, prior to the incurrence of each such Credit Obligation, an Authorized Officer of the University certifies in writing that (1) taking into account the incurrence of such proposed Credit Obligation (i) the University will have sufficient funds to meet all of its financial obligations, including its obligations to pay principal of and interest on all Credit Obligations, for all Fiscal Years to and including the second full Fiscal Year after the later of (A) the issuance of such proposed Credit Obligation and (B) the completion of any facility financed with the proceeds of such proposed Credit Obligation, and (ii) such Authorized Officer has no reason to believe that the University will not have sufficient funds to pay all amounts due under all indebtedness of the University during the term of such proposed Credit Obligation, (2) to the best of his or her knowledge, the University is not in default in the performance and observance of any of the provisions of this Program Resolution, and (3) in connection with the issuance of such proposed Credit Obligation, the University has received an opinion of Bond Counsel to the effect that such proposed Credit Obligation has been validly issued under Article X, Section 9(c) of the Constitution of Virginia.

Limitation on Other Credit Obligations, Including Section 9(d) Credit Obligations. The University may incur, assume, guarantee or otherwise become liable on any Credit Obligation not described elsewhere in this Section 6.2, including any Credit Obligation incurred pursuant to the provisions of Article X, Section 9(d) of the Constitution of Virginia, as such section may be amended from time to time, and may pledge and apply such portion of the Pledged Revenues as may be necessary for the payment of any such Credit Obligation, the funding of reasonable reserves therefor, or the payment of operating and other reasonable expenses of the facilities financed in whole or in part with the proceeds of such Credit Obligation or facilities reasonably related to such facilities and such pledge shall be senior and superior in all respects to the pledge of Pledged Revenues securing the Bonds and any other Parity Credit Obligations, but only if, prior to the incurrence of each such Credit Obligation, an Authorized Officer of the University certifies in writing that (1) taking into account the incurrence of such proposed Credit Obligation (i) the University will have sufficient funds to meet all of its financial obligations, including its obligations to pay principal of and interest on all Credit Obligations, for all Fiscal Years to and including the second full Fiscal Year after the later of (A) the issuance of such proposed Credit Obligation and (B) the completion of any facility financed with the proceeds of such proposed Credit Obligation, and (ii) such Authorized Officer has no reason to believe that the University will not have sufficient funds to pay all amounts due under all indebtedness of the University during the term of such proposed Credit Obligation, (2) to the best of his or her knowledge, the University is not in default in the performance and observance of any of the provisions of this Program Resolution, and (3) the University has received an opinion of Bond Counsel to the effect that such proposed Credit Obligation has been validly issued under the relevant provisions of the Constitution of Virginia.

Limitation on Issuance of Indebtedness on a Parity with Qualifying Senior Obligations. Except for Credit Obligations issued pursuant to subsections (b) or (c) above or to refund any Qualifying Senior Obligation as described in subsection (e) below, no additional bonds or other obligations may be issued or incurred by the University on a parity with any Qualifying Senior Obligation.

Limitation on Additional Encumbrances. The University shall not encumber the Pledged Revenues in any manner (except as permitted in connection with Credit Obligations issued pursuant to subsections (a), (b) or (c) above or to refund any Qualifying Senior Obligation as described below), unless any such encumbrance is made junior and subordinate in all respects to the liens, pledges, covenants and agreements of this Program Resolution. Notwithstanding anything to the contrary herein, however, the University may issue bonds to refund any Qualifying Senior Obligation and to secure such refunding bonds with the same source of revenues securing the Qualifying Senior Obligation being refunded. Upon the defeasance of the refunded Qualifying Senior Obligation pursuant to any such refunding, the refunding bonds will be considered Qualifying Senior Obligations for all purposes.

Disposition of Assets. The University may convey, sell or otherwise dispose of any property of the University as long as (1) such conveyance, sale or encumbrance is in the ordinary course of business, or (2) an Authorized Officer certifies in writing that, taking into account the conveyance, sale or other disposition of such property (i) the University will have sufficient funds to meet all of its financial obligations, including its obligations to pay principal of and interest on all Credit Obligations for all Fiscal Years to and including the second full Fiscal Year after such conveyance, sale or other disposition and (ii) such Authorized Officer has no reason to believe that the University will not have sufficient funds to pay all amounts due under all indebtedness of the University then outstanding.

Insurance. The University covenants that it will at all times carry or cause to be carried insurance policies with a responsible insurance company or companies, qualified to assume the risks thereof, or that it will maintain an adequate program of self-insurance, in either case sufficient to provide the University with insurance in such amount and covering such risks as the University shall deem to be reasonable and desirable.

Rights of Bondholders Not to Be Impaired. Except as otherwise set forth herein, the University covenants that no contract or contracts will be entered into or any action taken which might impair or diminish the rights of the Bondholders.

Further Instruments and Actions. The University covenants that it will, from time to time, execute and deliver such further instruments and take such further action as may be required to carry out the purposes of this Program Resolution.

Accurate Records and Accounts. The University covenants that it will keep accurate records and accounts of all items of cost and of all expenditures relating to Pledged Revenues collected and the application of such Pledged Revenues.

Recognized Accounting Principles. The University covenants that all of the accounts and records of the University will be kept according to generally accepted accounting principles consistently applied.

Security for Deposits. [TBD]

Permitted Investments. [TBD]



EVENTS OF DEFAULT AND REMEDIES

Events of Default. Each of the following events is hereby declared to be an "Event of Default" under this Program Resolution:

due and punctual payment of the principal, purchase price, or redemption premium, if any, of any of the Bonds is not made when the same become due and payable, either at maturity or by proceedings for purchase or redemption or otherwise;

due and punctual payment of any interest on any of the Bonds is not made when the same becomes due and payable;

the University, for any reason, is rendered incapable of fulfilling its obligations hereunder or under any Series Resolution or other Supplemental Resolution;

an order or decree is entered, with the consent or acquiescence of the University, appointing a receiver or receivers of the University or any part thereof or of the revenues thereof, or if such order or decree, having been entered without the consent or acquiescence of the University, is not vacated or discharged or stayed on appeal within sixty (60) days after the entry thereof;

any proceeding is instituted, with the consent or acquiescence of the University, for the purpose of effecting a composition between the University and its creditors or for the purpose of adjusting the claims of such creditors pursuant to any federal or state statute now or hereafter enacted; or

the University defaults in the due and punctual performance of any other of the covenants, conditions, agreements and provisions contained in the Bonds, in this Program Resolution or in any Series Resolution or other Supplemental Resolution on the part of the University to be performed, and such default continues for thirty (30) days after written notice specifying such default and requiring same to be remedied is given to the Board by any Bondholder, provided that if such default is such that it can be corrected but cannot be corrected within such thirty (30) day period, it shall not constitute an Event of Default if corrective action is instituted by the University within such period and is diligently pursued until the default is corrected.

Remedies. (a) Upon the happening and continuance of an Event of Default, hereunder, the Bondholders of not less than 25% in aggregate principal amount of the Bonds then outstanding, by instrument or instruments filed with the University and proved or acknowledged in the same manner as a deed to be recorded, may appoint a trustee to represent the Bondholders of the Bonds for the purposes herein, which trustee may be the State Treasurer and shall be the same trustee so appointed with respect to all other outstanding Parity Credit Obligations. Such trustee may, and upon written request of the Bondholders of not less than 25% aggregate in principal amount of the Bonds then outstanding shall, in its own name:

by mandamus or other suit, action or proceeding at law or in equity enforce all rights of the Bondholders of the Bonds, including the right to require the University and its Board to collect fees, rents, charges or other revenues adequate to carry out an agreement as to, or pledge of, such revenues, and to require the University and Board to carry out any other agreements with the Bondholders of the Bonds and to perform it and their duties under the Act;

bring suit upon the Bonds;

by action or suit in equity, require the University to account as if it were the trustee of an express trust for the Bondholders of the Bonds; or

by action or suit in equity, enjoin any acts or things which may be unlawful or in violation of the rights of the Bondholders of the Bonds.

Any such trustee, whether or not all such Bonds have been declared due and payable, shall be entitled as of right to the appointment of a receiver who may enter and take possession of any property of the University any of the revenues from which are pledged for the security of the Bonds and operate and maintain the same and collect and receive all fees, rents, charges and other revenues thereafter arising therefrom in the same manner as the University itself might do and shall deposit all such moneys in a separate account and apply the same in such manner as the court appointing such receiver shall direct. In any suit, action or proceeding by the trustee the fees, counsel fees and expenses of the trustee and of the receiver, if any, shall constitute taxable costs and disbursements and all costs and disbursements allowed by the court shall be a first charge on any fees, rents, charges and other revenues of the University pledged for the security of the Bonds.

Such trustee shall, in addition to the foregoing, have and possess all of the powers necessary or appropriate for the exercise of any functions specifically set forth herein or incident to the general representation of the Bondholders of the Bonds in the enforcement and protection of their rights.

To the extent permitted by law, upon the happening and continuance of any Event of Default, then and in every such case any Bondholder may proceed, subject to the provisions of Section 7.5, to protect and enforce the rights of the Bondholders by a suit, action or special proceeding in equity or at law, either for the specific performance of any covenant or agreement contained herein or in aid or execution of any power herein granted or for the enforcement of any proper legal or equitable remedy as such Bondholder shall deem most effectual to protect and enforce such rights.

Pro Rata Application of Funds. Anything in this Program Resolution to the contrary notwithstanding, except as otherwise provided in Section 7.2(a), if at any time the moneys available in the Debt Service Funds shall not be sufficient to pay the interest on or the principal of the Bonds as the same shall become due and payable, such moneys, together with any moneys then available or thereafter becoming available for such purpose, whether through the exercise of the remedies provided for in this Article or otherwise, shall be applied as follows:

If the principal of all the Bonds shall not have become due and payable, all such moneys shall be applied first to the payment of any fees and expenses of the Custodian, Paying Agent and Registrar and thereafter shall be applied:

first: to the payment to the persons entitled thereto of all installments of interest then due and payable in the order in which such installments became due and payable and, if the amount available shall not be sufficient to pay in full any particular installment, then to the payment, ratably, according to the amounts due on such installment, to the persons entitled thereto, without any discrimination or preference except as to any difference in the respective rates of interest specified in the Bonds; and

second: to the payment to the persons entitled thereto of the unpaid principal of any of the Bonds which shall have become due and payable (other than Bonds called for redemption for the payment of which moneys are held pursuant to the provisions of this Program Resolution), in the order of their due dates, with interest on the principal amount of such Bonds at the respective rates specified therein from the respective dates upon which such Bonds became due and payable, and, if the amount available shall not be sufficient to pay in full the principal of the Bonds due and payable on any particular date, together with such interest, then to the payment first of such interest, ratably, according to the amount of such interest due on such date, and then to the payment of such principal, ratably, according to the amount of such principal due on such date, to the persons entitled thereto without any discrimination or preference.

If the principal of all the Bonds shall have become due and payable, all such moneys shall be applied to the payment of the principal and interest then due and unpaid on the Bonds, without preference or priority of principal over interest or interest over principal, or of any installment of interest over any other installment of interest, or of any Bond over any other Bond, ratably, according to the amounts due, respectively, for principal and interest, to the persons entitled thereto, without any discrimination or preference.

Whenever moneys are to be applied by the trustee pursuant to the provisions of this Section, such moneys shall be applied by the trustee at such times, and from time to time, as the trustee in his or her sole discretion shall determine, having due regard to the amount of such moneys available for application and the likelihood of additional moneys becoming available for such application in the future; the deposit of such moneys with any Paying Agent, or otherwise setting aside such moneys, in trust for the proper purpose shall constitute proper application by the trustee; and the trustee shall incur no liability whatsoever to the Board, to any Bondholder or to any other person for any delay in applying any such moneys, so long as the trustee acts with reasonable diligence, having due regard to the circumstances, and ultimately applies the same in accordance with such provisions of this Program Resolution as may be applicable at the time of application by the trustee. Whenever the trustee shall exercise such discretion in applying such moneys, he or she shall fix the date (which shall be an Interest Payment Date unless the trustee shall deem another date more suitable) upon which such application is to be made and upon such date interest on the amounts of principal to be paid on such date shall cease to accrue. The trustee shall give such notice (or shall cause the Paying Agent to give such notice) as he or she may deem appropriate of the fixing of any such date and shall not be required to make payment to the Bondholder of any Bond until such Bond shall be surrendered to the trustee or any Paying Agent for appropriate endorsement, or for cancellation if fully paid.

Notwithstanding anything in this Program Resolution to the contrary, this Section 7.3 shall be interpreted so that the term "Bonds" shall include the Bonds and any other Parity Credit Obligations. In each resolution authorizing the issuance of any other Parity Credit Obligation, the University agrees to provide for the trustee or paying agent thereunder to be the same entity as under this Program Resolution, and further agrees to include provisions substantially identical to those contained in this Section 7.3.

Effect of Discontinuance of Proceedings. In case any proceeding taken by any Bondholder on account of any Event of Default shall have been discontinued or abandoned for any reason, then and in every such case the University and the Bondholders shall be restored to their former positions and rights hereunder, respectively, and all rights and remedies of the Bondholders shall continue as though no such proceeding had been taken.

Proceedings for Equal Benefit of All Bondholders. No Bondholder shall have any right in any manner whatever to affect, disturb or prejudice the security of this Program Resolution or any Series Resolution or to enforce any right hereunder or thereunder except in the manner herein provided, and all proceedings at law or in equity shall be instituted, had and maintained for the equal benefit of all Bondholders.

No Remedy Exclusive. No remedy herein conferred on the Bondholders is intended to be exclusive of any other remedy or remedies, and each and every remedy conferred shall be cumulative and shall be in addition to every other remedy given hereunder and under the Act or now or hereafter existing at law or in equity or by statute.

No Delay or Omission Construed to Be a Waiver. No delay or omission of any Bondholder to exercise any right or power accruing upon any Event of Default occurring and continuing as aforesaid shall impair any such right or power or shall be construed to be a waiver of any such Event of Default or an acquiescence therein; and every power and remedy given by this Article to the Bondholders may be exercised from time to time and as often as may be deemed expedient.

EXECUTION OF INSTRUMENTS BY BONDHOLDERS AND
PROOF OF OWNERSHIP OF THE BondS

Execution of Instruments; Proof of Ownership. Any request, direction, consent or other instrument in writing required or permitted by this Program Resolution or any Series Resolution to be signed or executed by Bondholders may be in any number of concurrent instruments of similar tenor and may be signed or executed by such Bondholders or their attorneys or legal representatives. Proof of the execution of any such instrument and of the ownership of the Bonds shall be sufficient for any purpose of this Program Resolution or any Series Resolution and shall be conclusive in favor of the University and the Paying Agent with regard to any action taken by them under such instrument if made in the following manner:

The fact and date of the execution by any person of any such instrument may be proved by the verification of any officer in any jurisdiction who, by the laws thereof, has power to take affidavits within such jurisdiction, to the effect that such instrument was subscribed and sworn to before him or her, or by an affidavit of a witness to such execution. Where such execution is by an officer of a corporation or association or a member of a partnership on behalf of such corporation, association or partnership such verification or affidavit shall also constitute sufficient proof of his or her authority.

The fact of the holding of the Bonds hereunder by any Bondholder and the amount and the numbers of such Bonds and the date of its holding the same shall be proved by the registration books kept under the provisions of Section 2.7.



SUPPLEMENTAL RESOLUTIONS

Supplemental Resolutions. The University may, from time to time and at any time, without the consent of any Bondholders of the Bonds, adopt such resolutions supplemental to this Program Resolution or any Supplemental Resolutions as shall not be inconsistent with the terms and provisions hereof or thereof (which Supplemental Resolutions shall thereafter form a part hereof), as follows:

to cure any ambiguity or formal defect or omission or to correct any inconsistent provisions in this Program Resolution or in any Supplemental Resolutions;

to provide for the issuance of Bonds pursuant to Section 4.2 of this Program Resolution, or to obtain or maintain a rating for the Bonds;

to add Modes for one or more Series of Bonds (other than Bonds already outstanding under this Program Resolution);

to grant to or confer upon the Bondholders any additional rights, remedies, powers, authority or security (including liquidity facilities) that may lawfully be granted to or conferred upon the Bondholders;

to add new conditions, limitations and restrictions on the issuance of other Credit Obligations by the University;

to add to the covenants and agreements of the Board in this Program Resolution other covenants and agreements thereafter to be observed by the Board or to surrender any right or power herein reserved to or conferred upon the Board;

to comply with any proposed, temporary or permanent regulations regarding the arbitrage rebate requirements of the Code;

to modify, alter, amend, add to or rescind, in any particular, any of the terms or provisions contained in this Program Resolution or any Supplemental Resolution, if in the opinion of the Paying Agent, who may rely upon an opinion of counsel nationally recognized in matters concerning municipal bonds, such Supplemental Resolution shall not adversely affect or prejudice the interests of the Bondholders;

to amend certain provisions of this Program Resolution or any Series Resolution in any manner consistent with Sections 103 and 141 through 150 of the Code (or such other sections of the Code as may be applicable to the Bonds) as in effect at the time of the amendment;

to confirm, as further assurance, any pledge under, and the subjection to any lien or pledge created or to be created by, this Program Resolution or any Series Resolution of the Pledged Revenues or any other moneys, property or Funds or Accounts;

to modify, amend or supplement this Program Resolution or any Supplemental Resolution as required to permit its qualification under the Trust Indenture Act of 1939, as amended, or any similar federal statute hereafter in effect, or to permit the qualification of any of the Bonds for sale under the securities laws of any of the states of the United States, and, if the University so determines, to add to this Program Resolution or any Supplemental Resolution such other terms, conditions and provisions as may be permitted by the Trust Indenture Act of 1939, as amended, or similar federal statute;

to amend, modify or change the terms of any agreements governing any book-entry-only system for any of the Bonds; and

to restate in one document this Program Resolution and all effective Series Resolutions and other Supplemental Resolutions, which restatement shall then become this Program Resolution for all purposes, effective as of the date of this Program Resolution with respect to matters set forth therein and as of the date of any Supplemental Resolution included in the restatement as to matters set forth in any such Supplemental Resolution – Series Resolutions and the Bonds issued thereunder prior to a restatement shall be deemed to relate to the restated Program Resolution without any further action or amendment.

At least thirty (30) days prior to the adoption of any Supplemental Resolution for any of the purposes of this Section (other than a Supplemental Resolution for the issuance of another Series of Bonds), the Secretary of the Board shall cause a notice of the proposed adoption of such Supplemental Resolution to be posted to the Municipal Securities Rulemaking Board's EMMA website (or its successor system). Such notice shall briefly set forth the nature of the proposed Supplemental Resolution and shall state that copies thereof are on file at the office of the Secretary of the Board for inspection by all Bondholders. Failure on the part of the Secretary of the Board to mail the notice required by this Section shall not affect the validity of such Supplemental Resolution.

Modification of Resolution with Consent of Bondholders. Subject to the terms and provisions contained in this Section, and not otherwise, the Bondholders of not less than a majority in aggregate outstanding principal amount of the Bonds then outstanding shall have the right, from time to time, anything contained in this Program Resolution to the contrary notwithstanding, to consent to and approve the adoption of such resolution or resolutions supplemental to this Program Resolution or any Supplemental Resolution as shall be deemed necessary or desirable by the Board for the purpose of modifying, altering, amending, adding to or rescinding, in any particular, any of the terms or provisions contained in this Program Resolution or in any Supplemental Resolution; provided, however, that nothing herein contained shall permit, or be construed as permitting, (a) without the approval of all of the Bondholders, (i) an extension of the maturity of the principal of or the interest on any Bond, (ii) a reduction in the principal amount of any Bond or the redemption premium or the rate of interest thereon, (iii) except as otherwise provided herein, a preference or priority of any Bond or Bonds over any other Bond or Bonds, or (iv) except as otherwise provided herein, the release of the lien created by this Program Resolution with respect to any Pledged Revenues, or (b) without the approval of all of the Bondholders, a reduction in the aggregate principal amount of the Bonds required for consent to such Supplemental Resolution. Nothing herein contained, however, shall be construed as making necessary the approval by Bondholders of the adoption of any Supplemental Resolution as authorized in Section 9.1 of this Article.

If at any time the Board shall determine that it is necessary or desirable to adopt any Supplemental Resolution for any of the purposes of this Section, the Secretary of the Board shall cause notice of the proposed adoption of such Supplemental Resolution to be mailed, not less than thirty (30) nor more than sixty (60) days prior to the date of such adoption, postage prepaid, to all registered owners of the Bonds at their addresses as they appear on the registration books held by Registrar. Such notice shall briefly set forth the nature of the proposed Supplemental Resolution and shall state that copies thereof are on file at the office of the Secretary of the Board for inspection by all Bondholders. The Board shall not, however, be subject to any liability to any Bondholder by reason of a failure to cause the notice required by this Section to be mailed and any such failure shall not affect the validity of such Supplemental Resolution when consented to and approved as provided in this Section.

Whenever, at any time within one year after the date of such notice, the Board shall deliver to the Paying Agent an instrument or instruments in writing purporting to be executed by the Bondholders of not less than a majority or all, as appropriate, in aggregate principal amount of the Bonds then outstanding, which instrument or instruments shall refer to the proposed Supplemental Resolution described in such notice and shall specifically consent to and approve the adoption thereof in substantially the form of the copy thereof referred to in such notice, thereupon, but not otherwise, the Board may adopt such Supplemental Resolution in substantially such form, without liability or responsibility to any Bondholder of any Bond, whether or not such Bondholder shall have consented thereto.

If the Bondholders of not less than a majority or all, as appropriate, in aggregate principal amount of the Bonds outstanding at the time of the adoption of such Supplemental Resolution shall have consented to and approved the adoption thereof as herein provided, no Bondholder shall have any right to object to the adoption of such Supplemental Resolution, or to object to any of the terms and provisions contained therein or the operation thereof, or in any manner to question the propriety of the adoption thereof, or to enjoin or restrain the Board from adopting the same or from taking any action pursuant to the provisions thereof.

Upon the adoption of any Supplemental Resolution pursuant to the provisions of this Section, this Program Resolution shall be and be deemed to be modified and amended in accordance therewith, and the respective rights, duties and obligations under this Program Resolution of the University, the Board, and all Bondholders of Bonds then outstanding shall thereafter be determined, exercised and enforced in all respects under the provisions of this Program Resolution as so modified and amended.

Supplemental Resolutions Part of This Resolution. Any Supplemental Resolution adopted in accordance with the provisions of this Article shall thereafter form a part of this Program Resolution, and all of the terms and conditions contained in any such Supplemental Resolution as to any provision authorized to be contained therein shall be and shall be deemed to be part of the terms and conditions of this Program Resolution for any and all purposes. In case of the adoption and approval of any Supplemental Resolution, express reference may be made thereto in the text of any Bonds issued thereafter, if deemed necessary or desirable by the Board.



DEFEASANCE

Defeasance. If the University shall pay or provide for the payment of the entire indebtedness on all Bonds outstanding in any one or more of the following ways:

by paying or causing to be paid the principal of (including redemption premium, if any) and interest on all Bonds outstanding, as and when the same become due and payable;

by depositing with the Paying Agent, in trust, at or before maturity, moneys in an amount sufficient to pay or redeem (when redeemable) all Bonds outstanding (including the payment of premium, if any, and interest payable on such Bonds to the maturity or redemption date thereof), provided that such moneys, if invested, shall be invested at the written direction of the University in noncallable Government Obligations in an amount, without consideration of any income or increment to accrue thereon, sufficient to pay or redeem (when redeemable) and discharge the indebtedness on all Bonds outstanding at or before their respective maturity dates; it being understood that the investment income on such Government Obligations may be used for any other lawful purpose;

by delivering to the Paying Agent, for cancellation by it, all Bonds outstanding; or

by depositing with the Paying Agent, in trust, noncallable Government Obligations in such amounts as will, together with the income or increment to accrue thereon, without consideration of any reinvestment thereof, and any uninvested cash, be fully sufficient to pay or redeem (when redeemable) and discharge the indebtedness on all Bonds outstanding at or before their respective maturity dates, as certified to the Paying Agent's satisfaction in a report by an independent certified public accountant;

and if the University shall pay or cause to be paid all other sums payable hereunder by the University, and, if any of the Bonds are to be redeemed before their maturity, notice of such redemption shall have been given as in Section 3.2 provided or provisions satisfactory to the Paying Agent shall have been made for the giving of such notice, this Program Resolution and the estate and rights granted hereunder shall cease, determine, and become null and void, and thereupon the Paying Agent shall, upon written request of the University, and upon receipt by the Paying Agent of a certificate of an Authorized Officer, each stating that in the opinion of the signers all conditions precedent to the satisfaction and discharge of this Program Resolution have been complied with, forthwith execute proper instruments acknowledging satisfaction of and discharging this Program Resolution and the lien hereof.

The University may at any time surrender to the Paying Agent for cancellation by it any Bonds previously authenticated and delivered, which the University may have acquired in any manner whatsoever, and such Bonds, upon such surrender and cancellation, shall be deemed to be paid and retired.

Liability of University Not Discharged. Upon the deposit with the Paying Agent, in trust, at or before maturity, of money or Government Obligations in the necessary amount to pay or redeem all Bonds outstanding (whether upon or before their maturity or the redemption date of such Bonds) and compliance with the other payment requirements of Section 10.1, provided that if such Bonds are to be redeemed before their maturity, notice of such redemption shall have been given as in Section 3.2 provided, or provisions satisfactory to the Paying Agent shall have been made for the giving of such notice, this Program Resolution may be discharged in accordance with the provisions hereof but the University's liability in respect of the Bonds shall continue provided that the Bondholders thereof shall thereafter be entitled to payment only out of the moneys or the Government Obligations deposited with the Paying Agent as aforesaid.

Provision for Payment of Particular Bonds. If the University shall pay or provide for the payment of the entire indebtedness on particular Bonds in any one or more of the following ways:

by paying or causing to be paid the principal of (including redemption premium, if any) and interest on such Bonds, as and when the same shall become due and payable;

by depositing with the Paying Agent, in trust, at or before maturity, moneys in an amount sufficient to pay or redeem (when redeemable) such Bonds (including the payment of premium, if any, and interest payable on such Bonds to the maturity or redemption date thereof), provided that such moneys, if invested, shall be invested at the written direction of the University in noncallable Government Obligations in an amount, without consideration of any income or increment to accrue thereon, sufficient to pay or redeem (when redeemable) and discharge the indebtedness on such Bonds at or before their respective maturity dates; it being understood that the investment income on such Government Obligations may be used for any lawful purpose;

by delivering to the Paying Agent, for cancellation by it, such Bonds; or

by depositing with the Paying Agent, in trust, noncallable Government Obligations in such amount as will, together with the income or increment to accrue thereon, and any uninvested cash, without consideration of any reinvestment thereof, be fully sufficient to pay or redeem (when redeemable) and discharge the indebtedness on such Bonds at or before their respective maturity dates, as an independent certified public accountant shall certify to Paying Agent's satisfaction;

and if the University shall also pay or cause to be paid all other sums payable hereunder by the University with respect to such Bonds, and, if such Bonds are to be redeemed before their maturity, notice of such redemption shall have been given as in Section 3.2 provided or provisions satisfactory to the Paying Agent shall have been made for the giving of such notice, such Bonds shall cease to be entitled to any lien, benefit or security under this Program Resolution. The University's liability in respect of such Bonds, if any, shall continue but the Bondholders thereof shall thereafter be entitled to payment (to the exclusion of all other Bondholders) only out of the moneys or Government Obligations deposited with the Paying Agent as aforesaid.



MISCELLANEOUS PROVISIONS

Effect of Covenants. All covenants, stipulations, obligations and agreements of the University and the Board contained in this Program Resolution shall be deemed to be covenants, stipulations, obligations and agreements of the University and the Board to the full extent authorized by the Act or permitted by the Constitution of Virginia. All such covenants, stipulations, obligations and agreements shall be binding upon the successor or successors thereof from time to time and upon any officer, board, body or commission to whom or to which any power or duty affecting such covenants, stipulations, obligations and agreements shall be transferred by or in accordance with law.

No covenant, stipulation, obligation or agreement herein contained shall be deemed to be a covenant, stipulation, obligation or agreement of any present or future director, member, agent or employee of the University or the Board in his or her individual capacity, and no agency of the Commonwealth nor any officer thereof or of the University, present or future, executing the Bonds shall be liable personally on the Bonds or be subject to any personal liability or accountability by reason of the issuance thereof.

Successor Paying Agents or Registrars. Any bank or trust company authorized to do business in the Commonwealth may be appointed by the University as successor Paying Agent or Registrar hereunder and under each Series Resolution and immediately upon acceptance of such appointment shall be deemed the successor of the Paying Agent or Registrar for the purposes of this Program Resolution. The University shall give notice to any Rating Agency of its appointment of any successor Paying Agent or Registrar. The reasonable fees and expenses of any such successor Paying Agent or Registrar shall be the sole obligation of the University and shall constitute a pledge of the Pledged Revenues prior to the Bonds, to the extent such fees and expenses are unpaid. Each of the Paying Agent and Registrar may resign and thereby become discharged from its obligations hereunder, by written notice mailed to the University by registered or certified mail. Such resignation shall take effect upon the appointment of a successor hereunder and acceptance of the successor to the obligations hereunder. Each of the Paying Agent and Registrar shall continue to serve as such until a successor is appointed. Each of the Paying Agent and the Registrar may, after 60 days subsequent to its resignation, petition the Circuit Court of the City of Charlottesville, Virginia, for the appointment of a successor if one has not yet been appointed.

Manner of Giving Notice. Any notice, demand, direction, request or other instrument authorized or required by this Program Resolution to be given to or filed with the University, the Paying Agent, the Registrar, the Custodian or the Rating Agencies shall be deemed to have been sufficiently given or filed for all purposes of this Program Resolution if and when sent by registered or certified mail, return receipt requested:

to the University, if addressed to the University of Virginia, P. O. Box 400210, Charlottesville, Virginia 22904-4210 (Attention: Executive Vice President and Chief Operating Officer and Vice President and Chief Financial Officer);

to the Custodian, Paying Agent and/or Registrar, if addressed to The Bank of New York Mellon Trust Company, N.A., 500 Ross Street, 12th Floor, AIM 154-1270, Pittsburgh, Pennsylvania 15262, Attention: Corporate Trust Administration;

to Moody's, if addressed to Moody's Investor Services, 7 World Trade Center, 250 Greenwich Street, New York, New York 10007, Attention: Structured Finance, Telecopier: (212) 298-6442;

to S&P, if addressed to S&P Global Ratings, at 55 Water Street, 38th Floor, New York, New York 10041, Attention: Public Finance Department (Surveillance), Telecopier: (212) 438-2152; and

to Fitch, if addressed to Fitch Ratings, One State Street Plaza, New York, New York 10004, Attention: Municipal Structured Finance Group, Telecopier: (212) 635-0466.

Alternative Notice. If, because of the temporary or permanent suspension of publication of any newspaper or financial journal or suspension of the mails or for any other reason, the University, the Board or the Custodian shall be unable to give any notice required to be published or mailed by the provisions of this Program Resolution, the University or the Custodian, as the case may be, shall give such notice in such other manner as in the judgment of the University or the Custodian shall most effectively approximate such publication thereof, and the giving of such notice in such manner shall for all purposes of this Program Resolution be deemed to be in compliance with the requirement for the publication thereof.

Effect of Partial Invalidity. In case any one or more of the provisions of this Program Resolution or of the Bonds issued hereunder shall for any reason be held to be illegal or invalid, such illegality or invalidity shall not affect any other provision of this Program Resolution or of the Bonds, but this Program Resolution and the Bonds shall be construed and enforced as if such illegal or invalid provision had not been contained therein. In case any covenant, stipulation, obligation or agreement contained in the Bonds or in this Program Resolution shall for any reason be held to be in violation of law, then such covenant, stipulation, obligation or agreement shall be deemed to be the covenant, stipulation, obligation or agreement of the University to the full extent permitted by law.

Governing Law. This Program Resolution is adopted with the intent that the laws of the Commonwealth shall govern its construction without regard to conflict of law principles.

Completion of and Amendments to Resolution; Approval, Execution and Delivery of Necessary and Appropriate Documents. Prior to the delivery of any Bonds, in accordance with the University's debt policy, each of the President of the University or the Chief Operating Officer, in consultation with the Chair of the Board's Finance Committee, may authorize completion of and any revisions to this Program Resolution which are not in conflict with the Authorizing Resolution or any future resolution by the Board or the Executive Committee of the Board, as shall be necessary to carry out the intent of this Program Resolution. Certification of this Program Resolution by the Secretary of the Board shall be conclusive evidence that the President of the University or the Chief Operating Officer, in consultation with the Chair of the Board's Finance Committee, has finally completed this Program Resolution.

Bond Delivery. All directors, officers and employees of the University are hereby authorized to take all actions necessary to accomplish the delivery of the Bonds to purchasers thereof.

Repeal of Inconsistent Provisions. Any prior resolutions or provisions of resolutions of the Board inconsistent with any provisions of this Program Resolution are hereby repealed.

Paying Agent/Registrar/Custodian Reliance and Other Matters.  For purposes of this Section 11.10 only, the term "Paying Agent" shall refer to the Paying Agent, the Registrar and the Custodian. The Paying Agent undertakes to perform only such duties as are expressly set forth herein and in each Series Resolution. The duties and responsibilities of the Paying Agent hereunder shall be determined solely by the express provisions of this Program Resolution and in each Series Resolution, and no further duties or responsibilities shall be implied. The Paying Agent shall not have any liability under, nor duty to inquire into the terms and provisions of, any agreement or instructions, other than as outlined in this Program Resolution and in each Series Resolution. The Paying Agent may consult with counsel and may rely conclusively and shall be protected in acting or refraining from acting upon any written notice, opinion, electronically transmitted communication, instruction or request furnished to it hereunder and believed by it to be genuine and to have been signed or presented by the proper party or parties. The Paying Agent shall be under no duty to inquire into or investigate the validity, accuracy or content of any such document. The Paying Agent shall have no duty to solicit any payments that may be due it hereunder. The Paying Agent shall not be liable for any action taken or omitted by it in good faith unless a court of competent jurisdiction determines that any loss to the University was the result of the Paying Agent's negligent or willful misconduct. The Paying Agent shall not incur any liability for following the instructions herein contained or expressly provided for, or written instructions given by the University. In the administration of its duties under this Program Resolution, the Paying Agent may execute any of its powers and perform its duties hereunder directly or through agents or attorneys and may consult with counsel, accountants and other skilled persons to be selected and retained by it. The Paying Agent shall not be liable for anything done, suffered or omitted in good faith by it in accordance with the advice or opinion of any such counsel, accountants or other skilled persons. The Paying Agent may resign and be discharged of its duties and obligations hereunder and under each Series Resolution by giving notice in writing of such resignation specifying a date when such resignation shall take effect. Any corporation or association into which the Paying Agent in its individual capacity may be merged or converted or with which it may be consolidated, or any corporation or association resulting from any merger, conversion or consolidation to which the Paying Agent in its individual capacity shall be a party, or any corporation or association to which all or substantially all the corporate trust business of the Paying Agent in its individual capacity may be sold or otherwise transferred, shall be the Paying Agent hereunder without further act. The University covenants and agrees to pay the Paying Agent its fees and expenses (including reasonable attorney's fees, costs and expenses) as agreed upon by the University and the Paying Agent. Furthermore, the University shall pay the Paying Agent for any extraordinary services or expenses performed or incurred by the Paying Agent in connection with its duties under this Program Resolution provided the University consents in writing prior to the performance of such services or the incurring of such expenses.

The Paying Agent shall not be responsible or liable for any failure or delay in the performance of its obligation under this Program Resolution arising out of or caused, directly or indirectly, by circumstances beyond its reasonable control, including, without limitation, acts of God, earthquakes, fire, flood, hurricanes or other storms; wars, terrorism, similar military disturbances; sabotage; epidemic, riots, interruptions; loss or malfunctions of utilities, computer (hardware or software) or communications services; accidents; labor disputes; acts of civil or military authority or governmental action; it being understood that the Paying Agent shall use commercially reasonable efforts which are consistent with accepted practices in the banking industry to resume performance as soon as reasonably practicable under the circumstances.

The Paying Agent shall have the right to accept and act upon instructions, including funds transfer instructions ("Instructions") given pursuant to this Program Resolution and delivered using Electronic Means; provided, however, that the University shall provide to the Paying Agent an incumbency certificate listing Authorized Officers and containing specimen signatures of such Authorized Officers, which incumbency certificate shall be amended by the University whenever a person is to be added or deleted from the listing. If the University elects to give the Paying Agent Instructions using Electronic Means and the Paying Agent in its discretion elects to act upon such Instructions, the Paying Agent's understanding of such Instructions shall be deemed controlling. The University understands and agrees that the Paying Agent cannot determine the identity of the actual sender of such Instructions and that the Paying Agent shall conclusively presume that directions that purport to have been sent by an Authorized Officer listed on the incumbency certificate provided to the Paying Agent have been sent by such Authorized Officer. The University shall be responsible for ensuring that only Authorized Officers transmit such Instructions to the Paying Agent and that the University and all respective Authorized Officers are solely responsible to safeguard the use and confidentiality of applicable user and authorization codes, passwords and/or authentication keys upon receipt by the University. The Paying Agent shall not be liable for any losses, costs or expenses arising directly or indirectly from the Paying Agent's reliance upon and compliance with such Instructions notwithstanding such directions conflict or are inconsistent with a subsequent written instruction. The University agrees: (i) to assume all risks arising out of the use of Electronic Means to submit Instructions to the Paying Agent, including without limitation the risk of the Paying Agent acting on unauthorized Instructions, and the risk of interception and misuse by third parties; (ii) that it is fully informed of the protections and risks associated with the various methods of transmitting Instructions to the Paying Agent and that there may be more secure methods of transmitting Instructions than the method(s) selected by the University; (iii) that the security procedures (if any) to be followed in connection with its transmission of Instructions provide to it a commercially reasonable degree of protection in light of its particular needs and circumstances; and (iv) to notify the Paying Agent immediately upon learning of any compromise or unauthorized use of the security procedures.



THE RECTOR AND VISITORS OF THE

UNIVERSITY OF VIRGINIA

_____________________________________

SERIES RESOLUTION – 2017C

_____________________________________

AUTHORIZING AND SECURING

$__________


GENERAL REVENUE PLEDGE BONDS

SERIES 2017C



AUTHORIZED SEPTEMBER __, 2017



ADOPTED __________, 2017



SERIES RESOLUTION



ADOPTED __________, 2017

THE RECTOR AND VISITORS OF

THE UNIVERSITY OF VIRGINIA

GENERAL REVENUE PLEDGE BONDS

SERIES 2017C

____________________

TABLE OF CONTENTS

____________________

Page

ARTICLE I
DEFINITIONS


Section 1.1 Definitions 2

Section 1.2 Rules of Construction/Use of Words and Phrases 3


ARTICLE II
AUTHORIZATION, FORM, EXECUTION, DELIVERY, REGISTRATION AND PAYMENT OF THE SERIES 2017C BONDS


Section 2.1 Authorization of the Series 2017C Bonds 3

Section 2.2 Details of the Series 2017C Bonds 3

Section 2.3 Form of the Series 2017C Bonds 4

Section 2.4 Terms and Conditions for Issuance and Delivery of the Series 2017C Bonds 4

Section 2.5 Book Entry Provisions 5

Section 2.6 Series Resolution 6


ARTICLE III
REDEMPTION OF THE SERIES 2017C BONDS


Section 3.1 Redemption of the Series 2017C Bonds 7

Section 3.2 Notice of Redemption 8

Section 3.3 Effect of Calling for Redemption 8

Section 3.4 The Series 2017C Bonds Redeemed Not Deemed Outstanding 8


ARTICLE IV
CUSTODY AND APPLICATION OF PROCEEDS OF THE SERIES 2017C BONDS


Section 4.1 Custody and Application of Proceeds of the Series 2017C Bonds 9

ARTICLE V
REVENUES AND FUNDS


Section 5.1 Funds Established 9

Section 5.2 Payments to Bondholders 10

Section 5.3 Pledge of Funds and Accounts 10

Section 5.4 No Risk to Paying Agent Funds 10


ARTICLE VI
PARTICULAR COVENANTS


Section 6.1 Payment of Principal and Interest; Pledge of Pledged Revenues 10

Section 6.2 Tax Covenants 11


ARTICLE VII
MISCELLANEOUS PROVISIONS


Section 7.1 Effect of Covenants 11

Section 7.2 Manner of Giving Notice 12

Section 7.3 Effect of Partial Invalidity 12

Section 7.4 Governing Law 12

Section 7.5 Completion of and Amendments to Series Resolution; Approval, Execution and Delivery of Necessary and Appropriate Documents 12

Section 7.6 Bond Delivery 13

Section 7.7 Repeal of Inconsistent Provisions 13

Section 7.8 Paying Agent/Registrar/Custodian Reliance and Other Matters 13


Exhibit A - Form of the Series 2017C Bonds

Exhibit B - Form of Requisition


A SERIES RESOLUTION AUTHORIZING THE ISSUANCE OF THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGINIA GENERAL REVENUE PLEDGE BONDS, SERIES 2017C; PLEDGING TO THE PAYMENT OF THE PRINCIPAL OF AND THE INTEREST ON SUCH BONDS CERTAIN REVENUES OF THE UNIVERSITY AS PROVIDED HEREIN; AND SETTING FORTH THE RIGHTS AND REMEDIES OF THE HOLDERS OF SUCH BONDS.

RECITALS

By Chapter 22, Title 23.1 of the Code of Virginia of 1950, as amended, there is created a corporation under the name and style of The Rector and Visitors of the University of Virginia (the "University"), which is governed by a Board of Visitors (the "Board"), which is vested with the supervision, management and control of the University.

Pursuant to Title 23.1 of the Code of Virginia of 1950, as amended, the University is classified as an educational institution of the Commonwealth.

By Chapter 10, Title 23.1 of the Code of Virginia of 1950, as amended (the "Act"), the University entered into a management agreement with the Commonwealth which was enacted as Chapter 3 of Chapter 933 of the 2006 Virginia Acts of Assembly, as amended, pursuant to which the University is classified as a public institution of higher education and the University is empowered with the authority to undertake and implement the acquisition of any interest in land, including improvements on the acquired land at the time of acquisition, new construction, improvements or renovations and to borrow money and make, issue and sell bonds of the University for such purposes, including the refinancing of any such facilities. 

Pursuant to a resolution adopted on September __, 2017 (the "Authorizing Resolution"), the Board determined to finance and refinance the costs of capital and other projects, including capitalized interest, financing costs, working capital, general corporate purposes and the refunding of prior obligations of the University (collectively, the "Projects"), and delegated to certain officers of the University pursuant to the University's Board-approved debt and interest rate risk management policies the power to approve the final terms of such financing, within certain stated parameters.

On __________, 2017, the Board adopted its Master Bond Resolution (Multi-Year Capital Program) (as supplemented and amended from time to time, the "Program Resolution"), under which the University is authorized to issue one or more Series of Bonds (as defined in the Program Resolution).

Pursuant to the Authorizing Resolution, the Board also determined to finance and refinance up to $__________ of the costs of the Projects through the issuance of a Series of Bonds.

NOW, THEREFORE, BE IT RESOLVED BY THE BOARD:



  1. DEFINITIONS

Definitions. Each capitalized term has the meaning given to it in the Program Resolution, and the following words and terms as used in this Series Resolution have the following meanings, unless some other meaning is plainly intended:

"Bond Purchase Agreement" means the Bond Purchase Agreement, dated as of the date of its execution and delivery, between the University and the Underwriters.

"Debt Service Fund" means The Rector and Visitors of the University of Virginia General Revenue Pledge Bonds, Series 2017C, Debt Service Fund, a special fund created and designated by Section 5.1.

"DTC" means The Depository Trust Company and any successor company.

"Interest Payment Dates" means the dates interest is due on the Series 2017C Bonds as described in Section 2.2.

"Principal Payment Date" means __________.

"Record Date" means the 15th day of the month preceding the applicable Interest Payment Date.

"Securities Depository" means The Depository Trust Company, a limited purpose trust corporation organized and existing under the laws of the State of New York, and any other securities depository for the Bonds appointed pursuant to Section 2.5.

"Series Resolution" or "Resolution" means this Series Resolution – 2017C adopted by the Board on __________, 2017, related to the issuance of the Series 2017C Bonds, as completed and amended pursuant to Section 7.5 hereof.

"Series 2017C Bonds" or "Bonds" means the General Revenue Pledge Bonds of the University issued pursuant to the Series 2017C Resolutions.

"Series 2017C Resolutions" means this Series Resolution, authorized by the Board on September __, 2017, and adopted on __________, 2017, with respect to the Series 2017C Bonds, the Authorizing Resolution and any other resolutions supplemental to such resolutions.

"Treasury Rate" means, with respect to any redemption date, the yield to maturity as of such redemption date of United States Treasury securities with a constant maturity excluding inflation indexed securities (as compiled and published in the most recent Federal Reserve Statistical Release H.15 (519) that has become publicly available at least two Business Days, but no more than 45 days, prior to such redemption date or, if such Statistical Release is no longer published, any publicly available source of similar market data) most nearly equal to the period from the redemption date to the maturity date of the bond to be redeemed; provided, however, that if the period from the redemption date to such maturity date is less than one year, the weekly average yield on actually traded United States Treasury securities adjusted to a constant maturity of one year will be used.

"Underwriters" mean Barclays Capital Inc., Goldman, Sachs & Co. and J.P. Morgan Securities LLC

"University" means The Rector and Visitors of the University of Virginia, an educational institution and a public body and governmental instrumentality for the dissemination of education, and its successor or successors.

Rules of Construction/Use of Words and Phrases.  Words of the masculine gender shall be deemed and construed to include correlative words of the feminine and neuter genders. Unless the context shall otherwise indicate, the word "person" shall include corporations and associations, including public bodies, as well as natural persons. Singular words shall connote the plural number as well as the singular and vice versa.

All references in this Series Resolution to particular Articles or Sections are references to Articles or Sections of this Series Resolution unless otherwise indicated.

The headings and table of contents as used in this Series Resolution are solely for convenience of reference and shall not constitute a part of this Series Resolution nor shall they affect its meaning, construction or effect.



AUTHORIZATION, FORM, EXECUTION, DELIVERY,
REGISTRATION AND PAYMENT OF THE SERIES 2017C BONDS

Authorization of the Series 2017C Bonds. For the purpose of providing funds, together with other available funds, to finance and refinance all or a portion of the costs of the Projects, there shall be issued, under the authority of the Act and the Program Resolution, Bonds of the University in the aggregate principal amount of __________ DOLLARS ($__________). The Bonds shall be designated "The Rector and Visitors of The University of Virginia General Revenue Pledge Bonds, Series 2017C."

Details of the Series 2017C Bonds.  The Series 2017C Bonds authorized in Section 2.1 shall be issued initially in book-entry form only in denominations of $5,000 or any multiple thereof, shall be dated the date of their delivery, shall be numbered RC-1, and shall have a final Maturity Date of __________, ____, in the amount of $__________ and shall bear interest at _____% per annum, payable on __________, 2017 and semi-annually thereafter on __________ and __________ in each year. [Insert Principal Payment Dates, if more than one principal payment date].

The Series 2017C Bonds shall be issued in Fixed Rate Mode and shall bear interest at the Fixed Rate set forth in Section 2.2(a).

All the Series 2017C Bonds shall bear interest (a) from their dated date, if authenticated prior to __________, 2017, or (b) otherwise from the __________ or __________ that is, or that immediately precedes, the date on which such Bond is authenticated (unless payment of interest is in default, in which case such Bond shall bear interest from the date of which interest has been paid).

Both principal of and interest on the Series 2017C Bonds shall be payable in lawful money of the United States of America, but only from the revenues lawfully available therefor pursuant to the Act and pledged to the payment thereof as hereinafter provided. Principal of the Series 2017C Bonds shall be payable upon presentation and surrender of the Series 2017C Bonds as they become due at the Designated Office of the Paying Agent. Interest on the Series 2017C Bonds shall be payable to the registered owners of the Series 2017C Bonds by check or draft mailed on the applicable Interest Payment Date to such owners at their addresses as they appear on the Record Date on registration books kept by the Registrar, or upon the written request of any Holder of at least $1,000,000 in aggregate principal amount of Series 2017C Bonds by wire transfer in immediately available funds to an account within the United States designated by such Holder at least three business days before the Record Date for the applicable Interest Payment Date.

Nothing herein shall be construed as prohibiting the University from issuing any maturity of the Series 2017C Bonds as one fully registered bond for the purpose of qualifying such Bonds for book entry registration by a Securities Depository or any similar arrangement whereby investors may hold a participation interest in such maturity of the Series 2017C Bonds.

Form of the Series 2017C Bonds. The Series 2017C Bonds shall be substantially in the form set forth in Exhibit A, with such appropriate variations, omissions and insertions as permitted or required by this Series Resolution.

Terms and Conditions for Issuance and Delivery of the Series 2017C Bonds. The Series 2017C Bonds authorized by this Series Resolution shall be executed in the form and manner hereinabove set forth and shall be deposited with the Registrar for delivery to the Underwriters pursuant to the Bond Purchase Agreement, but before the Series 2017C Bonds shall be delivered by the Registrar, there shall be filed with the Registrar the following:

the items required under Section 4.2 of the Program Resolution;

a copy, certified by the Secretary of the Board, of this Series Resolution;

an opinion of Bond Counsel (upon which the Registrar can rely) stating that the Series 2017C Bonds have been duly authorized, executed and delivered in accordance with the Act and this Resolution, that the Series 2017C Bonds and this Series Resolution constitute valid and binding limited obligations of the University, payable solely from the Pledged Revenues and other property pledged therefor under this Resolution.

When the documents mentioned above in this Section shall have been filed with the Registrar and when the Series 2017C Bonds shall have been executed as required by this Series Resolution, the Registrar shall authenticate and deliver such Bonds to or upon the order of the Underwriters pursuant to the Bond Purchase Agreement, but only upon payment to the Custodian of the purchase price of such Bonds. The Registrar shall be entitled to rely upon such Bond Purchase Agreement as to the names of the purchasers and the amount of such purchase price.

The proceeds of such Bonds shall be deposited by the Custodian as described in Section 4.1.

Book Entry Provisions. The provisions of this Section 2.5 shall apply to the Series 2017C Bonds so long as all of the Series 2017C Bonds shall be maintained in book-entry form with a Securities Depository, any other provisions of this Series Resolution to the contrary notwithstanding.

The principal or redemption price of and interest on the Series 2017C Bonds shall be payable to the Securities Depository, or registered assigns, as the registered owner of the Series 2017C Bonds, in same day funds on each date on which the principal of, and premium, if any, or interest on the Series 2017C Bonds is due as set forth in this Series Resolution and in the Series 2017C Bonds. Such payments shall be made to the offices of the Securities Depository specified by the Securities Depository to the University and Paying Agent in writing. Without notice to or the consent of the beneficial owners of the Series 2017C Bonds, the University and the Securities Depository may agree in writing to make payments of principal and interest in a manner different from that set out herein. If such different manner of payment is agreed upon, the University shall give the Paying Agent written notice thereof, and the Paying Agent shall make payments as if set forth herein. Neither the University nor the Paying Agent shall have any obligation with respect to the transfer or crediting of the appropriate principal, premium, if any, and interest payments to participants of the Securities Depository or the beneficial owners of the Series 2017C Bonds or their nominees.

The Paying Agent at the written direction of the University may replace any Securities Depository as the depository for the Series 2017C Bonds with another qualified securities depository or discontinue the maintenance of the Series 2017C Bonds in book-entry form at any time if the University determines to do so. Notice of any determination above shall be given to such Securities Depository at least 30 days prior to any such discontinuation (or such fewer number of days as shall be acceptable to such Securities Depository). The University may undertake to locate a qualified replacement Securities Depository and/or may discontinue the book-entry system of evidencing ownership of the Series 2017C Bonds.

If the University discontinues the maintenance of the Series 2017C Bonds in book-entry form, the University will issue replacement Series 2017C Bonds directly to the participants in the former Securities Depository or, to the extent requested by any such participant, to the beneficial owners of the Series 2017C Bonds as further described in this Section. At the written direction of the University, the Paying Agent shall notify participants and the beneficial owners of the Series 2017C Bonds, by mailing an appropriate notice to the Securities Depository, or by other means deemed appropriate by either the Securities Depository or the Paying Agent, that the University will issue replacement Series 2017C Bonds directly to the participants shown on the records of the Securities Depository or, to the extent requested by any participant, to beneficial owners of the Series 2017C Bonds shown on the records of such participant, as of a date set forth in such notice, which shall be a date at least 10 days after receipt of such notice by the Securities Depository (or such fewer number of days as shall be acceptable to the Securities Depository).

In the event that replacement Series 2017C Bonds are to be issued to participants in the Securities Depository or to beneficial owners of the Series 2017C Bonds, the University shall promptly have prepared replacement Series 2017C Bonds registered in the names of the participants as shown on the records of the former Securities Depository or, to the extent requested by any participant, in the names of the beneficial owners of Series 2017C Bonds shown on the records of such participant, as of the date set forth in the notice delivered in accordance with the immediately preceding paragraph. Replacement Series 2017C Bonds issued to participants in the Securities Depository or to beneficial owners shall be in fully registered form substantially in the form of Exhibit A. The form set forth in Exhibit A may be modified to include any variations, omissions or insertions that are necessary or desirable in the delivery of replacement certificates in printed form. In delivering replacement certificates, the Paying Agent shall be entitled to rely, without independent investigation, on the records of the former Securities Depository as to its participants and the records of the participants acting on behalf of the beneficial owners. The Series 2017C Bonds will thereafter be registrable and exchangeable as set forth in Sections 2.6 and 2.7 of the Program Resolution.

So long as there is a Securities Depository for the Series 2017C Bonds, (1) such Securities Depository shall be the registered owner of the Series 2017C Bonds, (2) transfers of ownership and exchanges shall be effected on the records of the Securities Depository and its participants pursuant to rules and procedures established by such Securities Depository and its participants, and (3) references in this Series Resolution to Bondholders, Holders or registered owners of the Series 2017C Bonds shall mean the Securities Depository and shall not mean the beneficial owners of the Series 2017C Bonds.

If the University replaces any Securities Depository as the depository for the Series 2017C Bonds with another qualified Securities Depository, replacement Series 2017C Bonds issued to such replacement Securities Depository shall have the same terms, form and content as the Series 2017C Bonds initially registered in the name of the predecessor Securities Depository or its nominee except for the name of the registered owner.

Each Securities Depository and the participants thereof and the beneficial owners of the Series 2017C Bonds, by their acceptance of the Series 2017C Bonds, agree that the University and the Paying Agent shall have no liability or responsibility with respect to (1) the accuracy of any records maintained by such Securities Depository or any Securities Depository participant; (2) the payment by such Securities Depository to any Securities Depository participant or by any Securities Depository participant to any beneficial owner of any amount due in respect of the principal of and premium, if any, and interest on the Series 2017C Bonds; (3) the delivery or timeliness of delivery by such Securities Depository to any Securities Depository participant or by any Securities Depository participant to any beneficial owner of any notice which is given to Bondholders; (4) the selection of the beneficial owners to receive payment in the event of any partial redemption of the Series 2017C Bonds; or (5) any consent given or other action taken by such Securities Depository or any nominee of such Securities Depository, as Bondholder.

Series Resolution.  This Series Resolution is adopted as a Supplemental Resolution pursuant to Section 4.2 and Section 9.1(b) of the Program Resolution.

The Series 2017C Bonds are hereby found, determined and declared to constitute "Bonds" within the meaning of the Program Resolution. The Series 2017C Bonds are entitled to the benefits, security and protection of the Program Resolution, equally and proportionally with any other Bonds issued under the Program Resolution, shall be payable from the Pledged revenues on a parity with all other Bonds, without priority or distinction by reason of Series, number, date, date of sale, date of issuance, Mode or otherwise.



REDEMPTION OF THE SERIES 2017C BONDS

Redemption of the Series 2017C Bonds.  The Series 2017C Bonds shall not be subject to prior redemption except as provided in this Article III.

The Series 2017C Bonds are subject to redemption, at the option of the University, in whole or in part on any date, at a redemption price equal to the greater of:

100% of the principal amount of the Series 2017C Bonds to be redeemed; or

the sum of the present values of the remaining scheduled payments of principal and interest to the maturity date of the Series 2017C Bonds to be redeemed, not including any portion of those payments of interest accrued and unpaid as of the date on which the Series 2017C Bonds are to be redeemed, discounted to the date on which the Series 2017C Bonds are to be redeemed on a semi-annual basis, assuming a 360-day year consisting of twelve 30-day months, at the Treasury Rate, plus ____ basis points;

plus, in each case, accrued interest on the Series 2017C Bonds to be redeemed to the redemption date.

Reserved. – Mandatory Redemption.

[The Series 2017C Bonds shall also be subject to redemption in whole or in part on any date, at the option of the University, from the proceeds of casualty insurance or condemnation awards, at a redemption price equal to 100% of the principal amount thereof to be redeemed, without premium, plus accrued interest to the redemption date, if all or any part of the Project financed with the Series 2017C Bonds is damaged or destroyed or taken through the exercise of the power of eminent domain and the President, Chief Operating Officer or Chief Financial Officer has delivered a certificate to the Custodian to the effect that the University has determined not to use such proceeds to replace or rebuild the damaged, destroyed or taken property. In the event of a redemption in part pursuant to this paragraph, the University shall redeem the Series 2017C Bonds from each maturity then outstanding, to the extent practicable, in the proportion that the principal amount of the Series 2017C Bonds of such maturity bears to the total principal amount of the Series 2017C Bonds then outstanding.] – TO BE DISCUSSED

If the Series 2017C Bonds are registered in book-entry only form and so long as a Securities Depository is the sole registered owner of the Series 2017C Bonds, if less than all of the Series 2017C Bonds of a maturity are called for prior redemption, the particular Series 2017C Bonds or portions thereof to be redeemed shall be selected on a pro-rata pass-through distribution of principal basis in accordance with the procedures of the Securities Depository; provided that, so long as the Series 2017C Bonds are held in book-entry form, the selection for redemption of such Series 2017C Bonds shall be made in accordance with the operational arrangements of the Securities Depository then in effect. If the Securities Depository's operational arrangements do not allow for the redemption of the Series 2017C Bonds on a pro rata pass-through distribution of principal basis as discussed above, then the Series 2017C Bonds will be selected for redemption, in accordance with the procedures of the Securities Depository, by lot. If a Securities Depository is no longer the sole registered owner of the Series 2017C Bonds, if less than all of the Series 2017C Bonds are called for redemption, the Paying Agent will select the Series 2017C Bonds to be redeemed on a pro rata basis.

Notice of Redemption.  Whenever the Series 2017C Bonds are to be redeemed under the provisions of this Series Resolution, the Paying Agent shall, not less than thirty (30) nor more than sixty (60) days prior to the redemption date, mail notice of redemption to all registered owners of all Series 2017C Bonds to be redeemed at their registered addresses. The Paying Agent shall also mail a copy of any such notice of redemption to any Rating Agency. Any such notice of redemption shall identify the Series 2017C Bonds to be redeemed, shall specify the redemption date and the redemption price, and shall state that on the redemption date the Series 2017C Bonds called for redemption will be payable at the Designated Office of the Paying Agent and that from that date interest will cease to accrue. The Paying Agent may use "CUSIP" numbers in notices of redemption as a convenience to Bondholders, provided that any such notice shall state that no representation is made as to the correctness of such numbers either as printed on the Series 2017C Bonds or as contained in any such notice.

If at the time of mailing of notice of any optional redemption the University shall not have caused to be deposited with the Paying Agent money sufficient to redeem all the Series 2017C Bonds called for redemption, such notice may state that it is conditional in that it is subject to the deposit of such moneys with the Paying Agent not later than the redemption date, and such notice shall be of no effect unless such moneys are so deposited. Failure by the Paying Agent to give any notice of redemption or any defect in such notice as to any particular Bonds shall not affect the validity of the call for redemption of any Bonds in respect of which no such failure or defect has occurred. Any notice mailed as provided in this Series Resolution shall be conclusively presumed to have been given whether or not actually received by any Holder.

Effect of Calling for Redemption. On the date designated for redemption, notice having been mailed in the manner and under the conditions hereinabove provided and moneys for payment of the redemption price being held in separate accounts by the Paying Agent in trust for the Holders of the Series 2017C Bonds to be redeemed, all as provided in this Series Resolution, the Series 2017C Bonds so called for redemption shall become and be due and payable at the redemption price provided for redemption of such Bonds on such date, interest on the Series 2017C Bonds so called for redemption shall cease to accrue, such Bonds shall cease to be entitled to any benefit or security under this Series Resolution and the Holders or registered owners of such Bonds shall have no rights with respect thereto except to receive payment of the redemption price.

The Series 2017C Bonds Redeemed Not Deemed Outstanding. The Series 2017C Bonds which have been duly called for redemption under the provisions of this Article, or with respect to which irrevocable instructions to call for redemption have been given by the Board to the Paying Agent in form satisfactory to him or her, and for the payment of the redemption price of which moneys shall be held in separate accounts by the Paying Agent in trust for the Holders of the Series 2017C Bonds to be redeemed, all as provided in this Series Resolution, shall not thereafter be deemed to be outstanding under the provisions of this Series Resolution.



CUSTODY AND APPLICATION OF PROCEEDS
OF THE SERIES 2017C BONDS

Custody and Application of Proceeds of the Series 2017C Bonds. The proceeds of the Series 2017C Bonds (par amount ($__________.00) plus original issue premium ($__________), less the underwriter's discount ($__________) shall be applied as follows:

$__________ shall be transferred to Construction Fund to be used to pay a portion of the costs of the Projects; and

$__________ shall be deposited into a special account created with the Custodian for the payment of expenses incident to the issuance of the Series 2017C Bonds. Any amounts remaining in the special account on __________, 2017, shall be deposited in the Debt Service Fund and applied to pay interest on such Series 2017C Bonds on the next Interest Payment Date.



REVENUES AND FUNDS

Funds Established.

Construction Fund. (i) A special fund is hereby created with the [University / Custodian] as the Construction Fund, to the credit of which there shall be deposited a portion of the proceeds of the Series 2017C Bonds. The moneys in the Construction Fund shall be held in trust and applied to the payment of the cost of the Projects, and, pending such application, shall be subject to a lien and charge in favor of the Bondholders of the Series 2017C Bonds and for the future security of such Bondholders until paid out or transferred as herein provided.

        1. (A) Payment of the costs of the Projects shall be made from the Construction Fund and other available funds, all as provided by law. All payments from the Construction Fund shall be subject to the provisions and restrictions set forth in this Section, and the Board covenants that it will not cause or permit to be paid from the Construction Fund any sums except in accordance with such provisions and restrictions.

          1. Moneys in the Construction Fund shall be paid out by in accordance with [requisitions substantially the form of Exhibit B hereto (or in such other form required by the [University / Custodian]) and shall state each amount to be paid, the appropriate Account (if any), the name of the person, firm or corporation to whom each such payment is due and the purpose for which the obligation to be paid was incurred, and shall certify that the goods or services specified have been received, or performed, payment therefor has not been previously authorized and that the expenditure is a proper charge to the appropriation for the Construction Fund.

        1. When the Projects shall have been completed and placed in operation, as evidenced by a certificate signed by an Authorized Officer and filed with the Secretary of the Board, any balance in the Construction Fund not deemed by the Board to be necessary to be reserved for the payment of any remaining part of the cost of the Projects shall be deposited to the credit of the Debt Service Fund for the Series 2017C Bonds, and used to pay interest on the Series 2017C Bonds on their next Interest Payment Date.

Debt Service Fund. A fund shall be created by the Paying Agent designated "The Rector and Visitors of the University of Virginia General Revenue Pledge Bonds, Series 2017C, Debt Service Fund" (the "Debt Service Fund"). All accrued interest, if any, received from the purchasers of the Series 2017C Bonds, as provided in Section 4.1, shall be transferred to the Paying Agent to the credit of the Debt Service Fund. On or before the day preceding each date on which payments of interest, premium or principal shall be due and payable on the Series 2017C Bonds (a "Payment Date"), the University shall transfer or cause to be transferred to the Paying Agent for deposit an amount of money sufficient to cause the amount held in the Debt Service Fund to be equal to the interest, premium and principal due on the Series 2017C Bonds on such Payment Date. The Paying Agent shall cause payment of the amounts due on the Series 2017C Bonds on each such Payment Date.

Payments to Bondholders. The Paying Agent shall, at appropriate times on or before each Payment Date, withdraw from the Debt Service Fund the amounts needed on such date to pay the principal of and premium, if any, and interest on the Series 2017C Bonds and shall pay or cause the same to be paid to the Bondholders as such principal, premium and interest become due and payable.

Pledge of Funds and Accounts. The moneys in the Debt Service Fund shall be held in trust and applied as herein provided and, pending such application, shall be pledged to, and subject to a lien and charge in favor, of the Holders of the Series 2017C Bonds issued and outstanding under this Series Resolution and for the further security of such Holders until paid out or transferred as herein provided.

No Risk to Paying Agent Funds. No provision herein shall require the Paying Agent to expend its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder or in the exercise of any of its rights or powers unless the Paying Agent shall have reasonable grounds for believing that repayment of such funds or adequate indemnity against such risk or liability is reasonably assured to it.







PARTICULAR COVENANTS

Payment of Principal and Interest; Pledge of Pledged Revenues. The University covenants that it will promptly pay or cause to be paid from the sources described herein the principal of and the interest on every Bond issued under the provisions of this Series Resolution at the place or places, on the dates and in the manner provided herein and in such Bonds, and any premium required for the retirement of such Bonds by purchase or redemption, according to the true intent and meaning thereof. Except as otherwise provided in this Series Resolution, such principal, interest and premium are payable solely from Pledged Revenues, which Pledged Revenues are hereby pledged to the payment thereof and to the payment of any Parity Credit Obligations issued by the University, which may include any interest rate swaps or other hedge mechanisms and any dedicated line of credit, standby bond purchase agreement or other liquidity facility related to the Series 2017C Bonds, including any Liquidity Facility.

THE UNIVERSITY SHALL NOT BE OBLIGATED TO PAY THE PRINCIPAL OF OR INTEREST ON THE SERIES 2017C BONDS EXCEPT FROM THE SOURCES NOTED HEREIN AS PLEDGED THEREFOR. THE SERIES 2017C BONDS AND THE INTEREST THEREON SHALL NOT BE DEEMED TO CONSTITUTE A DEBT OR LIABILITY OF THE COMMONWEALTH, LEGAL, MORAL OR OTHERWISE. NEITHER THE COMMONWEALTH NOR THE UNIVERSITY SHALL BE OBLIGATED TO PAY THE PRINCIPAL OF OR INTEREST ON THE SERIES 2017C BONDS OR OTHER COSTS INCIDENT THERETO EXCEPT FROM THE SOURCES NOTED HEREIN AS PLEDGED THEREFOR, AND NEITHER THE FAITH AND CREDIT NOR THE TAXING POWER OF THE COMMONWEALTH ARE PLEDGED TO THE PAYMENT OF THE PRINCIPAL OF OR INTEREST ON THE SERIES 2017C BONDS OR OTHER COSTS INCIDENT THERETO.

Tax Covenants. If Needed.



MISCELLANEOUS PROVISIONS

Effect of Covenants. All covenants, stipulations, obligations and agreements of the University and the Board contained in this Series Resolution and the Program Resolution shall be deemed to be covenants, stipulations, obligations and agreements of the University and the Board to the full extent authorized by the Act or permitted by the Constitution of Virginia. All such covenants, stipulations, obligations and agreements shall be binding upon the successor or successors thereof from time to time and upon any officer, board, body or commission to whom or to which any power or duty affecting such covenants, stipulations, obligations and agreements shall be transferred by or in accordance with law.

No covenant, stipulation, obligation or agreement herein contained shall be deemed to be a covenant, stipulation, obligation or agreement of any present or future director, member, agent or employee of the University or the Board in his or her individual capacity, and no agency of the Commonwealth nor any officer thereof or of the University, present or future, executing the Series 2017C Bonds shall be liable personally on the Series 2017C Bonds or be subject to any personal liability or accountability by reason of the issuance thereof.

Manner of Giving Notice. Any notice, demand, direction, request or other instrument authorized or required by this Series Resolution to be given to or filed with the University, the Paying Agent, the Registrar, the Custodian or the Rating Agencies shall be deemed to have been sufficiently given or filed for all purposes of this Series Resolution if and when sent in accordance with the Program Resolution.

Effect of Partial Invalidity. In case any one or more of the provisions of this Series Resolution or of the Series 2017C Bonds issued hereunder shall for any reason be held to be illegal or invalid, such illegality or invalidity shall not affect any other provision of this Series Resolution or of the Series 2017C Bonds, but this Series Resolution and the Series 2017C Bonds shall be construed and enforced as if such illegal or invalid provision had not been contained therein. In case any covenant, stipulation, obligation or agreement contained in the Series 2017C Bonds or in this Series Resolution shall for any reason be held to be in violation of law, then such covenant, stipulation, obligation or agreement shall be deemed to be the covenant, stipulation, obligation or agreement of the University to the full extent permitted by law.

Governing Law. This Series Resolution is adopted with the intent that the laws of the Commonwealth shall govern its construction without regard to conflict of law principles.

Completion of and Amendments to Series Resolution; Approval, Execution and Delivery of Necessary and Appropriate Documents.  Prior to the delivery of the Series 2017C Bonds, in accordance with the University's debt policy, each Authorized Officer, in consultation with the Chair of the Board's Finance Committee, may authorize completion of and any revisions to this Series Resolution which are not in conflict with the Authorizing Resolution or any future resolution by the Board or the Executive Committee of the Board, as shall be necessary to carry out the intent of this Series Resolution. Certification of this Series Resolution by the Secretary of the Board shall be conclusive evidence that an Authorized Officer, in consultation with the Chair of the Board's Finance Committee, has finally completed this Series Resolution.

Each Authorized Officer is authorized to negotiate, execute and deliver, in necessary and appropriate form, the following documents:

one or more Official Statement(s) or Offering Memorandum in preliminary and final forms relating to the offering of the Series 2017C Bonds for sale;

the Bond Purchase Agreement relating to the purchase of the Series 2017C Bonds; and

such other documents and instruments as he or she deems necessary or appropriate in connection with the issuance of the Series 2017C Bonds, including without limitation any interest rate swaps or other hedge mechanisms and any dedicated line of credit, standby bond purchase agreement or other liquidity facility related to the Series 2017C Bonds, so long as such documents and instruments do not conflict with the intent of this Series Resolution.

The distribution of any Official Statement or Offering Memorandum, in preliminary and final forms, by the Underwriters is hereby authorized and approved.

Bond Delivery. All directors, officers and employees of the University are hereby authorized to take all actions necessary to accomplish the delivery of the Series 2017C Bonds to purchasers thereof.

Repeal of Inconsistent Provisions. Any prior resolutions or provisions of resolutions of the Board inconsistent with any provisions of this Series Resolution are hereby repealed.

Paying Agent/Registrar/Custodian Reliance and Other Matters. For purposes of this Section 7.8 only, the term "Paying Agent" shall refer to the Paying Agent, the Registrar and the Custodian. The Paying Agent undertakes to perform only such duties as are expressly set forth herein and in the Program Resolution. The duties and responsibilities of the Paying Agent hereunder shall be determined solely by the express provisions of this Series Resolution, and no further duties or responsibilities shall be implied. The Paying Agent shall not have any liability under, nor duty to inquire into the terms and provisions of, any agreement or instructions, other than as outlined in the Series 2017C Resolutions and in the Program Resolution. The Paying Agent may consult with counsel and may rely conclusively and shall be protected in acting or refraining from acting upon any written notice, opinion, electronically transmitted communication, instruction or request furnished to it hereunder and believed by it to be genuine and to have been signed or presented by the proper party or parties. The Paying Agent shall be under no duty to inquire into or investigate the validity, accuracy or content of any such document. The Paying Agent shall have no duty to solicit any payments that may be due it hereunder. The Paying Agent shall not be liable for any action taken or omitted by it in good faith unless a court of competent jurisdiction determines that any loss to the University was the result of the Paying Agent's negligent or willful misconduct. The Paying Agent shall not incur any liability for following the instructions herein contained or expressly provided for, or written instructions given by the University. In the administration of its duties under this Series Resolution, the Paying Agent may execute any of its powers and perform its duties hereunder directly or through agents or attorneys and may consult with counsel, accountants and other skilled persons to be selected and retained by it. The Paying Agent shall not be liable for anything done, suffered or omitted in good faith by it in accordance with the advice or opinion of any such counsel, accountants or other skilled persons. The Paying Agent may resign and be discharged of its duties and obligations hereunder and under the Program Resolution by giving notice in writing of such resignation specifying a date when such resignation shall take effect. Any corporation or association into which the Paying Agent in its individual capacity may be merged or converted or with which it may be consolidated, or any corporation or association resulting from any merger, conversion or consolidation to which the Paying Agent in its individual capacity shall be a party, or any corporation or association to which all or substantially all the corporate trust business of the Paying Agent in its individual capacity may be sold or otherwise transferred, shall be the Paying Agent hereunder without further act. The University covenants and agrees to pay the Paying Agent its fees and expenses (including reasonable attorney's fees, costs and expenses) as agreed upon by the University and the Paying Agent. Furthermore, the University shall pay the Paying Agent for any extraordinary services or expenses performed or incurred by the Paying Agent in connection with its duties under this Series Resolution provided the University consents in writing prior to the performance of such services or the incurring of such expenses.

The Paying Agent shall not be responsible or liable for any failure or delay in the performance of its obligation under this Series Resolution arising out of or caused, directly or indirectly, by circumstances beyond its reasonable control, including, without limitation, acts of God, earthquakes, fire, flood, hurricanes or other storms; wars, terrorism, similar military disturbances; sabotage; epidemic, riots, interruptions; loss or malfunctions of utilities, computer (hardware or software) or communications services; accidents; labor disputes; acts of civil or military authority or governmental action; it being understood that the Paying Agent shall use commercially reasonable efforts which are consistent with accepted practices in the banking industry to resume performance as soon as reasonably practicable under the circumstances.

The Paying Agent shall have the right to accept and act upon instructions, including funds transfer instructions ("Instructions") given pursuant to this Series Resolution and delivered using Electronic Means; provided, however, that the University shall provide to the Paying Agent an incumbency certificate listing Authorized Officers and containing specimen signatures of such Authorized Officers, which incumbency certificate shall be amended by the University whenever a person is to be added or deleted from the listing.  If the University elects to give the Paying Agent Instructions using Electronic Means and the Paying Agent in its discretion elects to act upon such Instructions, the Paying Agent's understanding of such Instructions shall be deemed controlling.  The University understands and agrees that the Paying Agent cannot determine the identity of the actual sender of such Instructions and that the Paying Agent shall conclusively presume that directions that purport to have been sent by an Authorized Officer listed on the incumbency certificate provided to the Paying Agent have been sent by such Authorized Officer.  The University shall be responsible for ensuring that only Authorized Officers transmit such Instructions to the Paying Agent and that the University and all respective Authorized Officers are solely responsible to safeguard the use and confidentiality of applicable user and authorization codes, passwords and/or authentication keys upon receipt by the University.  The Paying Agent shall not be liable for any losses, costs or expenses arising directly or indirectly from the Paying Agent's reliance upon and compliance with such Instructions notwithstanding such directions conflict or are inconsistent with a subsequent written instruction.  The University agrees: (i) to assume all risks arising out of the use of Electronic Means to submit Instructions to the Paying Agent, including without limitation the risk of the Paying Agent acting on unauthorized Instructions, and the risk of interception and misuse by third parties; (ii) that it is fully informed of the protections and risks associated with the various methods of transmitting Instructions to the Paying Agent and that there may be more secure methods of transmitting Instructions than the method(s) selected by the University; (iii) that the security procedures (if any) to be followed in connection with its transmission of Instructions provide to it a commercially reasonable degree of protection in light of its particular needs and circumstances; and (iv) to notify the Paying Agent immediately upon learning of any compromise or unauthorized use of the security procedures.

[Remainder of Page Intentionally Left Blank]



EXHIBIT A

No. RC-1-__

UNITED STATES OF AMERICA

COMMONWEALTH OF VIRGINIA

THE RECTOR AND VISITORS OF THE

UNIVERSITY OF VIRGINIA

GENERAL REVENUE PLEDGE BOND

SERIES 2017C

INTEREST RATE:

MATURITY DATE:

DATED DATE:

CUSIP:            

%


__________, 20__

__________, 2017

915217 ___


REGISTERED OWNER: CEDE & CO.

PRINCIPAL AMOUNT: __________ DOLLARS ($__________)

The Rector and Visitors of the University of Virginia (the "University"), an educational institution established by the Commonwealth of Virginia, for value received, hereby promises to pay, solely from the revenues provided therefor, as hereinafter set forth, to the registered owner named above, on the maturity date set forth above (or earlier as hereinafter set forth), upon the presentation and surrender hereof, the principal sum set forth above and to pay, solely from such revenues, interest thereon from the date hereof at the rate per annum set forth above, until payment of said principal sum. Both the principal of and the interest on this Series 2017C Bond are payable in any coin or currency of the United States of America which on the respective dates of payment thereof is legal tender for the payment of public and private debts. The principal or redemption price of this Series 2017C Bond shall be payable, upon surrender of this Series 2017C Bond, at the office of The Bank of New York Mellon Trust Company, N.A., Pittsburgh, Pennsylvania, as Paying Agent, or at the designated corporate trust office of any successor Paying Agent appointed pursuant to the Series 2017C Resolutions (hereinafter defined). Payment of interest on this Series 2017C Bond shall be made by check or draft mailed on the applicable Interest Payment Date to the registered owner as of the close of business on the 15th date of the month immediately preceding such Interest Payment Date (a "Record Date") at its address as it appears in the registration books of the Registrar appointed pursuant to the Series 2017C Resolutions. The term "Interest Payment Date" with respect to the Series 2017C Bonds means each __________ and __________, commencing __________, 2017.

This Series 2017C Bond shall bear interest from the Interest Payment Date next preceding the date on which it is authenticated, unless this Series 2017C Bond is (a) authenticated before the first Interest Payment Date following the initial delivery of the Series 2017C Bonds, in which case it shall bear interest from its dated date, or (b) authenticated upon an Interest Payment Date, in which case it shall bear interest from such Interest Payment Date; provided, however, that if at the time of authentication of this Series 2017C Bond interest is in default, this Series 2017C Bond shall bear interest from the date to which interest has been paid. Interest on this Series 2017C Bond shall be computed on the basis of a 360-day year of twelve 30-day months.

[Reserved for Change in Mode / Interest Period – TBD].

The University shall not be obligated to pay the principal of or interest on this Series 2017C Bond except from the Pledged Revenues of the University and other legally available moneys, all as provided in the Series 2017C Resolutions and the Program Resolution. "Pledged Revenues" are all of the revenues now or hereafter lawfully available to the University which are not required by law, by binding contract entered into prior to the adoption of the Series 2017C Resolutions or, in certain circumstances described in the Series 2017C Resolutions, by binding contract entered into subsequent to the date of the Series 2017C Resolutions, to be devoted to some other purpose. This Series 2017C Bond and the interest hereon shall not be deemed to constitute a debt or liability of the Commonwealth of Virginia, legal, moral or otherwise. Neither the Commonwealth of Virginia nor the University shall be obligated to pay the principal of or interest on this Series 2017C Bond or other costs incident hereto except from the sources noted above, and neither the faith and credit nor the taxing power of the Commonwealth of Virginia are pledged to the payment of the principal of or interest on this Series 2017C Bond or other costs incident hereto.

This Series 2017C Bond is one of a duly authorized issue of Bonds of the University aggregating __________ DOLLARS ($__________) in principal amount, known as "General Revenue Pledge Bonds, Series 2017C" (the "Series 2017C Bonds"), issued pursuant to an authorizing resolution adopted by the Board of Visitors of the University (the "Board") on September __, 2017 (the "Series 2017 Authorizing Resolution") and, a Master Bond Resolution (Multi-Year Capital Program) executed on ____________, 2017 (as supplemented and amended, the "Program Resolution"), as supplemented by a Series Resolution executed on __________, 2017 (the "Series 2017 Resolution" and together with the Series 2017 Authorizing Resolution, the "Series 2017C Resolutions"). This Series 2017C Bond is issued and the Program Resolution and the Series 2017C Resolutions were adopted under and pursuant to the Constitution and laws of the Commonwealth of Virginia, particularly Chapter 10, Title 23.1, Code of Virginia of 1950, as amended (the "Act") to finance and refinance the costs of certain projects of the University. Reference is hereby made to the Program Resolution and the Series 2017C Resolutions for the provisions, among others, with respect to the custody and application of the proceeds of bonds issued under the Series 2017C Resolutions, the funds charged with and pledged to the payment of the interest on and the principal of the Series 2017C Bonds, the nature and extent of the security, the terms and conditions on which the Series 2017C Bonds are or may be issued, the rights, duties and obligations of the University and the rights of the holders of the Series 2017C Bonds. Capitalized terms not defined herein shall be as defined in the Program Resolution or the Series 2017C Resolutions (as applicable). By the acceptance of this Series 2017C Bond, the Holder hereof assents to all of the provisions of the Program Resolution and the Series 2017C Resolutions.

The Series 2017C Bonds are subject to redemption, at the option of the University, in whole or in part on any date, at a redemption price equal to the greater of:

(i) 100% of the principal amount of the Series 2017C Bonds to be redeemed; or

(ii) the sum of the present values of the remaining scheduled payments of principal and interest to the maturity date of the Series 2017C Bonds to be redeemed, not including any portion of those payments of interest accrued and unpaid as of the date on which the Series 2017C Bonds are to be redeemed, discounted to the date on which the Series 2017C Bonds are to be redeemed on a semi-annual basis, assuming a 360-day year consisting of twelve 30-day months, at the Treasury Rate, plus ____ basis points;

(iii) plus, in each case, accrued interest on the Series 2017C Bonds to be redeemed to the redemption date.

[The Series 2017C Bonds shall also be subject to redemption in whole or in part on any date, at the option of the University, from the proceeds of casualty insurance or condemnation awards, at a redemption price equal to 100% of the principal amount thereof to be redeemed, without premium, plus accrued interest to the redemption date, if all or any part of the Project financed with the Series 2017C Bonds is damaged or destroyed or taken through the exercise of the power of eminent domain and the President, Chief Operating Officer or Chief Financial Officer has delivered a certificate to the Custodian to the effect that the University has determined not to use such proceeds to replace or rebuild the damaged, destroyed or taken property. In the event of a redemption in part pursuant to this paragraph, the University shall redeem the Series 2017C Bonds from each maturity then outstanding, to the extent practicable, in the proportion that the principal amount of the Series 2017C Bonds of such maturity bears to the total principal amount of the Series 2017C Bonds then outstanding.] – TO BE DISCUSSED

Subject to applicable procedures of the Securities Depository while the Series 2017C Bonds are held in book-entry only form by the Securities Depository, if less than all of the Series 2017C Bonds are to be called for redemption, the Series 2017C Bonds to be redeemed shall be selected by the University in such manner as the University in its discretion may determine.

If the Series 2017C Bonds are registered in book-entry only form and so long as a Securities Depository is the sole registered owner of the Series 2017C Bonds, if less than all of the Series 2017C Bonds of a maturity are called for prior redemption, the particular Series 2017C Bonds or portions thereof to be redeemed shall be selected on a pro-rata pass-through distribution of principal basis in accordance with the procedures of the Securities Depository; provided that, so long as the Series 2017C Bonds are held in book-entry form, the selection for redemption of such Series 2017C Bonds shall be made in accordance with the operational arrangements of the Securities Depository then in effect. If the Securities Depository's operational arrangements do not allow for the redemption of the Series 2017C Bonds on a pro rata pass-through distribution of principal basis as discussed above, then the Series 2017C Bonds will be selected for redemption, in accordance with the procedures of the Securities Depository, by lot. If a Securities Depository is no longer the sole registered owner of the Series 2017C Bonds, if less than all of the Series 2017C Bonds are called for redemption, the Paying Agent will select the Series 2017C Bonds to be redeemed on a pro rata basis.

This Series 2017C Bond is transferable by the registered owner, in person or by its attorney duly authorized in writing, at the Designated Office of the Registrar, upon presentation of a written instrument of transfer and surrender of this Series 2017C Bond to the Registrar for cancellation. Upon the transfer, a new Series 2017C Bond or Bonds of the same aggregate principal amount, maturity date and interest rate will be issued to the transferee. No transfer will be effective unless represented by such surrender and reissue. This Series 2017C Bond may also be exchanged at the Designated Office of the Registrar for a new Series 2017C Bond or Bonds of the same aggregate principal amount, maturity date and interest rate without transfer to a new registered owner. Exchanges and transfers will be without expense to the holder except for applicable taxes or other governmental charges, if any. The Registrar shall not be required to transfer or exchange any Series 2017C Bond selected or called for redemption pursuant to the provisions hereof or from a Record Date through the next succeeding Interest Payment Date. All Bonds delivered in exchange or transfer shall be dated so that neither gain nor loss results from the transfer or exchange.

The University, the Paying Agent and the Registrar may treat the registered owner as the absolute owner of this Series 2017C Bond for all purposes, notwithstanding any notice to the contrary.

Neither the members of the Board nor any person executing this Series 2017C Bond are liable personally hereon or subject to any personal liability or accountability by reason of the issuance hereof.

This Series 2017C Bond will not be valid until the Certificate of Authentication has been signed by the Registrar.

The holder of this Series 2017C Bond shall have no right to enforce the provisions of the Program Resolution or the Series 2017C Resolutions or to institute action to enforce the covenants therein, or to take any action with respect to any Event of Default, or to institute, appear in or defend any suit or other proceeding with respect thereto, except as provided in the Program Resolution or the Series 2017C Resolutions.

All acts, conditions and things required by the Constitution and laws of the Commonwealth of Virginia and by the rules and regulations of the Board to happen, exist and be performed precedent to and in the issuance of this Series 2017C Bond have happened, exist and have been performed as so required.

[Signature Page Follows]

IN WITNESS WHEREOF, The Rector and Visitors of the University of Virginia has caused this Series 2017C Bond to be issued and caused this Series 2017C Bond to bear the manual or facsimile signatures of its Executive Vice President and Chief Operating Officer and its official seal to be impressed, imprinted, reproduced or lithographed hereon, all as of the dated date hereof.

[SEAL]


_________________________________________

[Executive Vice President and

Chief Operating Officer,]

University of Virginia

CERTIFICATE OF AUTHENTICATION

This Series 2017C Bond is one of the Bonds described in the within mentioned Series 2017C Resolutions.

Date of Authentication: THE BANK OF NEW YORK MELLON TRUST

__________, 2017 COMPANY, N.A., as Registrar




__________________________________________

Authorized Signatory

FORM OF ASSIGNMENT

FOR VALUE RECEIVED the undersigned hereby sells, assigns and transfers unto ________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

[Please print or typewrite name and address, including zip code, of Transferee]

PLEASE INSERT SOCIAL SECURITY OR

OTHER IDENTIFYING NUMBERS OF TRANSFEREE

___________________________________________

___________________________________________

the within Bond and all rights, thereunder, and hereby irrevocably constitutes and appoints __________________________________________________ attorney to transfer the within Bond on the books kept for registration thereof, with full power of substitution in the premises.

Dated: ______________________

______________________________

Registered Owner

The signature above must correspond to the name of the Registered Owner as it appears on the front of this Series 2017C Bond in every particular, without alteration or enlargement or any change whatsoever.

Signature Guaranteed:

____________________________________

Notice: Signature(s) must be guaranteed
by an approved eligible guarantor institution, an institution which is a participant in a Securities Transfer Association recognized signature guarantee program





EXHIBIT B


FORM OF REQUISITION

Requisition No:

This Requisition is submitted in connection with the Series Resolution – 2017C (the "Series 2017C Resolution") adopted on __________, 2017, by the Board of Visitors of The Rector and Visitors of the University of Virginia (the "University"). The Series 2017C Resolution authorizes the issuance of general revenue pledge bonds of the University (the "Series 2017C Bonds"). The undersigned requests payment of the following obligation or obligations from the "Construction Fund" pursuant to Section 5.1(a) of the Series 2017C Resolution:

Payee:

Address:

Amount to be Paid:

Paid from the following account and/or subaccount:

Purpose (in reasonable detail) for which the obligations(s) to be paid was incurred:

The undersigned certifies that:


(i) The obligation stated on the requisition has been incurred to pay the cost of the Projects, each item is a proper charge against the appropriate Construction Fund and is a cost permitted under the Act and the obligation has not been the basis for a prior requisition which has been paid; and

(ii) At the date of this certificate, no Event of Default has occurred which has not been cured or waived, and no event exists which, with notice or lapse of time or both, would constitute an Event of Default.

Unless otherwise defined, each capitalized term used in this Requisition shall have the meaning given it in the Series 2017C Resolution.

Date: ____________________

UNIVERSITY OF VIRGINIA

By:

Title: